<SEC-DOCUMENT>0001171843-26-003312.txt : 20260512
<SEC-HEADER>0001171843-26-003312.hdr.sgml : 20260512
<ACCEPTANCE-DATETIME>20260512163226
ACCESSION NUMBER:		0001171843-26-003312
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		17
FILED AS OF DATE:		20260512
DATE AS OF CHANGE:		20260512

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sono Group N.V.
		CENTRAL INDEX KEY:			0001840416
		STANDARD INDUSTRIAL CLASSIFICATION:	SEMICONDUCTORS & RELATED DEVICES [3674]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-295804
		FILM NUMBER:		26969177

	BUSINESS ADDRESS:	
		STREET 1:		WALDMEISTERSTRASSE 93
		CITY:			MUNICH
		STATE:			2M
		ZIP:			80935
		BUSINESS PHONE:		49-89-45205818

	MAIL ADDRESS:	
		STREET 1:		WALDMEISTERSTRASSE 93
		CITY:			MUNICH
		STATE:			2M
		ZIP:			80935
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>s3_050726.htm
<DESCRIPTION>S-3
<TEXT>
<html>
<head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>As filed with the Securities and Exchange Commission on May 12, 2026</b></p>

<p style="font-size: 10pt; text-align: right; margin: 0pt 0"><b>Registration No. 333-[__]</b></p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-top: black 1pt solid; padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  </table>
<p style="font-size: 18pt; text-align: center; margin: 0pt 0"><b>UNITED STATES</b></p>

<p style="font-size: 18pt; text-align: center; margin: 0pt 0"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Washington, D.C. 20549</b></p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-top: black 1pt solid; padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  </table>
<p style="font-size: 18pt; text-align: center; margin: 0pt 0"><b>FORM S-3</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>REGISTRATION STATEMENT&nbsp;UNDER</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>THE SECURITIES ACT OF 1933</b></p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-top: black 1pt solid; padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  </table>
<p style="font-size: 18pt; text-align: center; margin: 0pt 0"><b>SONO GROUP N.V.</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">(Exact name of registrant as specified in its charter)</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding: 1.5pt 1.25pt; vertical-align: bottom; font-size: 10pt; text-align: center; width: 29%"><font style="font-size: 10pt"><b>The Netherlands</b></font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt; width: 2%">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: bottom; font-size: 10pt; text-align: center; width: 29%"><font style="font-size: 10pt"><b>98-1828632</b></font></td></tr>
  <tr>
    <td style="padding: 1.5pt 1.25pt; vertical-align: bottom"><p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>(State or Other Jurisdiction of</b></p>
    <p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Incorporation or Organization)</b></p></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: bottom"><p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>(I.R.S. Employer</b></p>
    <p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Identification Number)</b></p></td></tr>
  </table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b></b></p>

<p style="margin: 0pt; font-size: 10pt; text-align: center"><font style="background-color: white"><b>Sono Group N.V.</b></font></p>

<p style="font-size: 10pt; text-align: center; margin: 0"><b>4965 Trinidad Drive</b></p>

<p style="margin: 0; font-size: 10pt; text-align: center"><b>Land O&rsquo; Lakes, FL 34639</b></p>

<p style="margin: 0; font-size: 10pt; text-align: center"><b>+1</b> <b>352-502-1191</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant&rsquo;s Principal Executive Offices)</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-top: black 1pt solid; padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  </table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b></b></p>

<p style="font-size: 10pt; text-align: center; margin: 0"><font style="background-color: white"><b>Kevin McGurn</b></font></p>

<p style="font-size: 10pt; text-align: center; margin: 0"><font style="background-color: white"><b>Chief Executive Officer</b></font></p>

<p style="font-size: 10pt; text-align: center; margin: 0"><b>4965 Trinidad Drive</B></P>

<P STYLE="margin: 0; font-size: 10pt; text-align: center"><B>Land O&rsquo; Lakes, FL 34639</B></P>

<P STYLE="margin: 0; font-size: 10pt; text-align: center"><B>+1</B> <B>352-502-1191</b></p>



<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b></b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent For Service)</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-top: black 1pt solid; padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  </table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b><i>Copies to:</i></b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Jeffrey C. Selman</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>DLA Piper LLP (US)</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>555 Mission Street, Suite 2400</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>San Francisco, California 94105</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>(415) 615-6035</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-top: black 1pt solid; padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  </table>
<p style="font-size: 10pt; margin: 0pt 0">Approximate date of commencement of proposed sale to the public: From time to time after this Registration Statement becomes effective.</p>

<p style="font-size: 10pt; margin: 0pt 0">If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. &#9744;</p>

<p style="font-size: 10pt; margin: 0pt 0">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, please check the following box. &#9746;</p>

<p style="font-size: 10pt; margin: 0pt 0">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</p>

<p style="font-size: 10pt; margin: 0pt 0">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</p>

<p style="font-size: 10pt; margin: 0pt 0">If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. &#9744;</p>

<p style="font-size: 10pt; margin: 0pt 0">If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. &#9744;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting company&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 under the Securities Exchange Act of 1934:</p>

<p style="margin: 0pt 0; font-size: 10pt">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt; width: 20%"><font style="font-size: 10pt">Large accelerated filer</font></td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt; width: 20%"><font style="font-size: 10pt">&#9744;</font></td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt; width: 20%"><font style="font-size: 10pt">Accelerated filer</font></td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt; width: 20%"><font style="font-size: 10pt">&#9744;</font></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><font style="font-size: 10pt">Non-accelerated filer</font></td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><font style="font-size: 10pt">&#9746;</font></td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><font style="font-size: 10pt">Smaller reporting company</font></td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><font style="font-size: 10pt">&#9746;</font></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: bottom; font-size: 10pt"><font style="font-size: 10pt">Emerging growth company</font></td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: bottom; font-size: 10pt"><font style="font-size: 10pt">&#9746;</font></td></tr>
  </table>
<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. &#9744;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt"><b>The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment that specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.</b></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>EXPLANATORY NOTE</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">We are filing this registration statement with the Securities and Exchange
Commission (the &ldquo;<b><i>SEC</i></b>&rdquo;) using a &ldquo;shelf&rdquo; registration on Form S-3 (File No. 333-[______]). Under
this registered &ldquo;shelf,&rdquo; in the future, we may, from time to time, sell any combination of the securities described herein,
in one or more offerings, up to a maximum aggregate offering price of $100,000,000. &nbsp;&nbsp;</p>



<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">This registration statement contains a base prospectus, which covers the
offering, issuance and sale by us of the securities identified therein from time to time in one or more offerings with a total value
of up to <font style="background-color: white">$100,000,000</font>. The specific terms of any securities to be offered pursuant to the
base prospectus will be specified in a prospectus supplement to the base prospectus.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0; color: #DE1A1E"><b>The information in this prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</b></p>

<p style="font-size: 10pt; margin: 0pt 0; color: #DE1A1E"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; color: #DE1A1E"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; color: #DE1A1E"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; color: #DE1A1E"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; color: #DE1A1E"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; color: #DE1A1E"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; color: #DE1A1E"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; color: #DE1A1E"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; color: #DE1A1E"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; color: #DE1A1E"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; color: #DE1A1E"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; color: #DE1A1E"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; color: #DE1A1E"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; color: #DE1A1E"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; color: #DE1A1E"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; color: #DE1A1E"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; color: #DE1A1E"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; color: #DE1A1E"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; color: #DE1A1E"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; color: #DE1A1E"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; color: #DE1A1E"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; color: #DE1A1E"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; color: #DE1A1E"><b></b></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; color: #DE1A1E"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0; color: #DE1A1E"><b>PRELIMINARY PROSPECTUS</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center; color: #DE1A1E">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0; color: #DE1A1E"><b>SUBJECT TO COMPLETION, DATED MAY 12, 2026</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center; color: #DE1A1E">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>SONO GROUP N.V.</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Up to <font style="background-color: white">$100,000,000</font></b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Ordinary Shares</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Preferred Shares</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Debt Securities</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Warrants</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Rights</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Units</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"><font style="background-color: white">We may, from time to time in one
or more offerings, offer and sell up to $100.0 million in the aggregate amount of our ordinary shares, nominal value &euro;0.01 per share
(&ldquo;<b><i>Ordinary Shares</i></b>&rdquo;), preferred shares, nominal value &euro;300.00 per share (&ldquo;<b><i>Preferred Shares</i></b>&rdquo;),
debt securities, warrants, rights and/or units, in one or more series or classes and in any combination, together or separately, in one
or more offerings in amounts, at prices and on the terms that we will determine at the time of the offering and which will be set forth
in a prospectus supplement to this prospectus and any related free writing prospectus.</font></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">We may offer these securities separately or together in units. This prospectus provides a general description of the securities we may offer. Each time we sell securities described herein, we will provide the specific terms of the securities offered in one or more supplements to this prospectus. We will provide prospective investors with a supplement to this prospectus that will specify the terms of the securities being offered. We may also authorize one or more free writing prospectuses to be provided to you in connection with these offerings. We may sell these securities to or through underwriters or dealers and also to other purchasers or through agents. We will set forth the names of any underwriters or agents, and any fees, conversions, or discount arrangements, in the applicable prospectus supplement. For additional information on the methods of sale, you should refer to the section entitled &ldquo;Plan of Distribution&rdquo;
in this prospectus and in the applicable prospectus supplement. The prospectus supplement and any related free writing prospectus may add, update or change information contained in this prospectus. Please read carefully this prospectus, the applicable prospectus supplement, any related free writing prospectus, and the documents incorporated by reference before you invest in any of our securities. We may not sell any securities under this prospectus without delivery of the applicable prospectus supplement. <b>This prospectus may not be used to offer or sell any securities unless accompanied by the applicable prospectus supplement.</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">You should read this prospectus and any prospectus supplement or amendment carefully before you invest in our securities. Our Ordinary Shares are listed on the Nasdaq Stock Market LLC (&ldquo;<b><i>Nasdaq</i></b>&rdquo;) and trade on the Nasdaq Capital Market (&ldquo;<b><i>Nasdaq-CM</i></b>&rdquo;) under the symbol &ldquo;SSM&rdquo;. On May 8, 2026, the closing price of our Ordinary Shares was $4.42.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">We are an &ldquo;emerging growth company&rdquo; as defined in Section 2(a) of the Securities Act of 1933, as amended (the &ldquo;<b><i>Securities Act</i></b>&rdquo;), until December 31, 2026, and a &ldquo;smaller reporting company&rdquo; as defined in Item 10(f)(1) of Regulation S-K of the U.S. Securities and Exchange Commission (the &ldquo;<b><i>SEC</i></b>&rdquo;), and are subject to reduced public company reporting requirements. This prospectus complies with the requirements that apply to an issuer that is an emerging growth company and a smaller reporting company.</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; margin: 0pt 0"><font style="font-size: 10pt"><b>Investing in our securities involves a high degree of risk. You should review carefully the risks and uncertainties referenced under the heading &ldquo;<i><a href="#a_001">Risk Factors</a></i>&rdquo; contained in this prospectus beginning on page  6 and any applicable prospectus supplement, and under similar headings in the other documents that are incorporated by reference into this prospectus. You should read the entire prospectus carefully before you make your investment decision.</b></font></p>

<p style="margin: 0pt 0; font-size: 10pt"><font style="font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"><b>Neither the SEC nor any other state securities commission has approved or disapproved of these securities or passed on the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>The date of this prospectus is May 12, 2026</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>TABLE OF CONTENTS</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt; width: 90%"><a href="#a_001">ABOUT THIS PROSPECTUS</a></td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt; width: 10%"><a href="#a_001"><font style="font-size: 10pt">1</font></a></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_002">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_002"><font style="font-size: 10pt">2</font></a></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_003">OUR COMPANY</a></td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_003"><font style="font-size: 10pt">3</font></a></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_004">RISK FACTORS</a></td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_004"><font style="font-size: 10pt">6</font></a></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_005">USE OF PROCEEDS</a></td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_005"><font style="font-size: 10pt">7</font></a></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_006">SECURITIES WE MAY OFFER</a></td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_006"><font style="font-size: 10pt">8</font></a></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_007">DESCRIPTION OF CAPITAL STOCK</a></td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_007"><font style="font-size: 10pt">9</font></a></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_008">DESCRIPTION OF DEBT SECURITIES</a></td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_008"><font style="font-size: 10pt">16</font></a></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_009">DESCRIPTION OF WARRANTS</a></td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_009"><font style="font-size: 10pt">21</font></a></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_010">DESCRIPTION OF RIGHTS</a></td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_010"><font style="font-size: 10pt">23</font></a></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_011">DESCRIPTION OF UNITS</a></td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_011"><font style="font-size: 10pt">24</font></a></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_012">MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS</a></td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_012"><font style="font-size: 10pt">27</font></a></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_013">PLAN OF DISTRIBUTION</a></td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_013"><font style="font-size: 10pt">28</font></a></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_014">LEGAL MATTERS</a></td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_014"><font style="font-size: 10pt">31</font></a></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_015">EXPERTS</a></td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_015"><font style="font-size: 10pt">31</font></a></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_016">WHERE YOU CAN FIND MORE INFORMATION</a></td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_016"><font style="font-size: 10pt">31</font></a></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_017">INFORMATION INCORPORATED BY REFERENCE</a></td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="#a_017"><font style="font-size: 10pt">32</font></a></td></tr>
  </table>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><a name="a_001"></a><b>ABOUT THIS PROSPECTUS</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">This prospectus is part of a registration statement on Form S-3 that
we filed with the Securities and Exchange Commission, or the SEC, under the Securities Act of 1933, as amended (the
&ldquo;<b><i>Securities Act</i></b>&rdquo;), using the &ldquo;shelf&rdquo; registration process for the offering and sale of
securities pursuant to Rule 415 under the Securities Act.&nbsp;Under this shelf registration process, we may, from time to time,
offer and sell any combination of the securities described in this prospectus in one or more offerings, up to a total dollar amount
of <font style="background-color: white">$100.0 </font> million.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">This prospectus provides a general description of the securities we may offer. Each time we sell securities under this prospectus, we will, to the extent required by law, provide a prospectus supplement that will contain specific information about the terms of that offering. We may also authorize one or more free writing prospectuses to be provided to you that may contain material information relating to a particular offering. The prospectus supplement and any related free writing prospectus may also add, update or change information contained in this prospectus or in any documents that we have incorporated by reference into this prospectus. To the extent there is a conflict between any statement contained in this prospectus, any applicable prospectus supplement, any related free writing prospectus or any document incorporated by reference into this prospectus, the statement in the document having the later date modifies or
supersedes the earlier statement.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">The information appearing in this prospectus, any applicable prospectus supplement or any related free writing prospectus is accurate only as of the date on the front of the document, and any information we have incorporated by reference is accurate only as of the date of the document incorporated by reference, regardless of the time of delivery of this prospectus, any applicable prospectus supplement or any related free writing prospectus, or the time of any sale of a security. Our business, financial condition, results of operations and prospects may have changed since those dates.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">You may rely only on the information contained in, or incorporated by reference into, this prospectus and any applicable prospectus supplement, or the information contained in any free writing prospectus we have authorized for use in connection with a specific offering. We have not authorized anyone to provide you with different or additional information. This prospectus is an offer to sell only the securities offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">As permitted by SEC rules and regulations, the registration statement of which this prospectus forms a part includes additional information not contained in this prospectus. This prospectus also contains summaries of certain provisions of the documents described herein, but all summaries are qualified in their entirety by reference to the actual documents. You may read the registration statement and the other reports we file with the SEC, and you may obtain copies of the actual documents summarized herein (if and when filed with the SEC), at the SEC&rsquo;s website or at its offices described in the section of this prospectus titled &ldquo;<i>Where You Can Find More Information</i>.&rdquo;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"><font style="background-color: white">Sono Group N.V. was incorporated on October 23, 2020 (at that
time as a Dutch limited liability company (<i>besloten vennootschap met beperkte aansprakelijkheid</i>) named Sono Motors Finance B.V.),
pursuant to the laws of the Netherlands, as a wholly owned subsidiary of Sono Motors GmbH, a German limited liability company (<i>Gesellschaft
mit beschr&auml;nkter Haftung</i>) (the &ldquo;<b><i>Subsidiary</i></b>&rdquo;). On November 27, 2020, as part of a corporate reorganization,
our then-existing shareholders contributed all of their shares in the Subsidiary to Sono Motors Finance B.V. in exchange for newly issued
common shares of Sono Motors Finance B.V. In addition, the sole issued and outstanding common share in Sono Motors Finance B.V. at that
time, which was held by the Subsidiary, was cancelled (<i>ingetrokken</i>). As a result, the Subsidiary became a wholly owned subsidiary
of Sono Motors Finance B.V. and the then-existing shareholders of the Subsidiary became the shareholders of Sono Motors Finance B.V. Also
on November 27, 2020, Sono Motors Finance B.V. was converted into a public company with limited liability under Dutch law (<i>naamloze
vennootschap</i>), and changed its legal name from Sono Motors Finance B.V. to Sono Group N.V. (the &ldquo;<b><i>Conversion</i></b>&rdquo;).
Following the Conversion, Sono Group N.V. will be referred to as the &ldquo;<b><i>Company</i></b>&rdquo; or &ldquo;<b><i>Sono N.V.</i></b>&rdquo;
Unless the context indicates otherwise, references in this prospectus to the &ldquo;Company,&rdquo; &ldquo;Sono N.V.,&rdquo; &ldquo;we,&rdquo;
&ldquo;us,&rdquo; &ldquo;our&rdquo; and similar terms refer to Sono Group N.V. (f/k/a Sono Motors Finance B.V.).</font></p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"><b>THIS PROSPECTUS MAY NOT BE USED TO OFFER AND SELL SECURITIES UNLESS IT IS ACCOMPANIED BY AN ADDITIONAL PROSPECTUS OR A PROSPECTUS SUPPLEMENT.</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b><a name="a_002"></a>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">This prospectus contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that relate to our current expectations and views of future events. We intend for such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Exchange Act. These forward-looking statements relate to events that involve known and unknown risks, uncertainties and other factors, including those listed under &ldquo;Risk Factors,&rdquo; which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. When used in this prospectus, the words &ldquo;believe,&rdquo; &ldquo;may,&rdquo; &ldquo;might,&rdquo; &ldquo;could,&rdquo; &ldquo;will,&rdquo; &ldquo;estimate,&rdquo;
&ldquo;continue,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;intend,&rdquo; &ldquo;expect,&rdquo; &ldquo;indicate,&rdquo; &ldquo;seek,&rdquo; &ldquo;should,&rdquo; &ldquo;plan,&rdquo; &ldquo;potential,&rdquo; &ldquo;is/are likely to,&rdquo; &ldquo;would,&rdquo; and similar expressions (including the negative of any of the foregoing) are intended to identify forward-looking statements, though not all forward-looking statements contain these identifying words. These forward-looking statements are not historical facts, and are based on current expectations, estimates and projections about our industry, management&rsquo;s beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions, estimates and uncertainties that are difficult to predict. These forward-looking statements include,
without limitation, statements about the following matters: </p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 60.5pt"></td><td style="width: 18pt"><font style="font-family: Symbol">&middot;</font></td><td>our ability to comply with the continuing standards of the Nasdaq-CM;</td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 60.5pt"></td><td style="width: 18pt"><font style="font-family: Symbol">&middot;</font></td><td>our strategies, plan, objectives and goals&#894;</td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 60.5pt"></td><td style="width: 18pt"><font style="font-family: Symbol">&middot;</font></td><td>our expectations regarding the development of our industry, market size and the regulatory and competitive environment in which we operate&#894;</td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 60.5pt"></td><td style="width: 18pt"><font style="font-family: Symbol">&middot;</font></td><td>our expectations and beliefs regarding accounting and tax matters;</td></tr></table>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Although we believe that the expectations reflected in these forward-looking statements are reasonable as of the date of this prospectus, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, those summarized below:</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 60.5pt"></td><td style="width: 18pt"><font style="font-family: Symbol">&middot;</font></td><td>our ability to maintain relationships with lenders and other third parties&#894;</td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 60.5pt"></td><td style="width: 18pt"><font style="font-family: Symbol">&middot;</font></td><td>our ability to raise any additional financing that may be required to continue as a going concern;</td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 60.5pt"></td><td style="width: 18pt"><font style="font-family: Symbol">&middot;</font></td><td>our future business and financial performance, including our ability to turn profitable, scale our operations and build a well-recognized and respected brand cost-effectively&#894;</td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 60.5pt"></td><td style="width: 18pt"><font style="font-family: Symbol">&middot;</font></td><td>our ability to develop and maintain relationships with key business partners who are crucial for our operations&#894;</td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 60.5pt"></td><td style="width: 18pt"><font style="font-family: Symbol">&middot;</font></td><td>our exposure to various liability risks resulting from past or existing employment relationships and labor laws&#894; and</td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 60.5pt"></td><td style="width: 18pt"><font style="font-family: Symbol">&middot;</font></td><td>changes in general political, economic and competitive conditions and specific market conditions.</td></tr></table>

<p style="font-size: 10pt; margin: 0pt 0 0pt 78.5pt">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">For additional information regarding known material factors that could cause our actual results to differ from our projected results, please read the descriptions under the heading &ldquo;Risk Factors&rdquo; contained in (1) Part I, Item 1A. of our 2025 Annual Report, (2) our other reports and registration statements filed from time to time with the SEC, and (3) other public announcements we make from time to time. Given these uncertainties, you should not place undue reliance on these forward-looking statements, which speak only as of the date of this prospectus. Except as required by law, we assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future. </p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">All forward-looking statements included herein attributable to Sono N.V. or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. </p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<div style="padding: 10pt; border: Black 1pt solid">

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b><a name="a_003"></a>OUR COMPANY</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"><i>This summary highlights selected information appearing in this prospectus. Because it is a summary, it may not contain all of the information that may be important to you. To understand this offering fully, you should read this entire prospectus carefully, including the information set forth in the sections entitled &ldquo;Risk Factors,&rdquo; before making an investment decision.</i></p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>The Company</b></p>

<p style="margin: 0pt 0; font-size: 10pt">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Sono Group N.V. (&ldquo;<b><i>Sono
N.V.</i></b>&rdquo;) is a public company with limited liability (<i>naamloze vennootschap</i>) duly incorporated and validly
existing under the laws of the Netherlands, having its registered office at 4965 Trinidad Drive, Land O&rsquo; Lakes, FL 34639. Our
telephone number is +1 352-502-1191, and our website address is https://ir.sonomotors.com/. During the year ended December 31, 2025,
our business consisted of our legacy solar operations conducted through the Subsidiary, as further described below under the
subheading &ldquo;<i>Overview</i>&rdquo; in this prospectus and in our 2025 Annual Report. As of December 31, 2025, we operated our
legacy solar business as a single business segment, managing our financing, research and development and product commercialization
on a consolidated basis. Subsequent to December 31, 2025, Sono N.V. adopted the digital asset treasury strategy and initiated an
exit from our legacy solar operations. As a result, we anticipate that future operating losses will be materially reduced compared
to historical periods, as the primary source of our historical cash consumption (the solar operations) has been eliminated. Our
long-term financial performance will depend on the successful implementation of the digital asset treasury strategy, the cash flows
generated through our digital asset holdings, and efficient management of our streamlined holding company cost structure. There can
be no assurance that the digital asset treasury strategy will generate the anticipated returns or that additional financing will not
be required. See the discussion in our 2025 Annual Report.</p>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">Sono N.V. was incorporated on October 23, 2020 <font style="background-color: white">(at that time
as a Dutch limited liability company (<i>besloten vennootschap met beperkte aansprakelijkheid</i>) named Sono Motors Finance B.V.)</font>,
pursuant to the laws of the Netherlands, as a wholly owned-subsidiary of Sono Motors GmbH<font style="background-color: white">, </font>a
German limited liability company (<i>Gesellschaft mit beschr</i>&auml;<i>nkter Haftung</i>) (the &ldquo;<b><i>Subsidiary</i></b>&rdquo;).
As part of the corporate reorganization that was completed on November 27, 2020, our then-existing shareholders contributed all of their
shares in the Subsidiary to Sono Motors Finance B.V. in exchange for newly issued common shares of Sono Motors Finance B.V. In addition,
the sole issued and outstanding common share in Sono Motors Finance B.V. at that time, which was held by the Subsidiary, was cancelled
(<i>ingetrokken</i>). As a result, the Subsidiary became a wholly owned subsidiary of Sono Motors Finance B.V. and the then-existing shareholders
of the Subsidiary became the shareholders of Sono Motors Finance B.V. Also on November 27, 2020, Sono Motors Finance B.V. was converted
into a public company with limited liability under Dutch law (<i>naamloze vennootschap</i>), and changed its legal name from Sono Motors
Finance B.V. to Sono Group N.V.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">On September 5, 2025, the Sono N.V. Ordinary Shares commenced trading on the Nasdaq-CM under the
ticker symbol &ldquo;SSM.&rdquo; The Sono N.V. high voting shares (&ldquo;<b><i>High Voting Shares</i></b>&rdquo;) and the Sono N.V. Preferred
Shares are not currently listed for trading on any securities exchange or included in any automatic quotation system.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">Additional information regarding Sono N.V. is
contained in the documents incorporated by reference into this prospectus and the other documents that we file with the SEC. See the
section entitled &ldquo;<i>Where You Can Find More Information</i>&rdquo; beginning on page 31 of this prospectus. The information
contained in, or that can be accessed through, Sono N.V.&rsquo;s website is not part of this prospectus or incorporated by reference
herein.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Overview </b></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0; background-color: white"><b><i>Digital Asset Treasury</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in; background-color: white">Subsequent to December 31, 2025, on March&nbsp;14, 2026, the Management Board, with the approval of the Supervisory Board, ratified Sono N.V.&rsquo;s entry into the ISDA Master Agreement, the Schedule and the Credit Support Annex (in each case, as defined below) and approved the adoption of a digital asset treasury strategy and digital asset treasury policy and the purchase by Sono N.V. of Bitcoin (&ldquo;<b><i>Bitcoin</i></b>&rdquo; or &ldquo;<b><i>BTC</i></b>&rdquo;) and other digital assets in connection therewith. Under Sono N.V.&rsquo;s digital asset treasury strategy, the principal holding in Sono N.V.&rsquo;s treasury reserve on its balance sheet will be allocated to digital assets, principally Bitcoin, by applying a covered-call yield strategy. Sono N.V. may use available liquidity, including proceeds from previously disclosed financing arrangements, to purchase Bitcoin and
other digital assets, subject to applicable law.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in; background-color: white">In connection with the digital
asset treasury strategy, on March 10, 2026, Sono N.V. entered into an International Swaps and Derivatives Association, Inc. (&ldquo;<b><i>ISDA</i></b>&rdquo;)
2002 ISDA Master Agreement, (the &ldquo;<b><i>ISDA Master Agreement</i></b>&rdquo;) with Blockchain.com (BVI) II Limited, a business
company incorporated under the laws of the British Virgin Islands (&ldquo;<b><i>Blockchain.com</i></b>&rdquo;), facilitating Sono N.V.
to enter into derivative and/or hedging transactions (collectively, the &ldquo;<b><i>Transactions</i></b>&rdquo;) to manage the risk
associated with the digital asset treasury strategy. The derivative and hedging transactions will be governed by the ISDA Master Agreement,
including the related Schedule to the ISDA Master Agreement executed by Sono N.V. and Blockchain.com on March 10, 2026 (the &ldquo;<b><i>Schedule</i></b>&rdquo;).
The structure of the Transactions may include forwards, swaps, futures, options or other derivatives transactions in respect of digital
assets. Certain events of default will apply to the Transactions under the ISDA Master Agreement and Schedule, including, but not limited
to, failure to pay or deliver, breach of the agreement, credit support default, cross-defaults and misrepresentation. In addition, in
connection with the ISDA Master Agreement, Sono N.V. and Blockchain.com entered into a Credit Support Annex to the Schedule to the ISDA
Master Agreement, dated as of March 10, 2026 (the &ldquo;<b><i>Credit Support Annex</i></b>&rdquo;), which sets forth the terms and conditions
upon which Sono N.V. will be required to deliver additional collateral to Blockchain.com (and Blockchain.com will be required to return
collateral to Sono N.V.) depending upon the mark to market exposure under the ISDA Master Agreement and the value of the collateral.
The ISDA Master Agreement, the Schedule and the Credit Support Annex are governed by the laws of England and Wales.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">&nbsp;</p>

</div>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in; background-color: white"></p>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<div style="padding: 10pt; border: Black 1pt solid">

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in; background-color: white">Under the strategy, we intend to use the net proceeds from our recent financings to purchase or otherwise acquire Bitcoin and other digital assets and to establish digital asset treasury operations.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0; background-color: white"><b><i>Overview of Legacy Solar Operations through Sono Motors GmbH</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in; background-color: white">For the year ended December 31, 2025, we were a technology company focused on the development and
commercialization of solar integration solutions for commercial vehicles, as further described in our 2025 Annual Report. After terminating
our Sion passenger car program due to a lack of available funding at the end of February 2023, we pivoted our business model to focus
exclusively on retrofitting and integrating our proprietary solar technology onto third party vehicles with an initial focus on our Solar
Bus Kit.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">In 2024, we expanded our product portfolio beyond the Solar Bus Kit to include similar solar integration solutions for additional commercial vehicle categories, including trucks, vans, RVs, refrigerated trailers, coach buses and panel vans. This strategic expansion was intended to align with the growing demand for sustainable energy solutions across multiple transportation sectors, allowing us to address a broader range of manufacturers and fleet operators looking to reduce fuel costs and emissions.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in; background-color: white">Expanding beyond our low-voltage retrofit solar solutions, in the beginning of 2025, we increased our offerings to also include high-voltage solar solutions, leveraging our proprietary solar charge controller, also known as the MCU. This advanced technology enables seamless solar energy integration into the high voltage system of commercial vehicles with larger energy demands. Additionally, we adjusted our distribution strategy and increased our focus on direct collaborations with original equipment manufacturers (&ldquo;<b><i>OEMs</i></b>&rdquo;) and certain partners including cooling unit and battery manufacturers. Building on a series of pilot projects, we aimed to collaborate with OEMs and certain partners to integrate our complete solar solutions and standalone solar products into vehicle structures, and work toward collaborations with several OEMs for specific vehicles, which
could enable customers to select solar-powered options at the time of vehicle or trailer purchase. This approach was designed to enhance accessibility and scalability while streamlining adoption for commercial fleets.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in; background-color: white">Historically, Sono N.V. has incurred recurring operating losses and negative cash flows from operations since inception, primarily attributable to the operations of the Subsidiary; however, in 2024, Sono N.V. recorded an operating profit due to the impact of revaluation gains following the reconsolidation of Sono Motors GmbH after the termination of the Self-Administration Proceedings in early 2024. This one-time accounting impact significantly influenced our reported net income for the year ended December 31, 2024. In 2025, we recorded an operating loss of &euro;7.7 million, although our net income for the same period was positive and amounted to &euro;4.0 million, primarily due to recorded gains in the fair value of convertible debentures carried at fair value.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0; background-color: white"><b><i>Exit from Legacy Solar Operations through Sono Motors GmbH</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in; background-color: white">On March 14, 2026, the Management
Board, with approval of our Supervisory Board resolved to terminate all current and future funding commitments to the Subsidiary and
to exit the legacy solar operations conducted through the Subsidiary, with immediate effect. Sono N.V.&rsquo;s decision was driven by
the Subsidiary&rsquo;s historical lack of profitability, which has resulted in Sono N.V. having to continuously provide funding to the
Subsidiary, and thus incur losses, and a determination by the Management Board that there was not a clear path for the Subsidiary to
achieve profitability in a reasonably desirable timeframe and thus, avoid future losses by Sono N.V. This decision was made in conjunction
with the decision on March 14, 2026 by the Management Board, with the approval of the Supervisory Board, to adopt the digital asset treasury
strategy. The digital asset treasury strategy is projected to generate cash flow for Sono N.V. in the first year of its execution. Sono
N.V. is also exploring other strategic alternatives to maximize shareholder value.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in; background-color: white">Sono N.V. is currently unable to make a good faith estimate of the total costs and charges, if any, that may be incurred in connection with the cessation of funding to the Subsidiary and the exit from our legacy solar business. The determination of any such costs is subject to significant uncertainties, including, among other things, the timing, scope and manner of any actions undertaken with respect to the Subsidiary following the cessation of funding, as well as the extent of any obligations of Sono&nbsp;N.V. in connection therewith. Potential costs, if any, may include legal, advisory and other professional fees and expenses associated with activities relating to the Subsidiary. Any such costs and expenditures, if incurred, are expected to be reduced by cash flow to Sono N.V. from the digital asset treasury strategy. Sono N.V. will disclose material costs, charges and cash expenditures
to be borne directly by Sono N.V., if and when such amounts become reasonably estimable.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

</div>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0; background-color: white"></p>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; background-color: white">&nbsp;</p>

<div style="padding: 10pt; border: Black 1pt solid">

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; background-color: white">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; background-color: white"><b>Corporate Information</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; background-color: white"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">We were incorporated
pursuant to the laws of the Netherlands as Sono Motors Finance B.V. on October 23, 2020 as a wholly-owned subsidiary of Sono Motors
GmbH. As part of the corporate reorganization that was completed on November 27, 2020, our then-existing shareholders contributed
all of their shares in Sono Motors GmbH to Sono Motors Finance B.V. in exchange for newly issued common shares of Sono Motors
Finance B.V. In addition, the sole issued and outstanding common share in Sono Motors Finance B.V. at that time, which was held by
Sono Motors GmbH, was cancelled (<i>ingetrokken</i>). As a result, Sono Motors GmbH became a wholly-owned subsidiary of Sono Motors
Finance B.V. and the then-existing shareholders of Sono Motors GmbH became the shareholders of Sono Motors Finance B.V. Also on
November 27, 2020, Sono Motors Finance B.V. was converted into a public company with limited liability under Dutch law (<i>naamloze
vennootschap</i>), and changed its legal name from Sono Motors Finance B.V. to Sono Group N.V. The corporate office of Sono Group
N.V. is located at 4965 Trinidad Drive, Land O&rsquo; Lakes, FL 34639 and its telephone number is +1 352-502-1191.</p>



<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0; background-color: white"><b>Implications of Being an Emerging Growth Company and a Smaller Reporting Company</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in; background-color: white">We are an emerging growth
company as defined in the Jumpstart Our Business Startups Act of 2012 (the &ldquo;<b><i>JOBS</i> <i>Act</i></b>&rdquo;). We will remain
an emerging growth company under the JOBS Act until the earliest of (i) the last day of our first fiscal year (a)&nbsp;following the
fifth anniversary of our IPO (November 17, 2026), (b) in which we have total annual gross revenue of at least $1.235 billion, or (c)
in which we are deemed to be a &ldquo;large accelerated filer&rdquo; under the rules of the SEC with at least $700.0 million of outstanding
securities held by non-affiliates; and (ii) the date on which we have issued more than $1.00 billion in non-convertible debt securities
during the prior three-year period.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in; background-color: white">We are also a &ldquo;smaller reporting company&rdquo; as defined in Item 10(f)(1) of Regulation S-K of the SEC. We may continue to be a smaller reporting company even after we are no longer an emerging growth company. We may take advantage of certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage of these scaled disclosures for so long as the market value of our voting and non-voting Ordinary Shares held by non-affiliates is less than $250.0 million measured on the last business day of our second fiscal quarter, or our annual revenue is less than $100.0 million during the most recently completed fiscal year and the market value of our voting and non-voting Ordinary Shares held by non-affiliates is less than $700.0 million measured on the last business day of our second fiscal quarter.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in; background-color: white"><font style="background-color: white">As
a result, the information in this prospectus and that we provide to our investors in the future may be different than what you might
receive from other public reporting companies or what has been shared/disclosed by Sono N.V. previously.</font></p>

<p style="font-size: 10pt; margin: 0pt 0"><b>&nbsp;</b></p>

</div>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b><a name="a_004"></a>RISK FACTORS</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">An investment in our securities involves a high degree of risk. Before investing in our securities, you should carefully consider the risk factors incorporated by reference into this prospectus, including any reports we file with the SEC after the date of this prospectus that are incorporated herein by reference, as well as the risk factors and other information contained in any applicable prospectus supplement and any applicable free writing prospectus we file with the SEC. The market price of our securities could decline if one or more of these risks or uncertainties actually occur, causing you to lose all or part of your investment in our securities. See &ldquo;<i>Where You Can Find More Information</i>&rdquo; and &ldquo;<i>Information Incorporated by Reference</i>&rdquo; elsewhere in this prospectus.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b><a name="a_005"></a>USE OF PROCEEDS</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">We will retain broad discretion over the use of the net proceeds from the sale of our securities offered hereby. Except as described in any prospectus supplement or any related free writing prospectus that we may authorize to be provided to you, we currently intend to use the net proceeds from the sale of our securities offered hereby for working capital and general corporate purposes. We may invest the net proceeds in a variety of capital preservation instruments, including purchasing or otherwise acquiring Bitcoin and other digital assets and establishing digital asset treasury operations, or may hold such proceeds as cash, until they are used for their stated purpose. We have not determined the amount of net proceeds to be used specifically for such purposes. As a result, management will retain broad discretion over the allocation of net proceeds. We will set forth in the applicable prospectus supplement or free writing prospectus
our intended use for the net proceeds received from the sale of any securities sold pursuant to the prospectus supplement or free writing prospectus. </p>

<p style="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"></p>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b><a name="a_006"></a>SECURITIES WE MAY OFFER</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">This prospectus contains summary descriptions of the securities we may offer from time to time. These summary descriptions are not meant to be complete descriptions of each security. The particular terms of any security will be described in the applicable prospectus supplement. This prospectus provides you with a general description of the securities we may offer. Each time we sell securities described herein, we will provide prospective investors with a supplement to this prospectus that will contain specific information about the terms of that offering, including the specific amounts, prices and terms of the securities offered. </p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">We may offer up to <font style="background-color: white">$100.0 </font>
million of securities under this prospectus. The prices and terms of any offering will be determined by market conditions at the
time of the offering. We may sell the securities to or through underwriters, dealers or agents, directly to purchasers or through a
combination of any of these methods of sale or as otherwise set forth below under &ldquo;<i>Plan of Distribution</i>.&rdquo; We, as
well as any agents acting on our behalf, reserve the sole right to accept and to reject in whole or in part any proposed purchase of
securities. This prospectus provides a general description of the securities we may offer. Each time we offer securities under this
prospectus, we will, to the extent required by law, provide offerees with a prospectus supplement that will describe the specific
amounts, prices and other important terms of the securities being offered. The prospectus supplement may also add, update or change
information in this prospectus. For more information, see &ldquo;<i>About this Prospectus</i>.&rdquo;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"></p>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b><a name="a_007"></a>DESCRIPTION OF CAPITAL STOCK</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"><font style="background-color: white">The following summary of the general terms and provisions
of our Ordinary Shares does not purport to be complete and is subject to and qualified in its entirety by reference to our articles of
association (as amended from time to time, our &ldquo;<b><i>Articles of Association</i></b>&rdquo;) and applicable Dutch law provisions.</font></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Ordinary Shares</b></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Our Ordinary Shares are issued in registered form. Our authorized
share capital is &euro;1,630,300, divided into 120,000,000&nbsp;ordinary shares, each with a nominal value of &euro;0.01, 40,000
high voting shares, each with a nominal value of &euro;0.25 and 1,401 preferred shares, each with a nominal value of &euro;300.
&nbsp;&nbsp;</p>



<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"><font style="background-color: white">On December 23, 2024, the Company
amended its Articles of Association to implement a reverse share split (the &ldquo;<b><i>Reverse Share Split</i></b>&rdquo;) of the Company&rsquo;s
Ordinary Shares and High Voting Shares at a ratio of 1-for-75. The Reverse Share Split took market effect on January 6, 2025, following
confirmation from the Financial Industry Regulatory Authority that it had received and reviewed all necessary documentation to process
the Reverse Share Split and was perfected pursuant to an amendment of the Company's Articles of Association on September 9, 2025.</font></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">I<font style="background-color: white">n addition, at Sono N.V.'s extraordinary general meeting
held on January 31, 2024, the shareholders approved a proposal to increase (in one or a series of amendments) our authorized share capital
in order to cover conversions under the convertible debentures held by YA II PN, Ltd. (&ldquo;<b><i>Yorkville</i></b>&rdquo;). At the
Company&rsquo;s extraordinary meeting of shareholders on November 7, 2024 (the &ldquo;<b><i>November 2024 EGM</i></b>&rdquo;), the shareholders
approved a proposal to inter alia (i) increase (in one or a series of amendments) our authorised share capital in order to cover the increase
of our authorised share capital under an authority of the management board to issue Ordinary Shares or grant rights to subscribe for Ordinary
Shares, and (ii) introduce a new class of preferred shares, with a nominal value of &euro;300.00 per preferred share, with each preferred
share being convertible into 30,000 Ordinary Shares, which changes were implemented by amendment to the Company's Articles of Association
on September 9, 2025.</font></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Under Dutch law, our authorized share capital is the maximum capital that we may issue without amending our Articles of Association.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Preferred Shares</b></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">We are authorized to issue 1,401 preferred shares, nominal value &euro;300.00 per share (the &ldquo;<b><i>Preferred
Shares</i></b>&rdquo;), all of which are issued, outstanding and held by Yorkville. The Preferred Shares were created as a new class of
shares approved by shareholders at the November 2024 EGM and were issued on September 9, 2025 solely in exchange for the surrender and
cancellation of all outstanding convertible debentures held by Yorkville pursuant to an exchange agreement dated December 30, 2024, as
amended (the &ldquo;<b><i>Exchange Agreement</i></b>&rdquo;). The total debt converted was approximately $42.1 million (inclusive of accrued
interest).</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Each Preferred Share is convertible into 30,000 Ordinary Shares, subject to the terms of the Exchange Agreement. The effective conversion price (the &ldquo;<b><i>Effective Conversion Price</i></b>&rdquo;) equals 85% of the lowest daily volume weighted average price of the Ordinary Shares during the 10 trading days immediately preceding the date of notice of conversion, subject to a floor price equal to $4.00 per Ordinary Share from the closing date until six months after the Nasdaq listing date, and $1.00 per Ordinary Share thereafter. Upon conversion, Yorkville must surrender the Preferred Shares being converted plus automatically sell back to the Company (for no consideration) additional Preferred Shares such that the total number of Preferred Shares surrendered and subject to the conversion will be equal to (a) the total number of Ordinary Shares issuable upon such conversion, multiplied by (b) the Effective Conversion Price,
divided by (c) 30,000.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Each Preferred Share carries 30,000 votes at any general meeting of shareholders. However, Yorkville is subject to a contractually agreed voting blocker equal to 4.99% of the combined voting power in the share capital of Sono N.V. In addition, Yorkville may not convert Preferred Shares if, after giving effect to such conversion, Yorkville (together with its affiliates) would beneficially own more than 4.99% of the number or voting power of the outstanding Ordinary Shares. This beneficial ownership limitation may be waived by Yorkville upon not less than 65 days&rsquo; prior notice to the Company.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Issuance of Shares</b></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"><font style="background-color: white">Under Dutch law and our Articles of Association, the issuance
of shares and/or the granting of rights to subscribe for shares requires a resolution of the general meeting. Another corporate body,
such as the management board or the supervisory board, may be designated as the authorized body to do so by the general meeting. Such
designation can be granted for a period not exceeding five years. A resolution of the general meeting to issue shares, grant rights to
subscribe for shares or designate another corporate body of the Company to do the same requires the approval of the relevant class meeting
whose rights are prejudiced. A designation of another corporate body is irrevocable unless stipulated differently. Our supervisory board
has been authorized to issue shares and/or rights to subscribe for shares, for a period of maximum eighteen months after an annual general
meeting of Sono N.V. held on August 13, 2025 (the &ldquo;<b><i>August 2025 AGM</i></b></font>&rdquo;)<font style="background-color: white">.</font></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt"><b>Preemptive Rights</b></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Under Dutch law and our Articles of Association, in the event of an issuance
of shares of a certain class, each shareholder will have a pro rata preemptive right in proportion to the aggregate nominal value of
the shares of such class held by such holder (with the exception of shares to be issued to employees or shares issued against a contribution
other than in cash or pursuant to the exercise of a previously acquired right to subscribe for shares). Under our Articles of Association,
the preemptive rights in respect of newly issued shares may be restricted or excluded by a resolution of the general meeting. Another
corporate body, such as the management board or the supervisory board, may restrict or exclude the preemptive rights in respect of newly
issued shares if it has been designated as the authorized body to do so by the general meeting. Such designation can be granted for a
period not exceeding five years. A resolution of the general meeting to restrict or exclude the preemptive rights or to designate another
corporate body as the authorized body to do so requires a majority of not less than two-thirds of the votes cast, if less than one-half
of our issued share capital is represented at the meeting. Our supervisory board has been authorized to restrict or exclude preemptive
rights, for a period of maximum eighteen months after the August 2025 AGM.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Conversion of Shares</b></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Under our Articles of Association, and subject to certain requirements,
each issued high voting share can be converted into twenty-five Ordinary Shares. Ordinary shares cannot be converted into High Voting
Shares. Upon the issuance of the Preferred Shares, and subject to certain requirements, each issued preferred share can be converted
into 30,000 Ordinary Shares. Ordinary shares cannot be converted into Preferred Shares.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Transfer of Ordinary Shares</b></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"><font style="background-color: white">Except as otherwise provided or allowed by Dutch law, the
issue or transfer of a share shall require a deed to that effect and, in the case of a transfer and unless the Company itself is a party
to the transaction, acknowledgement of the transfer by the Company. The acknowledgement shall be set out in the deed or shall be made
in such other manner as prescribed by law. For as long as any Ordinary Shares are admitted to trading on the New York Stock Exchange,
the Nasdaq Stock Market or on any other regulated stock exchange operating in the United States of America, the laws of the State of New
York shall apply to the property law aspects of the Ordinary Shares reflected in the register administered by the relevant transfer agent.</font></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Repurchase of Shares</b></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"><font style="background-color: white">An acquisition of Ordinary Shares for a consideration must
be authorized by our general meeting. Such authorization may be granted for a maximum period of 18 months and must specify the number
of Ordinary Shares that may be acquired, the manner in which Ordinary Shares may be acquired and the price limits within which Ordinary
Shares may be acquired. The actual acquisition may only be effected by a resolution of our management board, with the approval of our
supervisory board. No authorization of the general meeting of shareholders is required if fully paid Ordinary Shares are acquired by us
with the intention of transferring such Ordinary Shares to our employees under an applicable employee stock purchase plan or if shares
are acquired for no consideration.</font></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Requirements for Amendments to our Articles of Association</b></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">An amendment of our Articles of Association would require a resolution of the general meeting upon proposal by the management board with the approval of our supervisory board.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Limitations on the Right to Own Ordinary Shares</b></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Our Articles of Association contain no limitation on the rights to own
our shares provided that we cannot hold more than fifty per cent of the nominal value of our own share capital. Pursuant to our Articles
of Association, for as long as any of our Ordinary Shares are admitted to trading on any regulated stock exchange operating in the United
States of America, the laws of the State of New York shall apply to the property law aspects of our Ordinary Shares reflected in the
register administered by the relevant transfer agent. However, certain other aspects relating to our Ordinary Shares remain subject to
Dutch law and Dutch law continues to determine, for example, how new shares are issued.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt"><b>Shareholders&rsquo; Meetings</b></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">General meetings may be held in Amsterdam, Arnhem, Assen, The Hague, Haarlem, &lsquo;s-Hertogenbosch, Groningen, Leeuwarden, Lelystad, Maastricht, Middelburg, Rotterdam, Schiphol (Haarlemmermeer), Utrecht or Zwolle, all in the Netherlands. The annual general meeting shall be held within six months of the end of each financial year. Additional extraordinary general meetings may also be held, whenever considered appropriate by the management board or the supervisory board and shall be held within three months after our management board has considered it to be likely that our equity has decreased to an amount equal to or lower than half of its paid-in and called-up share capital, in order to discuss the measures to be taken if so required.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Pursuant to Dutch law, one or more shareholders or others with meeting rights under Dutch law that jointly represent at least one-tenth of the issued share capital may request us to convene a general meeting, setting out in detail the matters to be discussed. If we have not taken the steps necessary to ensure that such meeting can be held within six weeks after the request, the requesting party/parties may, on their application, be authorized by the competent Dutch court in preliminary relief proceedings to convene a general meeting. The court shall disallow the application if it does not appear that the applicants have previously requested our management board and our supervisory board to convene a general meeting and neither our management board nor our supervisory board has taken the necessary steps so that the general meeting could be held within six weeks after the request.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">General meetings must be convened by an announcement published in a Dutch
daily newspaper with national distribution. The notice must state the agenda, the time and place of the meeting, the record date (if
any), the procedure for participating in the general meeting by proxy, as well as other information as required by Dutch law. The notice
must be given at least 15 days prior to the day of the meeting. The agenda for the annual general meeting shall include &ndash; if possible
and applicable &ndash; among other things, the adoption of the annual accounts, appropriation of our profits and proposals relating to
the composition of the management board and supervisory board, including the filling of any vacancies in such bodies. In addition, the
agenda shall include such items as have been included therein by the management board or the supervisory board. The agenda shall also
include such items requested by one or more shareholders, or others with meeting rights under Dutch law, representing at least 3% of
the issued share capital. Requests must be made in writing or by electronic means and received by us at least 60 days before the day
of the meeting. No resolutions shall be adopted on items other than those that have been included in the agenda.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">In accordance with the Dutch Corporate Governance Code (the &ldquo;<b>DCGC</b>&rdquo;) and our Articles of Association, shareholders having the right to put an item on the agenda under the rules described above shall exercise such right only after consulting the management board in that respect. If one or more shareholders intend to request that an item be put on the agenda that may result in a change in the company&rsquo;s strategy (for example, the removal of management board members or supervisory board members), the management board must be given the opportunity to invoke a reasonable period to respond to such intention. Such period shall not exceed 180 days (or such other period as may be stipulated for such purpose by Dutch law and/or the DCGC from time to time). If invoked, the management board must use such response period for further deliberation and constructive consultation, in any event with the shareholders(s) concerned,
and shall explore the alternatives. At the end of the response time, the management board shall report on this consultation and the exploration of alternatives to the general meeting. This shall be supervised by our supervisory board. The response period may be invoked only once for any given general meeting and shall not apply: (a) in respect of a matter for which a response period or a statutory cooling-off period (as discussed below) has been previously invoked; or (b) if a shareholder holds at least 75% of the company&rsquo;s issued share capital as a consequence of a successful public bid. The response period may also be invoked in response to shareholders or others with meeting rights under Dutch law requesting that a general meeting be convened, as described above.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Moreover, our management board, with the approval of our supervisory board, can invoke a cooling-off period of up to 250 days when shareholders, using their right to have items added to the agenda for a general meeting or their right to request a general meeting, propose an agenda item for our general meeting to dismiss, suspend or appoint one or more management board members or supervisory board members (or to amend any provision in our Articles of Association dealing with those matters) or when a public offer for our company is made or announced without our support, provided, in each case, that our management board believes that such proposal or offer materially conflicts with the interests of our company and its business. During a cooling-off period, our general meeting cannot dismiss, suspend or appoint management board members and supervisory board members (or amend the provisions in our Articles of Association dealing
with those matters) except at the proposal of our management board. During a cooling-off period, our management board must gather all relevant information necessary for a careful decision-making process and at least consult with shareholders representing 3% or more of our issued share capital at the time the cooling-off period was invoked, as well as with our Dutch works council (if we or, under certain circumstances, any of our subsidiaries would have one). Formal statements expressed by these stakeholders during such consultations must be published on our website to the extent these stakeholders have approved that publication. Ultimately one week following the last day of the cooling-off period, our management board must publish a report in respect of its policy and conduct of affairs during the cooling-off period on our website. This report must remain available for inspection by shareholders and others with meeting rights under Dutch law at our office and must be tabled for discussion
at the next general meeting. Shareholders representing at least 3% of our issued share capital may request the Enterprise Chamber of the Amsterdam Court of Appeal, or the Enterprise Chamber (Ondernemingskamer), for early termination of the cooling-off period. The Enterprise Chamber must rule in favor of the request if the shareholders can demonstrate that:</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt"></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>our management board, in light of the circumstances at hand when the cooling-off period was invoked, could not reasonably have concluded that the relevant proposal or hostile offer constituted a material conflict with the interests of our company and its business;</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>our management board cannot reasonably believe that a continuation of the cooling-off period would contribute to careful policy-making; or</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>other defensive measures, having the same purpose, nature and scope as the cooling-off period, have been activated during the cooling-off period and have not since been terminated or suspended within a reasonable period at the relevant shareholders&rsquo; request (i.e., no &lsquo;stacking&rsquo; of defensive measures).</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">The general meeting is presided over by the chairperson of the supervisory board. If no chairperson has been elected or if he or she is not present at the meeting, the general meeting shall be presided over by another supervisory board member present at the meeting. If no supervisory board member is present, the meeting shall be presided over by our CEO. If the CEO is not present at the meeting, the general meeting shall be presided over by another management board member present at the meeting. If no management board member is present at the meeting, the general meeting shall be presided over by any other person appointed by the general meeting. In each case, the person who should chair the general meeting pursuant to the rules described above may appoint another person to chair the general meeting instead. Management board members and supervisory board members may always attend a general meeting. In these meetings, they have
an advisory vote. The chairman of the meeting may decide, at his or her discretion, to admit other persons to the meeting.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">All shareholders and others with meeting rights under Dutch law are authorized to attend the general meeting, to address the meeting and, insofar as they have such right, to vote pro rata to the total nominal value of his or her shareholding. Shareholders may exercise these rights, if they are the holders of shares on the record date, if any, as required by Dutch law, which is currently the 28th day before the day of the general meeting. Under our Articles of Association, shareholders and others with meeting rights under Dutch law must notify us in writing or by electronic means of their identity and intention to attend the general meeting. This notice must be received by us ultimately on the seventh day prior to the general meeting, unless indicated otherwise when such meeting is convened.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"><font style="background-color: white">Each ordinary share confers the
right on the holder to cast one vote at the general meeting and each high voting share confers the right on the holder to cast twenty-five
votes at the general meeting. Each preferred share confers the right to cast 30,000 votes at a general meeting. Shareholders may vote
by proxy. No votes may be cast at a general meeting on shares held by us or our subsidiaries or on shares for which we or our subsidiaries
hold depository receipts. Nonetheless, the holders of a right of usufruct (<i>vruchtgebruik</i>) and the holders of a right of pledge
(<i>pandrecht</i>) in respect of shares held by us or our subsidiaries in our share capital are not excluded from the right to vote on
such shares, if the right of usufruct (<i>vruchtgebruik</i>) or the right of pledge (<i>pandrecht</i>) was granted prior to the time
such shares were acquired by us or any of our subsidiaries. Neither we nor any of our subsidiaries may cast votes in respect of a share
on which we or such subsidiary holds a right of usufruct (<i>vruchtgebruik</i>) or a right of pledge (<i>pandrecht</i>). Shares which
are not entitled to voting rights pursuant to the preceding sentences will not be taken into account for the purpose of determining the
number of shareholders that vote and that are present or represented, or the amount of the share capital that is provided or that is
represented at a general meeting.</font></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"><font style="background-color: white">Decisions of the general meeting
are taken by a simple majority of votes cast in a meeting where at least one third of the entire issued share capital is represented,
except where Dutch law or our Articles of Association provide for a qualified majority or unanimity.</font></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt"><b>Dividends and Other Distributions</b></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><i>Dividends</i></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">We may only make distributions, whether a distribution of profits or of freely distributable reserves, to our shareholders to the extent our shareholders&rsquo; equity (eigen vermogen) exceeds the sum of the paid-in and called-up share capital plus any reserves required by Dutch law or by our Articles of Association. Under our Articles of Association, our management board may decide that all or part of the profits are carried to reserves. After reservation by the management board of any profit, any remaining profit will be at the disposal of the general meeting for distribution, subject to restrictions of Dutch law and approval by our supervisory board.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">We only make a distribution to our shareholders after the adoption of our annual accounts demonstrating that such distribution is legally permitted. The management board is permitted, subject to certain requirements, to declare interim distributions without the approval of the general meeting, but only with the approval of the supervisory board.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Dividends and other distributions shall be made payable not later than the date determined by the management board. Claims to dividends and other distributions not made within five years from the date that such dividends or distributions became payable will lapse and any such amounts will be considered to have been forfeited to us (verjaring).</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><i>Exchange Controls</i></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Under Dutch law, there are no exchange controls applicable to the transfer to persons outside of the Netherlands of dividends or other distributions with respect to, or of the proceeds from the sale of, shares of a Dutch company, albeit those transfers being subject to applicable restrictions under trade and economic sanctions and measures, including those concerning export control, pursuant to European Union regulations, the Sanctions Act 1977 (Sanctiewet 1977) or other legislation, applicable anti-boycott regulations, applicable anti-money-laundering regulations and similar rules and provided that, under circumstances, such dividends or other distributions must be reported to the Dutch Central Bank for statistical purposes. There are no special restrictions in the Articles of Association or Dutch law that limit the right of shareholders who are not citizens or residents of the Netherlands to hold or vote shares.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><i>Squeeze-Out Procedures</i></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">A shareholder who holds at least 95% of our issued share capital for
his or her own account, alone or together with group companies, may initiate proceedings against the other shareholders jointly for
the transfer of their shares to such shareholder. The proceedings are held before the Enterprise Chamber and can be instituted by
means of a writ of summons served upon each of the other shareholders in accordance with the provisions of the Dutch Code of Civil
Procedure (Wetboek van Burgerlijke Rechtsvordering). The Enterprise Chamber may grant the claim for squeeze-out in relation to the
other shareholders and will determine the price to be paid for the shares, if necessary, after appointment of one or three experts
who will offer an opinion to the Enterprise Chamber on the value to be paid for the shares of the other shareholders. Once the order
to transfer becomes final before the Enterprise Chamber, the person acquiring the shares shall give written notice of the date and
place of payment and the price to the holders of the shares to be acquired whose addresses are known to him. Unless the addresses of
all of them are known to the acquiring person, such person is required to publish the same in a daily newspaper with a national
circulation.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><i>Dissolution and Liquidation</i></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Under our Articles of Association, we may be dissolved by a resolution of the general meeting, subject to a proposal of the management board approved by our supervisory board. In the event of a dissolution, the liquidation shall be effected by the management board, under supervision of our supervisory board, unless the general meeting decides otherwise. During liquidation, the provisions of our Articles of Association will remain in force as far as possible. To the extent that any assets remain after payment of all debts, those remaining assets shall be distributed to our shareholders in proportion to their number of shares.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Provisions Impacting any Change of Control</b></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Under Dutch law, various protective measures are possible and permissible within the boundaries set by Dutch law and Dutch case law. In this respect, certain provisions of our Articles of Association may make it more difficult for a third party to acquire control of us or effect a change in our management board and supervisory board. These provisions include:</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>a<font style="background-color: white"> multi-class share structure, which consists of Ordinary
Shares, High Voting Shares and Preferred Shares, with Ordinary Shares carrying one vote per share, High Voting Shares carrying 25 votes
per share and Preferred Shares carrying 30,000 votes;</font></td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>t<font style="background-color: white">he High Voting Shares and the Preferred Shares are not being
listed on a stock exchange</font>;</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>a provision that our management board members and the supervisory board members are appointed on the basis of a binding nomination prepared by our supervisory board which can only be overruled by a two-thirds majority of votes cast representing more than half of our issued share capital;</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>a provision that our management board members and the supervisory board members may only be dismissed by the general meeting by a two-thirds majority of votes cast representing more than half of our issued share capital (unless the dismissal is proposed by the supervisory board in which case a simple majority of the votes cast would be sufficient);</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>a provision allowing, among other matters, the former chairperson of our supervisory board to manage our affairs if all of our supervisory board members are removed from office and to appoint others to be charged with the supervision of our affairs, until new supervisory board members are appointed by the general meeting on the basis of the binding nominations discussed above; and</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>a requirement that certain matters, including an amendment of our Articles of Association, may only be brought to our general meeting for a vote upon a proposal by our management board with the approval of our supervisory board.</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">In addition, Dutch law allows for staggered multi-year terms of our management board members and supervisory board members, as a result of which only part of our management board members and supervisory board members may be subject to appointment or re-appointment in any one year.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">In accordance with the DCGC and our Articles of Association, shareholders having the right to put an item on the agenda under the rules described above shall exercise such right only after consulting the management board in that respect. If one or more shareholders intend to request that an item be put on the agenda that may result in a change in the company&rsquo;s strategy (for example, the removal of management board members or supervisory board members), the management board must be given the opportunity to invoke a reasonable period to respond to such intention. Such period shall not exceed 180 days (or such other period as may be stipulated for such purpose by Dutch law and/or the DCGC from time to time). If invoked, the management board must use such response period for further deliberation and constructive consultation, in any event with the shareholders(s) concerned, and shall explore the alternatives. At the end of
the response time, the management board shall report on this consultation and the exploration of alternatives to the general meeting. This shall be supervised by our supervisory board. The response period may be invoked only once for any given general meeting and shall not apply: (a) in respect of a matter for which a response period or a statutory cooling-off period (as discussed below) has been previously invoked; or (b) if a shareholder holds at least 75% of the Company&rsquo;s issued share capital as a consequence of a successful public bid. The response period may also be invoked in response to shareholders or others with meeting rights under Dutch law requesting that a general meeting be convened, as described above.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Moreover, our management board, with the approval of our supervisory board, can invoke a cooling-off period of up to 250 days when shareholders, using their right to have items added to the agenda for a general meeting or their right to request a general meeting, propose an agenda item for our general meeting to dismiss, suspend or appoint one or more management board members or supervisory board members (or to amend any provision in our Articles of Association dealing with those matters) or when a public offer for our company is made or announced without our support, provided, in each case, that our management board believes that such proposal or offer materially conflicts with the interests of our company and its business. During a cooling-off period, our general meeting cannot dismiss, suspend or appoint management board members and supervisory board members (or amend the provisions in our Articles of Association dealing
with those matters) except at the proposal of our management board. During a cooling-off period, our management board must gather all relevant information necessary for a careful decision-making process and at least consult with shareholders representing 3% or more of our issued share capital at the time the cooling-off period was invoked, as well as with our Dutch works council (if we or, under certain circumstances, any of our subsidiaries would have one). Formal statements expressed by these stakeholders during such consultations must be published on our website to the extent these stakeholders have approved that publication. Ultimately one week following the last day of the cooling-off period, our management board must publish a report in respect of its policy and conduct of affairs during the cooling-off period on our website. This report must remain available for inspection by shareholders and others with meeting rights under Dutch law at our office and must be tabled for discussion
at the next general meeting. Shareholders representing at least 3% of our issued share capital may request the Enterprise Chamber of the Amsterdam Court of Appeal, or the Enterprise Chamber (Ondernemingskamer), for early termination of the cooling-off period. The Enterprise Chamber must rule in favor of the request if the shareholders can demonstrate that:</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>our management board, in light of the circumstances at hand when the cooling-off period was invoked, could not reasonably have concluded that the relevant proposal or hostile offer constituted a material conflict with the interests of our company and its business;</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>our management board cannot reasonably believe that a continuation of the cooling-off period would contribute to careful policy-making; or</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>other defensive measures, having the same purpose, nature and scope as the cooling-off period, have been activated during the cooling-off period and have not since been terminated or suspended within a reasonable period at the relevant shareholders&rsquo; request (i.e., no &lsquo;stacking&rsquo; of defensive measures).</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Limitations on Liability and Indemnification of Officers and Directors</b></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Pursuant to the Articles of Association, Sono N.V. will indemnify its managing directors and supervisory
directors from any financial losses or damages and any expenses reasonably paid or incurred by such managing director or supervisory director
in connection with any legal proceedings in which such managing director or supervisory director becomes involved.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Dissenters&rsquo; Rights of Appraisal </b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in"><font style="background-color: white">Under </font>article 2:333h of the
Dutch Civil Code<font style="background-color: white">, with certain exceptions, registered shareholders who vote against a cross-border
merger will have statutory appraisal rights in connection with such transaction. However, Dutch law does not provide statutory appraisal
or dissenters&rsquo; rights for shareholders in purely domestic mergers.</font></p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Shareholders&rsquo; Derivative Actions</b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">Dutch law does not provide for derivative suits. As such, individual shareholders do not have a general right to bring an action on behalf of the Company.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Transfer Agent and Warrant Agent</b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">The transfer agent and registrar for our capital stock is Equiniti Trust Company, LLC.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Listing of Ordinary Shares</b></p>

<p style="margin: 0pt 0; font-size: 10pt">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Our Ordinary Shares trade on the Nasdaq-CM under the ticker symbol &ldquo;SSM<font style="background-color: white">&rdquo;.</font></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b><a name="a_008"></a>DESCRIPTION OF DEBT SECURITIES</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">We may issue debt securities from time to time, in one or more series, as either senior or subordinated debt or as senior or subordinated convertible debt. While the terms we have summarized below will apply generally to any debt securities that we may offer under this prospectus, we will describe the particular terms of any debt securities that we may offer in more detail in the applicable prospectus supplement. The terms of any debt securities offered under a prospectus supplement may differ from the terms described below. Unless the context requires otherwise, whenever we refer to the indenture, we also are referring to any supplemental indentures that specify the terms of a particular series of debt securities. </p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">We will issue the debt securities under the indenture that we will enter into with the trustee named in the indenture. The indenture will be qualified under the Trust Indenture Act of 1939, as amended (the &ldquo;<b><i>Trust Indenture Act</i></b>&rdquo;). We have filed the form of indenture as an exhibit to the registration statement of which this prospectus is a part, and supplemental indentures and forms of debt securities containing the terms of the debt securities being offered will be filed as exhibits to the registration statement of which this prospectus is a part, or will be incorporated by reference from, reports that we file with the SEC. </p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">The following summary of material provisions of the debt securities and the indenture is subject to, and qualified in its entirety by reference to, all of the provisions of the indenture applicable to a particular series of debt securities. We urge you to read the applicable prospectus supplements and any related free writing prospectuses related to the debt securities that we may offer under this prospectus, as well as the complete indenture that contains the terms of the debt securities.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>General </b></p>

<p style="margin: 0pt 0; font-size: 10pt">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">The indenture does not limit the amount of debt securities that we may issue. It provides that we may issue debt securities up to the principal amount that we may authorize and may be in any currency or currency unit that we may designate. Except for the limitations on consolidation, merger and sale of all or substantially all of our assets contained in the indenture, the terms of the indenture do not contain any covenants or other provisions designed to give holders of any debt securities protection against changes in our operations, financial condition or transactions involving us. </p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">We may issue the debt securities issued under the indenture as &ldquo;discount securities,&rdquo; which means they may be sold at a discount below their stated principal amount. These debt securities, as well as other debt securities that are not issued at a discount, may be issued with &ldquo;original issue discount&rdquo; (&ldquo;<b><i>OID</i></b>&rdquo;) for U.S. federal income tax purposes because of interest payment and other characteristics or terms of the debt securities. Material U.S. federal income tax considerations applicable to debt securities issued with OID will be described in more detail in any applicable prospectus supplement. </p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">We will describe in the applicable prospectus supplement the terms of the series of debt securities being offered, including:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>the title of the series of debt securities; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>any limit upon the aggregate principal amount that may be issued; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>the maturity date or dates; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>the form of the debt securities of the series; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>the applicability of any guarantees; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>whether or not the debt securities will be secured or unsecured, and the terms of any secured debt; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>whether the debt securities rank as senior debt, senior subordinated debt, subordinated debt or any combination thereof, and the terms of any subordination; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>if the price (expressed as a percentage of the aggregate principal amount thereof) at which such debt securities will be issued is a price other than the principal amount thereof, the portion of the principal amount thereof payable upon declaration of acceleration of the maturity thereof, or if applicable, the portion of the principal amount of such debt securities that is convertible into another security or the method by which any such portion shall be determined;</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>the interest rate or rates, which may be fixed or variable, or the method for determining the rate and the date interest will begin to accrue, the dates interest will be payable and the regular record dates for interest payment dates or the method for determining such dates; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>our right, if any, to defer payment of interest and the maximum length of any such deferral period; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>if applicable, the date or dates after which, or the period or periods during which, and the price or prices at which, we may, at our option, redeem the series of debt securities pursuant to any optional or provisional redemption provisions and the terms of those redemption provisions; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>the date or dates, if any, on which, and the price or prices at which we are obligated, pursuant to any mandatory sinking fund or analogous fund provisions or otherwise, to redeem, or at the holder&rsquo;s option to purchase, the series of debt securities and the currency or currency unit in which the debt securities are payable; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>the denominations in which we will issue the series of debt securities, if other than denominations of $1,000 and any integral multiple thereof; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>any and all terms, if applicable, relating to any auction or remarketing of the debt securities of that series and any security for our obligations with respect to such debt securities and any other terms which may be advisable in connection with the marketing of debt securities of that series; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>whether the debt securities of the series shall be issued in whole or in part in the form of a global security or securities; the terms and conditions, if any, upon which such global security or securities may be exchanged in whole or in part for other individual securities; and the depositary for such global security or securities; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>if applicable, the provisions relating to conversion or exchange of any debt securities of the series and the terms and conditions upon which such debt securities will be so convertible or exchangeable, including the conversion or exchange price, as applicable, or how it will be calculated and may be adjusted, any mandatory or optional (at our option or the holders&rsquo; option) conversion or exchange features, the applicable conversion or exchange period and the manner of settlement for any conversion or exchange;</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>if other than the full principal amount thereof, the portion of the principal amount of debt securities of the series which shall be payable upon declaration of acceleration of the maturity thereof; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>additions to or changes in the covenants applicable to the particular debt securities being issued, including, among others, the consolidation, merger or sale covenant; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>additions to or changes in the events of default with respect to the securities and any change in the right of the trustee or the holders to declare the principal, premium, if any, and interest, if any, with respect to such securities to be due and payable; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>additions to or changes in or deletions of the provisions relating to covenant defeasance and legal defeasance; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>additions to or changes in the provisions relating to satisfaction and discharge of the indenture; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>additions to or changes in the provisions relating to the modification of the indenture both with and without the consent of holders of debt securities issued under the indenture; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>the currency of payment of debt securities if other than U.S. dollars and the manner of determining the equivalent amount in U.S. dollars; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>whether interest will be payable in cash or additional debt securities at our or the holders&rsquo; option and the terms and conditions upon which the election may be made; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>the terms and conditions, if any, upon which we will pay amounts in addition to the stated interest, premium, if any and principal amounts of the debt securities of the series to any holder that is not a &ldquo;United States person&rdquo; for federal tax purposes; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>any restrictions on transfer, sale or assignment of the debt securities of the series; and</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>any other specific terms, preferences, rights or limitations of, or restrictions on, the debt securities, any other additions or changes in the provisions of the indenture, and any terms that may be required by us or advisable under applicable laws or regulations. </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Conversion or Exchange Rights </b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in"><font style="background-color: white">We will set forth in the applicable prospectus supplement
the terms on which a series of debt securities may be convertible into or exchangeable for our Ordinary Shares or our other securities.
We will include provisions as to settlement upon conversion or exchange and whether conversion or exchange is mandatory, at the option
of the holder or at our option. We may include provisions pursuant to which the number of our Ordinary Shares or our other securities
that the holders of the series of debt securities receive would be subject to adjustment.</font></p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Consolidation, Merger or Sale </b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">Unless we provide otherwise in the prospectus supplement applicable to a particular series of debt securities, the indenture will not contain any covenant that restricts our ability to merge or consolidate, or sell, convey, transfer or otherwise dispose of our assets as an entirety or substantially as an entirety. However, any successor to or acquirer of such assets (other than any subsidiary of ours) must assume all of our obligations under the indenture or the debt securities, as appropriate.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Events of Default under the Indenture </b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">Unless we provide otherwise in the prospectus supplement applicable to a particular series of debt securities, the following are events of default under the indenture with respect to any series of debt securities that we may issue:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>if we fail to pay any installment of interest on any series of debt securities, as and when the same shall become due and payable, and such default continues for a period of 90 days; provided, however, that a valid extension of an interest payment period by us in accordance with the terms of any indenture supplemental thereto shall not constitute a default in the payment of interest for this purpose; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>if we fail to pay the principal of, or premium, if any, on any series of debt securities as and when the same shall become due and payable whether at maturity, upon redemption, by declaration or otherwise, or in any payment required by any sinking or analogous fund established with respect to such series; provided, however, that a valid extension of the maturity of such debt securities in accordance with the terms of any indenture supplemental thereto shall not constitute a default in the payment of principal or premium, if any; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>if we fail to observe or perform any other covenant or agreement contained in the debt securities or the indenture, other than a covenant specifically relating to another series of debt securities, and our failure continues for 90 days after we receive written notice of such failure, requiring the same to be remedied and stating that such is a notice of default thereunder, from the trustee or holders of at least 25% in aggregate principal amount of the outstanding debt securities of the applicable series; and </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>if specified events of bankruptcy, insolvency or reorganization occur. </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">If an event of default with respect to debt securities of any series occurs and is continuing, other than an event of default specified in the last bullet point above, the trustee or the holders of at least 25% in aggregate principal amount of the outstanding debt securities of that series, by notice to us in writing, and to the trustee if notice is given by such holders, may declare the unpaid principal of, premium, if any, and accrued interest, if any, due and payable immediately. If an event of default specified in the last bullet point above occurs with respect to us, the principal amount of and accrued interest, if any, of each issue of debt securities then outstanding shall be due and payable without any notice or other action on the part of the trustee or any holder. </p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">The holders of a majority in principal amount of the outstanding debt securities of an affected series may waive any default or event of default with respect to the series and its consequences, except defaults or events of default regarding payment of principal, premium, if any, or interest, unless we have cured the default or event of default in accordance with the indenture. Any waiver shall cure the default or event of default. </p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">Subject to the terms of the indenture, if an event of default under an indenture shall occur and be continuing, the trustee will be under no obligation to exercise any of its rights or powers under such indenture at the request or direction of any of the holders of the applicable series of debt securities, unless such holders have offered the trustee reasonable indemnity. The holders of a majority in principal amount of the outstanding debt securities of any series will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the trustee, or exercising any trust or power conferred on the trustee, with respect to the debt securities of that series, provided that:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>the direction so given by the holder is not in conflict with any law or the applicable indenture; and </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>subject to its duties under the Trust Indenture Act, the trustee need not take any action that might involve it in personal liability or might be unduly prejudicial to the holders not involved in the proceeding. </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>A holder of the debt securities of any series will have the right to institute a proceeding under the indenture or to appoint a receiver or trustee, or to seek other remedies only if: </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>the holder has given written notice to the trustee of a continuing event of default with respect to that series; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>the holders of at least 25% in aggregate principal amount of the outstanding debt securities of that series have made written request, </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>such holders have offered to the trustee indemnity satisfactory to it against the costs, expenses and liabilities to be incurred by the trustee in compliance with the request; and </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>the trustee does not institute the proceeding, and does not receive from the holders of a majority in aggregate principal amount of the outstanding debt securities of that series other conflicting directions within 90 days after the notice, request and offer. </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">These limitations do not apply to a suit instituted by a holder of debt securities if we default in the payment of the principal, premium, if any, or interest on, the debt securities.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">We will periodically file statements with the trustee regarding our compliance with specified covenants in the indenture.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Modification of Indenture; Waiver</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>We and the trustee may change an indenture without the consent of any holders with respect to specific matters: </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>to cure any ambiguity, defect or inconsistency in the indenture or in the debt securities of any series; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>to comply with the provisions described above under &ldquo;<i>Description of Debt Securities&thinsp;-&thinsp;Consolidation, Merger or Sale</i>&rdquo;; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>to provide for uncertificated debt securities in addition to or in place of certificated debt securities; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>to add to our covenants, restrictions, conditions or provisions such new covenants, restrictions, conditions or provisions for the benefit of the holders of all or any series of debt securities, to make the occurrence, or the occurrence and the continuance, of a default in any such additional covenants, restrictions, conditions or provisions an event of default or to surrender any right or power conferred upon us in the indenture; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>to add to, delete from or revise the conditions, limitations, and restrictions on the authorized amount, terms, or purposes of issue, authentication and delivery of debt securities, as set forth in the indenture; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>to make any change that does not adversely affect the interests of any holder of debt securities of any series in any material respect;</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>to provide for the issuance of and establish the form and terms and conditions of the debt securities of any series as provided above under &ldquo;Description of Debt Securities&thinsp;-&thinsp;General&rdquo; to establish the form of any certifications required to be furnished pursuant to the terms of the indenture or any series of debt securities, or to add to the rights of the holders of any series of debt securities; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>to evidence and provide for the acceptance of appointment under any indenture by a successor trustee; or </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>to comply with any requirements of the SEC in connection with the qualification of any indenture under the Trust Indenture Act. </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">In addition, under the indenture, the rights of holders of a series of debt securities may be changed by us and the trustee with the written consent of the holders of at least a majority in aggregate principal amount of the outstanding debt securities of each series that is affected. However, unless we provide otherwise in the prospectus supplement applicable to a particular series of debt securities, we and the trustee may make the following changes only with the consent of each holder of any outstanding debt securities affected:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>extending the fixed maturity of any debt securities of any series; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>reducing the principal amount, reducing the rate of or extending the time of payment of interest, or reducing any premium payable upon the redemption of any series of any debt securities; or </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>reducing the percentage of debt securities, the holders of which are required to consent to any amendment, supplement, modification or waiver. </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Discharge</b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">Each indenture provides that we can elect to be discharged from our obligations with respect to one or more series of debt securities, except for specified obligations, including obligations to:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>provide for payment; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>register the transfer or exchange of debt securities of the series; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>replace stolen, lost or mutilated debt securities of the series; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>pay principal of and premium and interest on any debt securities of the series; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>maintain paying agencies; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>hold monies for payment in trust; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>recover excess money held by the trustee; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>compensate and indemnify the trustee; and </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>appoint any successor trustee. </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">In order to exercise our rights to be discharged, we must deposit with the trustee money or government obligations sufficient to pay all the principal of, any premium, if any, and interest on, the debt securities of the series on the dates payments are due.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Form, Exchange and Transfer </b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">We will issue the debt securities of each series only in fully registered form without coupons and, unless we provide otherwise in the applicable prospectus supplement, in denominations of $1,000 and any integral multiple thereof. The indenture provides that we may issue debt securities of a series in temporary or permanent global form and as book-entry securities that will be deposited with, or on behalf of, The Depository Trust Company (&ldquo;<b><i>DTC</i></b>&rdquo;) or another depositary named by us and identified in the applicable prospectus supplement with respect to that series. To the extent the debt securities of a series are issued in global form and as book-entry, a description of terms relating to any book-entry securities will be set forth in the applicable prospectus supplement. </p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">At the option of the holder, subject to the terms of the indenture and the limitations applicable to global securities described in the applicable prospectus supplement, the holder of the debt securities of any series can exchange the debt securities for other debt securities of the same series, in any authorized denomination and of like tenor and aggregate principal amount. </p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">Subject to the terms of the indenture and the limitations applicable to global securities set forth in the applicable prospectus supplement, holders of the debt securities may present the debt securities for exchange or for registration of transfer, duly endorsed or with the form of transfer endorsed thereon duly executed if so required by us or the security registrar, at the office of the security registrar or at the office of any transfer agent designated by us for this purpose. Unless otherwise provided in the debt securities that the holder presents for transfer or exchange, we will impose no service charge for any registration of transfer or exchange, but we may require payment of any taxes or other governmental charges. </p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">We will name in the applicable prospectus supplement the security registrar, and any transfer agent in addition to the security registrar, that we initially designate for any debt securities. We may at any time designate additional transfer agents or rescind the designation of any transfer agent or approve a change in the office through which any transfer agent acts, except that we will be required to maintain a transfer agent in each place of payment for the debt securities of each series. </p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">If we elect to redeem the debt securities of any series, we will not be required to:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>issue, register the transfer of, or exchange any debt securities of that series during a period beginning at the opening of business 15 days before the day of mailing of a notice of redemption of any debt securities that may be selected for redemption and ending at the close of business on the day of the mailing; or </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>register the transfer of or exchange any debt securities so selected for redemption, in whole or in part, except the unredeemed portion of any debt securities we are redeeming in part. </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Information Concerning the Trustee </b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">The trustee, other than during the occurrence and continuance of an event of default under an indenture, undertakes to perform only those duties as are specifically set forth in the applicable indenture. Upon an event of default under an indenture, the trustee must use the same degree of care as a prudent person would exercise or use in the conduct of his or her own affairs. Subject to this provision, the trustee is under no obligation to exercise any of the powers given it by the indenture at the request of any holder of debt securities unless it is offered reasonable security and indemnity against the costs, expenses and liabilities that it might incur.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Payment and Paying Agents </b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">Unless we otherwise indicate in the applicable prospectus supplement, we will make payment of the interest on any debt securities on any interest payment date to the person in whose name the debt securities, or one or more predecessor securities, are registered at the close of business on the regular record date for the interest. </p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">We will pay principal of and any premium and interest on the debt securities of a particular series at the office of the paying agents designated by us, except that unless we otherwise indicate in the applicable prospectus supplement, we will make interest payments by check that we will mail to the holder or by wire transfer to certain holders. Unless we otherwise indicate in the applicable prospectus supplement, we will designate the corporate trust office of the trustee as our sole paying agent for payments with respect to debt securities of each series. We will name in the applicable prospectus supplement any other paying agents that we initially designate for the debt securities of a particular series. We will maintain a paying agent in each place of payment for the debt securities of a particular series. </p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">All money we pay to a paying agent or the trustee for the payment of the principal of or any premium or interest on any debt securities that remains unclaimed at the end of two years after such principal, premium or interest has become due and payable will be repaid to us, and the holder of the debt security thereafter may look only to us for payment thereof.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Governing Law </b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">The indenture and the debt securities will be governed by and construed in accordance with the laws of the State of New York, except to the extent that the Trust Indenture Act is applicable.</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b><a name="a_009"></a>DESCRIPTION OF WARRANTS</b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">The following description, together with the additional information we may include in any applicable prospectus supplements, summarizes the material terms and provisions of the warrants that we may offer under this prospectus and the related warrant agreements and warrant certificates. While the terms summarized below will apply generally to any warrants that we may offer, we will describe the particular terms of any series of warrants in more detail in the applicable prospectus supplement. If we indicate in the prospectus supplement, the terms of any warrants offered under that prospectus supplement may differ from the terms described below. Specific warrant agreements will contain additional important terms and provisions and will be incorporated by reference as an exhibit to the registration statement, which includes this prospectus. Following the description of the warrants that we may offer under this prospectus and the
related warrant agreements and warrant certificates is a description of our outstanding warrants.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>General </b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in"><font style="background-color: white">We may issue warrants for the purchase of Ordinary Shares,
Preferred Shares and/or debt securities in one or more series. We may issue warrants independently or together with Ordinary Shares, Preferred
Shares and/or debt securities, and the warrants may be attached to or separate from these securities.</font></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">We will evidence each series of warrants by warrant certificates that we will issue under a separate warrant agreement. We will enter into the warrant agreement with a warrant agent. We will indicate the name and address of the warrant agent in the applicable prospectus supplement relating to a particular series of warrants.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">We will describe in the applicable prospectus supplement the terms of the series of warrants, including:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">the offering price and aggregate number of warrants offered;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">the currency for which the warrants may be purchased;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">if applicable, the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each such security or each principal amount of such security;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">if applicable, the date on and after which the warrants and the related securities will be separately transferable;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">in the case of warrants to purchase debt securities, the principal amount of debt securities purchasable upon exercise of one warrant and the price at, and currency in which, this principal amount of debt securities may be purchased upon such exercise;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">i<font style="background-color: white">n the case of warrants to purchase Ordinary Shares or Preferred
Shares, the number of shares of Ordinary Shares or Preferred Shares, as the case may be, purchasable upon the exercise of one warrant
and the price at which these shares may be purchased upon such exercise;</font></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">the effect of any merger, consolidation, sale or other disposition of our business on the warrant agreement and the warrants;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">the terms of any rights to redeem or call the warrants;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">any provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise of the warrants;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">the periods during which, and places at which, the warrants are exercisable;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">the manner of exercise;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">the dates on which the right to exercise the warrants will commence and expire;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">the manner in which the warrant agreement and warrants may be modified;</td>
</tr></table>



<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">applicable material U.S. <font style="background-color: white">federal income tax consequences of
holding or exercising the warrants; </font></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">the terms of the securities issuable upon exercise of the warrants; and</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">any other specific terms, preferences, rights or limitations of or restrictions on the warrants.</td>
</tr></table>

<p style="font-size: 10pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt"><b>Outstanding Warrants</b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in"><i>Pre-Funded Warrant Private Placement </i></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">On March 10, 2026, the Company and Yorkville entered into a Pre-Funded Warrant Securities Purchase Agreement, dated March 10, 2026 (the &ldquo;<b><i>Warrant Purchase Agreement</i></b>&rdquo;), pursuant to which, at the closing which occurred on March 10, 2026, the Company issued and sold to Yorkville a pre-funded warrant to purchase up to 283,367 Ordinary Shares of the Company (the &ldquo;<b><i>Warrant Shares</i></b>&rdquo;), exercisable in whole or in part at any time after issuance (the &ldquo;<b><i>Pre-Funded Warrant</i></b>&rdquo;). The aggregate subscription amount for the Pre-Funded Warrant was $2,000,004.29. Such amount was paid by Yorkville at the closing of the Warrant Purchase Agreement. The aggregate gross proceeds to the Company from the private placement were approximately $2,000,004.29, before deducting the offering expenses payable by the Company, which expenses consist solely of legal fees. The Company intends
to use the net proceeds from the offering for working capital purposes. In addition, the per share exercise price of the Pre-Funded Warrant is &euro;0.01.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">The Pre-Funded Warrant is exercisable for up to 283,367 Ordinary Shares at an exercise price of &euro;0.01 per share (subject to certain adjustments), is exercisable immediately upon issuance, and may be exercised, in whole or in part, at any time until exercised in full. Yorkville (together with its Attribution Parties (as defined in the Pre-Funded Warrant)) may not exercise any Pre-Funded Warrant to the extent that Yorkville would own more than 4.99% of the outstanding Ordinary Shares immediately after giving effect to the issuance of Ordinary Shares issuable upon exercise of such Pre-Funded Warrant, which percentage may be changed at Yorkville&rsquo;s election to a lower or higher percentage not in excess of 9.99% upon 61 days&rsquo; notice to the Company, subject to the terms of the Pre-Funded Warrant. The Pre-Funded Warrant provides for standard anti-dilution adjustments to the exercise price and the number of Warrant Shares
issuable upon exercise in connection with stock dividends, splits, combinations, reclassifications and similar events.</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"></p>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b><a name="a_010"></a>DESCRIPTION OF RIGHTS</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"><font style="background-color: white">We may issue or distribute rights
to our shareholders for the purchase of our Ordinary Shares, Preferred Shares or debt securities. We may issue rights independently or
together with other securities, and the rights may be attached to or separate from any offered or distributed securities and may or may
not be transferable by the shareholder receiving the rights. In connection with any offering of rights, we may enter into a standby underwriting,
backstop or other arrangement with one or more underwriters or other persons pursuant to which the underwriters or other persons may
agree to purchase any securities remaining unsubscribed for after such rights offering. Each series of rights will be issued under a
separate rights agreement to be entered into between us and a bank or trust company, as rights agent, all as set forth in an accompanying
prospectus supplement relating to the particular issue of rights. The rights agent will act solely as an agent of the Company in connection
with the certificates relating to the rights of such series and will not assume any obligation or relationship of agency or trust for
or with any holders of rights certificates or beneficial owners of rights.</font></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">The following summary of material provisions of the rights are subject to, and qualified in their entirety by reference to, all the provisions of the certificates representing rights applicable to a particular series of rights. The terms of any rights offered or distributed under an accompanying prospectus supplement may differ from the terms described below. We urge you to read the accompanying prospectus supplement as well as the complete certificates representing the rights that contain the terms of the rights. The particular terms of any issue of rights will be described in an accompanying prospectus supplement relating to the issue, and may include:</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>in the case of a distribution of rights to our shareholders, the date for determining the shareholders entitled to the rights distribution;</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>in the case of a distribution of rights to our shareholders, the number of rights issued or to be issued to each shareholder;</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>t<font style="background-color: white">he aggregate number of Ordinary Shares, Preferred Shares
or debt securities purchasable upon exercise of such rights and the exercise price;</font></td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>the aggregate number of rights being issued;</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>the extent to which the rights are transferable;</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>the date on which the holder&rsquo;s ability to exercise such rights shall commence and the date on which such right shall expire;</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>the extent to which the rights may include an over-subscription privilege with respect to unsubscribed securities;</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td><font style="background-color: white">a discussion of applicable material U.S. federal income tax
considerations;</font></td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>any other material terms of such rights, including terms, procedures and limitations relating to the distribution, exchange and exercise of such rights; and</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td>if applicable, the material terms of any standby underwriting, backstop or purchase arrangement which may be entered into by the Company in connection with the offering, issuance or distribution of rights.</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Each right will entitle the holder of rights (&ldquo;<b><i>Holders</i></b>&rdquo;)
to purchase for cash the number of Ordinary or Preferred Shares or the principal amount of debt securities at the exercise price provided
in the accompanying prospectus supplement. Rights may be exercised at any time up to the close of business on the expiration date for
the rights provided in the accompanying prospectus supplement. After the close of business on the expiration date, all unexercised rights
will be void and of no further force and effect.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Holders may exercise rights as described in the accompanying prospectus
supplement. Upon receipt of payment and the rights certificate properly completed and duly executed at the corporate trust office of
the rights agent or any other office indicated in an accompanying prospectus supplement, we will, as soon as practicable, forward the
Ordinary Shares or Preferred Shares or principal amount of debt securities purchased upon exercise of the rights. If less than all of
the rights issued in any rights offering are exercised, we may offer any unsubscribed Ordinary Shares or Preferred Shares or principal
amount of debt securities directly to persons, which may be to or through agents, underwriters or dealers or through a combination of
such methods, including pursuant to standby underwriting arrangements, as described in the accompanying prospectus supplement.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Until any rights to purchase Ordinary Shares or Preferred Shares are exercised,
the holders of any rights will not have any rights of holders of the underlying Ordinary Shares or Preferred Shares, including any rights
to receive dividends or payments upon any liquidation, dissolution or winding up on the Ordinary Shares or Preferred Shares, if any.
Until any rights to purchase debt securities are exercised, the holder of any rights will not have any rights of holders of the debt
securities that can be purchased upon exercise, including any rights to receive payments of principal, premium or interest on the underlying
debt securities or to enforce covenants in the applicable indenture.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b><a name="a_011"></a>DESCRIPTION OF UNITS</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">We may issue units comprised of shares of Ordinary Shares, Preferred
Shares, debt securities and warrants in any combination. We may issue units in such amounts and in as many distinct series as we wish.
This section outlines certain provisions of the units that we may issue. If we issue units, they will be issued under one or more unit
agreements to be entered into between us and a bank or other financial institution, as unit agent. The information described in this
section may not be complete in all respects and is qualified entirely by reference to the unit agreement with respect to the units of
any particular series. The specific terms of any series of units offered will be described in the applicable prospectus supplement. If
so described in a particular supplement, the specific terms of any series of units may differ from the general description of terms presented
below. We urge you to read any prospectus supplement related to any series of units we may offer, as well as the complete unit agreement
and unit certificate that contain the terms of the units. If we issue units, forms of unit agreements and unit certificates relating
to such units will be incorporated by reference as exhibits to the registration statement, which includes this prospectus. </p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">Each unit that we may issue will be issued so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations of a holder of each included security. The unit agreement under which a unit is issued may provide that the securities included in the unit may not be held or transferred separately, at any time or at any time before a specified date. The applicable prospectus supplement may describe:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">the designation and terms of the units and of the securities comprising the units, including whether and under what circumstances those securities may be held or transferred separately;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">any provisions of the governing unit agreement;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">the price or prices at which such units will be issued;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">t<font style="background-color: white">he applicable material U.S. federal income tax considerations
relating to the units;</font></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">any provisions for the issuance, payment, settlement, transfer or exchange of the units or of the securities comprising the units; and</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">any other terms of the units and of the securities comprising the units.</td>
</tr></table>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">The provisions described in this section, as well as those described under &ldquo;<i>Description of Capital Stock,&rdquo; &ldquo;Description of Debt Securities</i>&rdquo; and &ldquo;<i>Description of Warrants</i>&rdquo; will apply to the securities included in each unit, to the extent relevant and as may be updated in any prospectus supplements.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Issuance in Series</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">We may issue units in such amounts and in as many distinct series as we wish. This section summarizes terms of the units that apply generally to all series. Most of the financial and other specific terms of a particular series of units will be described in the applicable prospectus supplement.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Unit Agreements </b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">We will issue the units under one or more unit agreements to be entered into between us and a bank or other financial institution, as unit agent. We may add, replace or terminate unit agents from time to time. We will identify the unit agreement under which each series of units will be issued and the unit agent under that agreement in the applicable prospectus supplement. </p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">The following provisions will generally apply to all unit agreements unless otherwise stated in the applicable prospectus supplement:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Modification without Consent</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">We and the applicable unit agent may amend any unit or unit agreement without the consent of any holder:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">to cure any ambiguity, including modifying any provisions of the governing unit agreement that differ from those described below;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">to correct or supplement any defective or inconsistent provision; or</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">to make any other change that we believe is necessary or desirable and will not adversely affect the interests of the affected holders in any material respect.</td>
</tr></table>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">We do not need any approval to make changes that affect only units to be issued after the changes take effect. We may also make changes that do not adversely affect a particular unit in any material respect, even if they adversely affect other units in a material respect. In those cases, we do not need to obtain the approval of the holder of the unaffected unit; we need only obtain any required approvals from the holders of the affected units.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Modification with Consent </b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">We may not amend any particular unit or a unit agreement with respect to any particular unit unless we obtain the consent of the holder of that unit, if the amendment would:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">impair any right of the holder to exercise or enforce any right under a security included in the unit if the terms of that security require the consent of the holder to any changes that would impair the exercise or enforcement of that right; or</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">reduce the percentage of outstanding units or any series or class the consent of whose holders is required to amend that series or class, or the applicable unit agreement with respect to that series or class, as described below.</td>
</tr></table>

<p style="font-size: 10pt; margin: 0pt 0 0pt 0.25in">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">Any other change to a particular unit agreement and the units issued under that agreement would require the following approval:</p>

<p style="margin: 0pt 0 0pt 0.25in; font-size: 10pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">If the change affects only the units of a particular series issued under that agreement, the change must be approved by the holders of a majority of the outstanding units of that series; or</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">If the change affects the units of more than one series issued under that agreement, it must be approved by the holders of a majority of all outstanding units of all series affected by the change, with the units of all the affected series voting together as one class for this purpose.</td>
</tr></table>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">These provisions regarding changes with majority approval also apply to changes affecting any securities issued under a unit agreement, as the governing document.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">In each case, the required approval must be given by written consent.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Unit Agreements Will Not Be Qualified under Trust Indenture Act </b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">No unit agreement will be qualified as an indenture, and no unit agent will be required to qualify as a trustee, under the Trust Indenture Act. Therefore, holders of units issued under unit agreements will not have the protections of the Trust Indenture Act with respect to their units.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Mergers and Similar Transactions Permitted; No Restrictive Covenants or Events of Default </b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">The unit agreements will not restrict our ability to merge or consolidate with, or sell our assets to, another corporation or other entity or to engage in any other transactions. If at any time we merge or consolidate with, or sell our assets substantially as an entirety to, another corporation or other entity, the successor entity will succeed to and assume our obligations under the unit agreements. We will then be relieved of any further obligation under these agreements. </p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">The unit agreements will not include any restrictions on our ability to put liens on our assets, nor will they restrict our ability to sell our assets. The unit agreements also will not provide for any events of default or remedies upon the occurrence of any events of default.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Governing Law </b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">The unit agreements and the units will be governed by Dutch law.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Form, Exchange and Transfer</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">We will issue each unit in global&thinsp; &mdash;&thinsp;&thinsp;i.e.,
book-entry&thinsp; &mdash;&thinsp;&thinsp;form only. Units in book-entry form may be represented by a global security registered in the
name of a depositary, which will be the holder of all the units represented by the global security. Those who own beneficial interests
in a unit will do so through participants in the depositary&rsquo;s system, and the rights of these indirect owners will be governed
solely by the applicable procedures of the depositary and its participants. We will describe book-entry securities, and other terms regarding
the issuance and registration of the units in the applicable prospectus supplement. </p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">Each unit and all securities comprising the unit will be issued in the same form. </p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">If we issue any units in registered, non-global form, the following will apply to them. </p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">The units will be issued in the denominations stated in the applicable prospectus supplement. Holders may exchange their units for units of smaller denominations or combined into fewer units of larger denominations, as long as the total amount is not changed.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">Holders may exchange or transfer their units at the office of the unit agent. Holders may also replace lost, stolen, destroyed or mutilated units at that office. We may appoint another entity to perform these functions or perform them ourselves.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">Holders will not be required to pay a service charge to transfer or exchange their units, but they may be required to pay for any tax or other governmental charge associated with the transfer or exchange. The transfer or exchange, and any replacement, will be made only if our transfer agent is satisfied with the holder&rsquo;s proof of legal ownership. The transfer agent may also require an indemnity before replacing any units.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">If we have the right to redeem, accelerate or settle any units before their maturity, and we exercise our right as to less than all those units or other securities, we may block the exchange or transfer of those units during the period beginning 15 days before the day we mail the notice of exercise and ending on the day of that mailing, in order to freeze the list of holders to prepare the mailing. We may also refuse to register transfers of or exchange any unit selected for early settlement, except that we will continue to permit transfers and exchanges of the unsettled portion of any unit being partially settled. We may also block the transfer or exchange of any unit in this manner if the unit includes securities that are or may be selected for early settlement.</td>
</tr></table>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">Only the depositary will be entitled to transfer or exchange a unit in global form, since it will be the sole holder of the unit.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Payments and Notices </b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">In making payments and giving notices with respect to our units, we will follow the procedures as described in the applicable prospectus supplement.</p>

<p style="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"></p>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b><a name="a_012"></a>MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS</b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">Certain material U.S. federal income tax considerations relating to the
purchase, ownership and disposition of the securities offered by this prospectus will be set forth in the prospectus supplement pertaining
to those securities.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in"></p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt"></p>

<p style="margin: 0pt 0; font-size: 10pt"><b></b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b></b></p>



<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b><a name="a_013"></a>PLAN OF DISTRIBUTION</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">We may sell the securities offered through this prospectus and any accompanying prospectus supplement, if required, in any of the following ways: (i) to or through underwriters or dealers, (ii) directly to purchasers, including our affiliates, (iii) through agents, (iv) in an &ldquo;at the market offering,&rdquo; within the meaning of Rule 415(a)(4) of the Securities Act or (v) through a combination of any of these methods or any other method permitted by law. The securities may be distributed at a fixed price or prices, which may be changed, market prices prevailing at the time of sale, prices related to the prevailing market prices, or negotiated prices, either:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">on or through the facilities of the Nasdaq-CM or any other securities exchange or quotation or trading
service on which such securities may be listed, quoted or traded at the time of sale; and/or</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify"><p style="margin: 0; font-size: 10pt">to or through a market maker otherwise than on the Nasdaq-CM or such other securities exchanges
or quotation or trading service.</p></td>
</tr></table>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">In addition, we may issue the securities as a dividend or distribution or in a subscription rights offering to our existing security holders.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">We may directly solicit offers to purchase securities, or agents may be designated to solicit such offers. In the prospectus supplement relating to such offering, we will name any agent that could be viewed as an underwriter under the Securities Act and describe any commissions that we must pay to any such agent. Any such agent will be acting on a best efforts basis for the period of its appointment or, if indicated in the applicable prospectus supplement, on a firm commitment basis. This prospectus may be used in connection with any offering of our securities through any of these methods or other methods described in the applicable prospectus supplement.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Each prospectus supplement will describe the method of distribution of the securities and any applicable restrictions.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">The prospectus supplement with respect to the securities of a particular series will describe the terms of the offering of the securities, including the following:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">the name of the agent or any underwriters;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">the public offering or purchase price;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">any discounts and commissions to be allowed or paid to the agent or underwriters;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">all other items constituting underwriting compensation;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">any discounts and commissions to be allowed or paid to dealers; and</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">any exchanges on which the securities will be listed.</td>
</tr></table>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">If any underwriters or agents are used in the sale of the securities in respect of which this prospectus is delivered, we will enter into an underwriting agreement, sales agreement or other agreement with them at the time of sale to them, and we will set forth in the prospectus supplement relating to such offering the names of the underwriters or agents and the terms of the related agreement with them.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">In connection with the offering of securities, we may grant to the underwriters an option to purchase additional securities with an additional underwriting commission, as may be set forth in the accompanying prospectus supplement. If we grant any such option, the terms of such option will be set forth in the prospectus supplement for such securities.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">If a dealer is used in the sale of the securities in respect of which the prospectus is delivered, we will sell such securities to the dealer, as principal. The dealer, who may be deemed to be an &ldquo;underwriter&rdquo; as that term is defined in the Securities Act, may then resell such securities to the public at varying prices to be determined by such dealer at the time of resale.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">If we offer securities in a subscription rights offering to our existing security holders, we may enter into a standby underwriting agreement with dealers, acting as standby underwriters. We may pay the standby underwriters a commitment fee for the securities they commit to purchase on a standby basis. If we do not enter into a standby underwriting arrangement, we may retain a dealer-manager to manage a subscription rights offering for us.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 36 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">Agents, underwriters, dealers and other persons may be entitled under agreements which they may enter into with us to indemnification by us against certain civil liabilities, including liabilities under the Securities Act, and may be customers of, engage in transactions with or perform services for us in the ordinary course of business.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">If so indicated in the applicable prospectus supplement, we will authorize underwriters or other persons acting as our agents to solicit offers by certain institutions to purchase securities from us pursuant to delayed delivery contracts providing for payment and delivery on the date stated in the prospectus supplement. Each contract will be for an amount not less than, and the aggregate amount of securities sold pursuant to such contracts shall not be less nor more than, the respective amounts stated in the prospectus supplement. Institutions with whom the contracts, when authorized, may be made include commercial and savings banks, insurance companies, pension funds, investment companies, educational and charitable institutions and other institutions, but shall in all cases be subject to our approval. Delayed delivery contracts will not be subject to any conditions except that:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">the purchase by an institution of the securities covered under that contract shall not at the time of delivery be prohibited under the laws of the jurisdiction to which that institution is subject; and</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"></td><td style="width: 20pt; text-align: left">&bull;</td><td style="text-align: justify">if the securities are also being sold to underwriters acting as principals for their own account, the underwriters shall have purchased such securities not sold for delayed delivery. The underwriters and other persons acting as our agents will not have any responsibility in respect of the validity or performance of delayed delivery contracts.</td>
</tr></table>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">Offered securities may also be offered and sold, if so indicated in the prospectus supplement, in connection with a remarketing upon their purchase, in accordance with a redemption or repayment pursuant to their terms, or otherwise, by one or more remarketing firms, acting as principals for their own accounts or as agents for us. Any remarketing firm will be identified and the terms of its agreement, if any, with us and its compensation will be described in the applicable prospectus supplement. Remarketing firms may be deemed to be underwriters in connection with their remarketing of offered securities.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">Certain agents, underwriters and dealers, and their associates and affiliates, may be customers of, have borrowing relationships with, engage in other transactions with, or perform services, including investment banking services, for us or one or more of our respective affiliates in the ordinary course of business.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">Certain underwriters may use this prospectus and any accompanying prospectus supplement for offers and sales related to market-making transactions in the securities. These underwriters may act as principal or agent in these transactions, and the sales will be made at prices related to prevailing market prices at the time of sale. Any underwriters involved in the sale of the securities may qualify as &ldquo;underwriters&rdquo; within the meaning of Section 2(a)(11) of the Securities Act. In addition, the underwriters&rsquo; commissions, discounts or concessions may qualify as underwriters&rsquo; compensation under the Securities Act and the rules of the Financial Industry Regulatory Authority.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">In order to facilitate the offering of the securities, any underwriters may engage in transactions that stabilize, maintain or otherwise affect the price of the securities or any other securities the prices of which may be used to determine payments on such securities. Specifically, any underwriters may over allot in connection with the offering, creating a short position for their own accounts. In addition, to cover overallotments or to stabilize the price of the securities or of any such other securities, the underwriters may bid for, and purchase, the securities or any such other securities in the open market. Finally, in any offering of the securities through a syndicate of underwriters, the underwriting syndicate may reclaim selling concessions allowed to an underwriter or a dealer for distributing the securities in the offering if the syndicate repurchases previously distributed securities in transactions to cover syndicate
short positions, in stabilization transactions or otherwise. Any of these activities may stabilize or maintain the market price of the securities above independent market levels. Any such underwriters are not required to engage in these activities and may end any of these activities at any time.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">We may engage in at the market offerings into an existing trading market in accordance with Rule 415(a)(4) under the Securities Act. In addition, we may enter into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions. If the applicable prospectus supplement so indicates, in connection with those derivatives, the third parties may sell securities covered by this prospectus and the applicable prospectus supplement, including in short sale transactions. If so, the third party may use securities pledged by us or borrowed from us or others to settle those sales or to close out any related open borrowings of stock, and may use securities received from us in settlement of those derivatives to close out any related open borrowings of stock. The third party in such sale transactions will be an underwriter and, if not identified in this prospectus,
will be named in the applicable prospectus supplement (or a post-effective amendment). In addition, we may otherwise loan or pledge securities to a financial institution or other third party that in turn may sell the securities short using this prospectus and an applicable prospectus supplement. Such financial institution or other third party may transfer its economic short position to investors in our securities or in connection with a concurrent offering of other securities.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 37 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">Under Rule 15c6-1 of the Exchange Act, trades in the secondary market generally are required to settle in one business day, unless the parties to any such trade expressly agree otherwise. The applicable prospectus supplement may provide that the original issue date for your securities may be more than one scheduled business day after the trade date for your securities. Accordingly, in such a case, if you wish to trade securities on any date prior to the first business day before the original issue date for your securities, you will be required, by virtue of the fact that your securities initially are expected to settle in more than one scheduled business day after the trade date for your securities, to make alternative settlement arrangements to prevent a failed settlement.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">The securities may be new issues of securities and may have no established trading market. The securities may or may not be listed on a national securities exchange. We can make no assurance as to the liquidity of or the existence of trading markets for any of the securities.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">The specific terms of any lock-up provisions in respect of any given offering will be described in the applicable prospectus supplement.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">Any underwriters, dealers and agents may engage in transactions with us, or perform services for us, in the ordinary course of business for which they receive compensation.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">The anticipated date of delivery of offered securities will be set forth in the applicable prospectus supplement relating to each offer.</p>

<p style="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"></p>

<!-- Field: Page; Sequence: 38 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b><a name="a_014"></a>LEGAL MATTERS</b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in"><font style="background-color: white">Unless otherwise indicated in the
applicable prospectus supplement, the validity of any Ordinary Shares offered under this prospectus and any supplement hereto will be
passed upon for us by DLA Piper LLP (US). Any underwriters will also be advised about the validity of the securities and other legal
matters by their own counsel, which will be named in the prospectus supplement.</font></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b><a name="a_015"></a>EXPERTS</b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">The consolidated financial statements of Sono N.V. as of December 31, 2025 and 2024 and for each of the two years in the period ended December 31, 2025, and management&rsquo;s assessment of the effectiveness of Sono N.V.&rsquo;s internal control over financial reporting as of December 31, 2025, incorporated by reference in this prospectus have been so incorporated in reliance on the report (which contains an explanatory paragraph relating to Sono N.V.&rsquo;s ability to continue as a going concern as described in Note&nbsp;3 to the consolidated financial statements) of Grassi &amp; Co., CPAs, P.C., an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b><a name="a_016"></a>WHERE YOU CAN FIND MORE INFORMATION</b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">We have filed with the SEC this registration statement on Form S-3, including exhibits, with respect
to the shares of Ordinary Shares offered hereby. This prospectus does not contain all of the information set forth in the registration
statement and the exhibits and schedules thereto. For further information with respect to the Company and its Ordinary Shares, reference
is made to the registration statement and the exhibits and any schedules filed therewith. Statements contained in this prospectus as to
the contents of any contract or other document referred to are not necessarily complete and in each instance, if such contract or document
is filed as an exhibit, reference is made to the copy of such contract or other document filed as an exhibit to the registration statement,
each statement being qualified in all respects by such reference.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">We are required to file annual, quarterly and current reports, proxy statements and other information with the SEC as required by the Exchange Act. You can read our SEC filings, including this prospectus, over the Internet at the SEC&rsquo;s website at <i>http://www.sec.gov</i>.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">Our website address is https://ir.sonomotors.com/. Through our website, we make available, free of charge, the following documents as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC, including our Annual Reports on Form 10-K (and previously on Form 20-F), our Quarterly Reports on Form 10-Q, and our Current Reports on Form 8-K (and previously on Form 6-K), and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act. The information contained on, or that may be accessed through, our website is not a part of, and is not incorporated into, this prospectus.</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b></b></p>

<!-- Field: Page; Sequence: 39 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b><a name="a_017"></a>INFORMATION INCORPORATED BY REFERENCE</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">The SEC allows us to &ldquo;incorporate by reference&rdquo; into this prospectus information we file with the SEC in other documents. This means that we can disclose important information to you by referring to another document we filed with the SEC. The information relating to us contained in this prospectus should be read together with the information in the documents incorporated by reference.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">We incorporate by reference the documents listed below that Sono N.V. has previously filed with the SEC (other than any document or portion of any document furnished or deemed furnished and not filed in accordance with SEC rules, including Items 2.02 and 7.01 of Form 8-K and Item 9.01 related thereto):</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td style="text-align: justify">Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001840416/000117184326002178/sev20251231_10k.htm">April 1, 2026</a>; and</td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Symbol">&middot;</font></td><td style="text-align: justify">Current Reports on Form 8-K, filed with the SEC on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001840416/000117184326000517/f8k_012926.htm">January 29, 2026</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001840416/000117184326001054/f8k_022426.htm">February 24, 2026</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001840416/000117184326001464/f8k_031026.htm">March 10, 2026</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001840416/000117184326001589/f8k_031626.htm">March 16, 2026</a> and <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001840416/000117184326001794/f8k_031926.htm">March 19, 2026</a> (as amended by the Form 8-K/A filed with the SEC on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001840416/000117184326003196/f8ka_050826.htm">May 8, 2026</a>).</td></tr></table>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">We are also incorporating by reference all documents subsequently filed by the registrant pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, other than any document or portion of any document furnished or deemed furnished and not filed in accordance with SEC rules, including Items 2.02 and 7.01 on Form 8-K and Item 9.01 related thereto.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in">The information incorporated by reference is considered to be part of this prospectus, and information that we file later with the SEC and incorporate by reference in this prospectus will automatically update and supersede this previously filed information, as applicable, including information in previously filed documents or reports that have been incorporated by reference into this prospectus. Any statement so modified or superseded will not be deemed, except as so modified or superseded, to constitute a part of this prospectus.</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"></p>

<!-- Field: Page; Sequence: 40 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>SONO GROUP N.V.</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b></b></p>

<p style="font-size: 10pt; text-align: center; margin: 0"><font style="background-color: white"><b>$100,000,000</b></font></p>
<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b></b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Ordinary Shares</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Preferred Shares</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Debt Securities</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Warrants</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Rights</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Units</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding: 0.75pt 1pt">&nbsp;</td>
    <td style="padding: 0.75pt 1pt">&nbsp;</td>
    <td style="padding: 0.75pt 1pt">&nbsp;</td></tr>
  <tr>
    <td colspan="3" style="border-top: black 1pt solid; padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  </table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">PROSPECTUS</p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding: 0.75pt 1pt">&nbsp;</td>
    <td style="padding: 0.75pt 1pt">&nbsp;</td>
    <td style="padding: 0.75pt 1pt">&nbsp;</td></tr>
  <tr>
    <td colspan="3" style="border-top: black 1pt solid; padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  </table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">, 2026</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0; color: #CC062A">We have not authorized any dealer, salesperson or other person to give any information or represent anything not contained in this prospectus. You must not rely on any unauthorized information. If anyone provides you with different or inconsistent information, you should not rely on it. This prospectus does not offer to sell any securities in any jurisdiction where it is unlawful. Neither the delivery of this prospectus, nor any sale made hereunder, shall create any implication that the information in this prospectus is correct after the date hereof.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 41 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>PART II</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>INFORMATION NOT REQUIRED IN PROSPECTUS</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Item 14. Other expenses of issuance and distribution</b></p>

<p style="margin: 0pt 0; font-size: 10pt">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">The following table sets forth the estimated fees and expenses payable by the registrant in connection with the offering and sale of our Ordinary Shares and other securities:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding: 1.5pt 1.25pt 1.5pt 10.25pt; font-size: 10pt; text-indent: -9pt; width: 60%"><font style="font-size: 10pt">SEC registration fee</font></td>
    <td style="padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.25pt; font-size: 10pt; width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="padding-top: 1.5pt; padding-bottom: 1.5pt; font-size: 10pt; text-align: right; width: 14%">13,810 <font style="font-size: 10pt"> </font></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding: 1.5pt 1.25pt"><p style="font-size: 10pt; text-indent: -9pt; margin: 0pt 0 0pt 9pt; border-left-width: 0in; border-left-color: Black">Printing expenses*</p></td>
    <td style="padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.25pt; font-size: 10pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-top: 1.5pt; padding-bottom: 1.5pt; font-size: 10pt; text-align: right"><font style="font-size: 10pt">10,000 </font></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding: 1.5pt 1.25pt"><p style="font-size: 10pt; text-indent: -9pt; margin: 0pt 0 0pt 9pt; border-left-width: 0in; border-left-color: Black">Legal fees and expenses*</p></td>
    <td style="padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.25pt; font-size: 10pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-top: 1.5pt; padding-bottom: 1.5pt; font-size: 10pt; text-align: right"><font style="font-size: 10pt">25,000 </font></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding: 1.5pt 1.25pt"><p style="font-size: 10pt; text-indent: -9pt; margin: 0pt 0 0pt 9pt; border-left-width: 0in; border-left-color: Black">Accounting fees and expenses*</p></td>
    <td style="padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.25pt; font-size: 10pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-top: 1.5pt; padding-bottom: 1.5pt; font-size: 10pt; text-align: right"><font style="font-size: 10pt">7,500</font></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding: 1.5pt 1.25pt"><p style="font-size: 10pt; text-indent: -9pt; margin: 0pt 0 0pt 9pt; border-left-width: 0in; border-left-color: Black">Miscellaneous*</p></td>
    <td style="padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.25pt; font-size: 10pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-top: 1.5pt; padding-bottom: 1.5pt; font-size: 10pt; text-align: right"><font style="font-size: 10pt">- </font></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding: 1.5pt 1.25pt"><p style="font-size: 10pt; text-indent: -9pt; margin: 0pt 0 0pt 9pt; border-left-width: 0in; border-left-color: Black"><b>Total</b>&nbsp;</p></td>
    <td style="padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.25pt; font-size: 10pt"><font style="font-size: 10pt"><b>$</b></font></td>
    <td style="padding-top: 1.5pt; padding-bottom: 1.5pt; font-size: 10pt; text-align: right"><font style="font-size: 10pt"><b>56,310</b>&nbsp;</font></td>
    </tr>
  </table>

<p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">_______________________</p>

<p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">*Estimated expenses are not presently known. The applicable prospectus supplement or one or more Current Reports on Form 8-K, which will be incorporated by reference, will set forth the estimated amount of such expenses payable in respect of any offering of the securities.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">We will bear all costs, expenses and fees in connection with the registration of the securities, including with regard to compliance with state securities or &ldquo;blue sky&rdquo; laws. All amounts are estimates except the SEC registration fee and the FINRA filing fee.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Item 15. Indemnification of Directors and Officers</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0; background-color: white"><i>Indemnification of Directors and Officers Under Dutch Law</i></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Sono N.V. has entered into indemnification agreements with the members of the Supervisory Board
and the Management Board. Such members, including former members, will have the benefit of the following indemnification provisions in
the Articles of Association:</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Current and former members of the Supervisory Board and the Management Board shall be reimbursed for all expenses (including reasonably incurred and substantiated attorneys&rsquo; fees), financial effects of judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection with such action, suit or proceeding, provided he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to our best interests or out of his mandate, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. Any indemnification shall be made only (unless ordered by a court) upon a determination that indemnification of a director or former director is proper under the circumstances because he or she had met the applicable standard of conduct set.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Expenses that a director or former director has incurred in defending a civil or criminal action, suit or proceeding may be paid by the registrant in advance of the final disposition of such action, suit or proceeding, upon a resolution of the board of directors with respect to the specific case upon receipt of an undertaking by or on behalf of the director to repay such amount, unless it is ultimately determined that such director is entitled to be indemnified by us.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0; background-color: white">A director or former director of the registrant shall not be entitled to any indemnification, if and to the extent:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; background-color: white">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top"><td style="width: 20px"></td><td style="width: 20px">&#8226;</td><td>Dutch law would not permit such indemnification;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"><td style="width: 20px"></td><td style="width: 20px">&#8226;</td><td>a Dutch court, a judicial tribunal or, in case of an arbitration, an arbitrator has established by final judgment that is not open to challenge or appeal, that the acts or omissions of the director can be considered intentional, fraudulent, grossly negligent, willfully reckless, seriously culpable, or willful misconduct on the part of the director, unless this would in the given circumstances be unacceptable according to the standards of reasonableness and fairness;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top"><td style="width: 20px"></td><td style="width: 20px">&#8226;</td><td>the costs or the decrease in assets of the director are covered by an insurance and the insurer started payment of the costs or the decrease in assets; or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top"><td style="width: 20px"></td><td style="width: 20px">&#8226;</td><td>the registrant brought up the procedure in question before a court.</td></tr></table>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt"></p>

<!-- Field: Page; Sequence: 42; Options: NewSection; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt"><b>Item 16. Exhibits and Financial Statement Schedules. </b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">See the Exhibit Index immediately preceding the signature page for a list of exhibits filed as part of this registration statement, which Exhibit Index is incorporated herein by reference.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Item 17. Undertakings</b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; margin: 0pt 0">The undersigned registrant hereby undertakes:</p>

<p style="margin: 0pt 0; font-size: 10pt">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><font style="font-size: 10pt">A.</font></td>
    <td style="width: 92%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><font style="font-size: 10pt">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><font style="font-size: 10pt">(i)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><font style="font-size: 10pt">To include any prospectus required by section 10(a)(3) of the Securities Act;</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><font style="font-size: 10pt">(ii)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><font style="font-size: 10pt">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration Fee&rdquo; table in the effective
    registration statement; and</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><font style="font-size: 10pt">(iii)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><p style="font-size: 10pt; text-align: justify; margin: 0pt 0">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement.</p>
    <p style="font-size: 10pt; text-align: justify; margin: 0pt 0">Provided, however, that paragraphs (a)(1)(i), (ii), and (iii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.</p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><font style="font-size: 10pt">B.</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><font style="font-size: 10pt">That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><font style="font-size: 10pt">C.</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><font style="font-size: 10pt">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</font></td></tr>
  </table>
<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0; background-color: white">The undersigned registrant hereby undertakes:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify; background-color: white">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><font style="font-size: 10pt">D.</font></td>
    <td style="width: 92%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><font style="font-size: 10pt">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><font style="font-size: 10pt">(i)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><font style="font-size: 10pt">To include any prospectus required by section 10(a)(3) of the Securities Act;</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><font style="font-size: 10pt">(ii)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><font style="font-size: 10pt">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration Fee&rdquo; table in the effective
    registration statement; and</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><font style="font-size: 10pt">(iii)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><p style="font-size: 10pt; text-align: justify; margin: 0pt 0">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement.</p>
    <p style="font-size: 10pt; text-align: justify; margin: 0pt 0">Provided, however, that paragraphs (a)(1)(i), (ii), and (iii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.</p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</td></tr>
</table>

<p style="margin: 0">&nbsp;</p>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; width: 8%"><font style="font-size: 10pt">E.</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify; width: 92%"><font style="font-size: 10pt">That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><font style="font-size: 10pt">F.</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><font style="font-size: 10pt">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><font style="font-size: 10pt">G.</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><font style="font-size: 10pt">That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><font style="font-size: 10pt">(i)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><font style="font-size: 10pt">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><font style="font-size: 10pt">(ii)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><font style="font-size: 10pt">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><font style="font-size: 10pt">(iii)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><font style="font-size: 10pt">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><font style="font-size: 10pt">(iv)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><font style="font-size: 10pt">Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><font style="font-size: 10pt">H.</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><font style="font-size: 10pt">The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant's annual report pursuant to section 13(a) or section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan's annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><font style="font-size: 10pt">I.</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><font style="font-size: 10pt">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling
    precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify">&nbsp;</td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt"><b>EXHIBIT INDEX</b></font></p>



<p style="margin: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: Black 1pt solid; padding: 1.5pt 1.25pt; vertical-align: bottom; font-size: 10pt; width: 10%"><font style="font-size: 10pt"><b>Exhibit No.</b></font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt; width: 2%">&nbsp;</td>
    <td style="border-bottom: black 1pt solid; padding: 1.5pt 1.25pt; vertical-align: bottom; font-size: 10pt; width: 88%"><font style="font-size: 10pt"><b>Description</b></font></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td colspan="2" style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><font style="font-size: 10pt">1.1***</font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><font style="font-size: 10pt">Form of Underwriting Agreement</font></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1840416/000117184325007436/ex_890171.htm"><font style="font-size: 10pt">3.1*</font></a></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1840416/000117184325007436/ex_890171.htm"><font style="font-size: 10pt">Articles of Association of Sono Group N.V., as amended effective September 9, 2025 (Dutch and English translations) (incorporated herein by reference to Exhibit 3.1 of Sono N.V.&rsquo;s Quarterly Report on Form 10-Q filed with the SEC on November 20, 2025)</font></a></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1840416/000117184325002284/ex_798206.htm"><font style="font-size: 10pt">4.1*</font></a></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1840416/000117184325002284/ex_798206.htm"><font style="font-size: 10pt">Description of the rights of each class of Sono N.V. securities registered under Section 12 of the Securities Exchange Act of 1934 (incorporated herein by reference to Exhibit 4.1 of Sono N.V.&rsquo;s Annual Report on Form 10-K filed with the SEC on April 17, 2025)</font></a></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1840416/000117184326001464/exh_41.htm"><font style="font-size: 10pt">4.2*</font></a></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1840416/000117184326001464/exh_41.htm"><font style="font-size: 10pt">Pre-Funded Warrant, dated March 10, 2026, issued by Sono N.V. to YA II PN, Ltd. (incorporated herein by reference to Exhibit 4.1 of Sono N.V.&rsquo;s Current Report on Form 8-K filed with the SEC on March 10, 2026)</font></a></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><font style="font-size: 10pt">4.3***</font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><font style="font-size: 10pt">Form of Specimen Ordinary Shares Certificate </font></td></tr>
  <tr>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt; font-size: 10pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt">&nbsp;</td></tr>
  <tr>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><font style="font-size: 10pt">4.4***</font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt; font-size: 10pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><font style="font-size: 10pt">Form of Specimen Preferred Shares Certificate</font></td></tr>
  <tr>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt; font-size: 10pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt">&nbsp;</td></tr>
  <tr>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><font style="font-size: 10pt">4.5***</font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt; font-size: 10pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><font style="font-size: 10pt">Form of Indenture</font></td></tr>
  <tr>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt; font-size: 10pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt">&nbsp;</td></tr>
  <tr>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><font style="font-size: 10pt">4.6***</font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt; font-size: 10pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><font style="font-size: 10pt">Form of Debt Security&nbsp;with respect to Senior Debt Securities </font></td></tr>
  <tr>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt; font-size: 10pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt">&nbsp;</td></tr>
  <tr>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><font style="font-size: 10pt">4.7***</font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt; font-size: 10pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><font style="font-size: 10pt">Form of Debt Security&nbsp;with respect to Subordinated Debt Securities</font></td></tr>
  <tr>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt; font-size: 10pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt">&nbsp;</td></tr>
  <tr>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><font style="font-size: 10pt">4.8***</font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt; font-size: 10pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><font style="font-size: 10pt">Form of Warrant Agreement </font></td></tr>
  <tr>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt; font-size: 10pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt">&nbsp;</td></tr>
  <tr>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><font style="font-size: 10pt">4.9***</font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt; font-size: 10pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><font style="font-size: 10pt">Form of Rights Agreement</font></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="vertical-align: top; padding-right: 1.25pt; padding-left: 1.25pt; font-size: 10pt">&nbsp;</td></tr>
  <tr>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><font style="font-size: 10pt">4.10***</font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><font style="font-size: 10pt">Form of Unit Agreement</font></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt; font-size: 10pt">&nbsp;</td></tr>
  <tr>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><font style="font-size: 10pt"><a href="exh_51.htm">5.1**</a></font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><font style="font-size: 10pt"><a href="exh_51.htm">Opinion of DLA Piper LLP (US)</a></font></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><a href="exh_231.htm"><font style="font-size: 10pt">23.1**</font></a></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><a href="exh_231.htm"><font style="font-size: 10pt">Consent of Grassi &amp; Co., CPAs, Independent Registered Public Accounting Firm for Sono Group N.V. </font></a></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><a href="exh_51.htm"><font style="font-size: 10pt">23.2**</font></a></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><a href="exh_51.htm"><font style="font-size: 10pt">Consent of DLA Piper LLP (US) (included in Exhibit 5.1)</font></a></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><a href="#poa"><font style="font-size: 10pt">24**</font></a></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><a href="#poa"><font style="font-size: 10pt">Power of Attorney (included on signature page to initial filing of this Registration Statement)</font></a></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><font style="font-size: 10pt">25.1****</font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><font style="font-size: 10pt">Form T-1 Statement of Eligibility of Trustee for Indenture under the Trust Indenture Act of 1939, as amended.</font></td></tr>
  <tr>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt">&nbsp;</td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 1.25pt; padding-left: 1.25pt; font-size: 10pt"><font style="font-size: 10pt"><a href="exh_107.htm">107**</a></font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt; font-size: 10pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt; font-size: 10pt"><font style="font-size: 10pt"><a href="exh_107.htm">Filing Fee Table</a></font></td>
    </tr>
  </table>
<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"> __________________</p>



<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0pt"></td><td style="width: 40pt; text-align: left">*</td><td style="text-align: justify">Previously filed and incorporated herein by reference.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0pt"></td><td style="width: 40pt; text-align: left">**</td><td style="text-align: justify">Filed Herewith.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0pt"></td><td style="width: 40pt; text-align: left">***</td><td style="text-align: justify">To be filed, if necessary, by amendment or as an exhibit to a document to be incorporated or deemed to be incorporated by reference in this registration statement, including a Current Report on Form 8-K.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0pt"></td><td style="width: 40pt; text-align: left">****</td><td style="text-align: justify">To be filed pursuant to Section 305(b)(2) of the Trust Indenture Act of 1939, as amended, as applicable.</td>
</tr></table>

<p style="margin: 0pt 0; font-size: 10pt; text-align: left">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>SIGNATURES</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Pursuant to the requirements of the Securities Act of 1933, as amended, the undersigned has duly caused this registration statement on Form S-3 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Westfield, State of New Jersey on May 12, 2026.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
  <tr>
    <td colspan="2" style="vertical-align: bottom; padding: 1.5pt 1.25pt; font-size: 10pt"><font style="font-size: 10pt"><b>SONO GROUP N.V.</b></font></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt; width: 10%">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt; width: 90%">&nbsp;</td></tr>
  <tr>
    <td style="padding: 1.5pt 1.25pt; vertical-align: bottom; font-size: 10pt"><font style="font-size: 10pt">By:</font></td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: bottom; font-size: 10pt"><font style="font-size: 10pt">/s/ Kevin McGurn </font></td></tr>
  <tr>
    <td style="padding: 1.5pt 1.25pt; vertical-align: bottom; font-size: 10pt"><font style="font-size: 10pt">Name:</font></td>
    <td style="border-top: black 1pt solid; padding: 1.5pt 1.25pt; vertical-align: bottom; font-size: 10pt"><font style="font-size: 10pt">Kevin McGurn </font></td></tr>
  <tr>
    <td style="padding: 1.5pt 1.25pt; vertical-align: bottom; font-size: 10pt"><font style="font-size: 10pt">Title:</font></td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: bottom; font-size: 10pt"><font style="font-size: 10pt">Chief Executive Officer and Managing Director</font></td></tr>
  </table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b><a name="poa"></a>POWER OF ATTORNEY</b></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">KNOW ALL PERSONS BY THESE PRESENTS, that each of the undersigned constitutes and appoints Kevin McGurn, acting alone, his or her true and lawful attorney-in-fact and agents, with full power of substitution and resubstitution, for such person and in his or her name, place and stead, in any and all capacities, to sign this Registration Statement on Form S-3 (including all pre-effective and post-effective amendments and registration statements filed under the Securities Act of 1933), and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming that such attorney-in-fact
and agent, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.25in">&nbsp;<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding: 1.5pt 1.25pt; font-size: 10pt; text-align: center"><font style="font-size: 10pt"><b>Signature</b></font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="vertical-align: bottom; padding: 1.5pt 1.25pt; font-size: 10pt; text-align: center"><font style="font-size: 10pt"><b>Position</b></font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="vertical-align: bottom; padding: 1.5pt 1.25pt; font-size: 10pt; text-align: center"><font style="font-size: 10pt"><b>Date</b></font></td></tr>
  <tr>
    <td style="border-top: black 1pt solid; padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="border-top: black 1pt solid; padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="border-top: black 1pt solid; padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding: 1.5pt 1.25pt; font-size: 10pt"><font style="font-size: 10pt">/s/ Kevin McGurn </font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td rowspan="2" style="padding: 1.5pt 1.25pt">
    <p style="font-size: 10pt; margin: 0pt 0">Chief Executive Officer and Managing Director</p>
    <p style="font-size: 10pt; margin: 0pt 0">(Principal Executive Officer)</p></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="vertical-align: bottom; padding: 1.5pt 1.25pt; font-size: 10pt; text-align: center"><font style="font-size: 10pt">May 12, 2026</font></td></tr>
  <tr>
    <td style="vertical-align: bottom; border-top: black 1pt solid; padding: 1.5pt 1.25pt; font-size: 10pt"><font style="font-size: 10pt">Kevin McGurn</font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding: 1.5pt 1.25pt; font-size: 10pt"><font style="font-size: 10pt">/s/ M. Scott Calhoun</font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td rowspan="2" style="padding: 1.5pt 1.25pt">
    <p style="font-size: 10pt; margin: 0pt 0">Chief Financial Officer</p>
    <p style="font-size: 10pt; margin: 0pt 0">(Principal Financial and Accounting Officer)</p></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="vertical-align: bottom; padding: 1.5pt 1.25pt; font-size: 10pt; text-align: center"><font style="font-size: 10pt">May 12, 2026</font></td></tr>
  <tr>
    <td style="vertical-align: bottom; border-top: black 1pt solid; padding: 1.5pt 1.25pt; font-size: 10pt"><font style="font-size: 10pt">M. Scott Calhoun</font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding: 1.5pt 1.25pt; font-size: 10pt"><font style="font-size: 10pt">/s/ David Dodge</font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="vertical-align: bottom; padding: 1.5pt 1.25pt; font-size: 10pt"><font style="font-size: 10pt">Chairperson of the Supervisory Board</font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="vertical-align: bottom; padding: 1.5pt 1.25pt; font-size: 10pt; text-align: center"><font style="font-size: 10pt">May 12, 2026</font></td></tr>
  <tr>
    <td style="vertical-align: bottom; border-top: black 1pt solid; padding: 1.5pt 1.25pt; font-size: 10pt"><font style="font-size: 10pt">David Dodge</font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding: 1.5pt 1.25pt; font-size: 10pt"><font style="font-size: 10pt">/s/ Christopher Schreiber</font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="vertical-align: bottom; padding: 1.5pt 1.25pt; font-size: 10pt"><font style="font-size: 10pt">Member of the Supervisory Board</font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="vertical-align: bottom; padding: 1.5pt 1.25pt; font-size: 10pt; text-align: center"><font style="font-size: 10pt">May 12, 2026</font></td></tr>
  <tr>
    <td style="vertical-align: bottom; border-top: black 1pt solid; padding: 1.5pt 1.25pt; font-size: 10pt"><font style="font-size: 10pt">Christopher Schreiber</font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding: 1.5pt 1.25pt; font-size: 10pt"><font style="font-size: 10pt">/s/ Owen May</font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="vertical-align: bottom; padding: 1.5pt 1.25pt; font-size: 10pt"><font style="font-size: 10pt">Member of the Supervisory Board</font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="vertical-align: bottom; padding: 1.5pt 1.25pt; font-size: 10pt; text-align: center"><font style="font-size: 10pt">May 12, 2026</font></td></tr>
  <tr>
    <td style="vertical-align: bottom; border-top: black 1pt solid; padding: 1.5pt 1.25pt; font-size: 10pt"><font style="font-size: 10pt">Owen May</font></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&nbsp;</td></tr>
  </table>
<p style="margin: 0pt 0; font-size: 10pt; text-align: center">
<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">II-5</p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="font-size: 1pt; border-top: Black 4pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"></p>








</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>exh_51.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt"><B>Exhibit 5.1</B></FONT></P>

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 74%; padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><IMG SRC="dlapiper.jpg" ALT="" STYLE="height: 106px; width: 165px"></FONT></TD>
    <TD STYLE="vertical-align: top; width: 26%; padding: 0.25pt">
    <P STYLE="font-size: 10pt; margin: 0"><B>DLA Piper LLP (US)</B></P>
    <P STYLE="font-size: 10pt; margin: 0">555 Mission St. #2400</P>
    <P STYLE="font-size: 10pt; margin: 0">San Francisco, California 94105</P>
    <P STYLE="font-size: 10pt; margin: 0">www.dlapiper.com</P></TD></TR>
  </TABLE>
<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">May 12, 2026</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0">Sono Group N.V.</P>

<P STYLE="margin: 0; font-size: 10pt; text-align: justify">4965 Trinidad Drive</P>

<P STYLE="margin: 0; font-size: 10pt; text-align: justify">Land O&rsquo;Lakes, FL 34639</P>

<P STYLE="margin: 0; font-size: 10pt; text-align: justify">United States of America</P>

<P STYLE="margin: 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; padding: 0.5pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Re:</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0.5pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Sono Group N.V.</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding: 0.5pt; font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 0.5pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Registration Statement on Form S-3 (File No. 333-[______])</FONT></TD></TR>
  </TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0">Ladies and Gentlemen:</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">We have acted as special United States counsel to Sono Group N.V., a public
company with limited liability organized under the laws of the Netherlands (the &#8220;<B>Company</B>&#8221;), in connection with the
Registration Statement (as defined below) filed by the Company relating to the offering of up to $100,000,000 in total value of: (a) ordinary
shares, (b) preferred shares, (c) debt securities of the Company (the &#8220;<B>Debt Securities</B>&#8221;), which may be issued in one
or more series, as either senior or subordinated debt securities, (d) warrants to purchase ordinary shares, preferred shares and/or Debt
Securities of the Company (the &#8220;<B>Warrants</B>&#8221;), (e) rights to purchase ordinary shares, preferred shares and/or Debt Securities
of the Company (the &#8220;<B>Rights</B>&#8221;), and (f) units comprised of any combination of ordinary shares, preferred shares, Debt
Securities and/or Warrants of the Company (the &#8220;<B>Units</B>&#8221;). The Debt Securities, Warrants, Rights, and Units are collectively
referred to herein as the &#8220;<B>Securities</B>.&#8221; The Registration Statement provides that the Securities may be offered separately
or together, in separate series, in amounts, at prices and on terms to be set forth in one or more supplements to the Prospectus (each,
a &#8220;<B>Prospectus Supplement</B>&#8221;) or any related free writing prospectus (each, a &#8220;<B>Free Writing Prospectus</B>&#8221;).&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0">This opinion is being furnished in accordance with the requirements of Item
601(b)(5) of Regulation S-K under the Securities Act of 1933, as amended (the &#8220;<B>Securities Act</B>&#8221;), and no opinion is
expressed herein as to any matter pertaining to the contents of the Registration Statement or related prospectus, or any prospectus supplement
or amendment filed with respect thereto, other than as expressly stated herein with respect to the issuance of the Debt Securities, the
Warrants, the Rights, and the Units.</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">In rendering the opinions stated herein, we have examined and relied upon
the registration statement on Form S-3 (File No. 333-[______]) of the Company relating to the Securities, filed on May 12, 2026
with the Securities and Exchange Commission (the &#8220;<B>Commission</B>&#8221;) under the Securities Act (the &#8220;<B>Registration
Statement</B>&#8221;), and the exhibits thereto.</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">We have also examined originals or copies, certified or otherwise identified
to our satisfaction, of such records of the Company and such agreements, certificates and receipts of public officials, certificates of
officers or other representatives of the Company and others, and such other documents and matters as we have deemed necessary or appropriate
as a basis for the opinions stated below.</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">In our examination, we have assumed the genuineness of all signatures on
all documents, including electronic signatures, the legal capacity and competency of all natural persons executing any documents, the
authenticity and completeness of all documents submitted to us as originals, the completeness and conformity to original documents of
all documents submitted to us as facsimile, electronic, certified or photocopied copies or which we obtained from the Commission&#8217;s
Electronic Data Gathering, Analysis and Retrieval system (&#8220;<B>EDGAR</B>&#8221;) or other sites on the internet, and the authenticity
of the originals thereof. As to any facts and the consequences thereof relevant to the opinions stated herein that we did not independently
establish or verify, we have, to the extent deemed appropriate, relied without independent investigation or verification upon, and assumed
the accuracy and completeness of, statements and representations of officers and other representatives of the Company and others and of
public officials.</P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify">Sono Group N.V.</P>

<P STYLE="font-size: 10pt; margin: 0 0 0.25in">May 12, 2026<BR>
Page 2</P>

<P STYLE="margin: 6pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;We further assume that:&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
issuance, sale, amount and terms of the Securities to be offered from time to time by the Company will be authorized and determined by
proper action of the Management Board of the Company, and with the approval of the Supervisory Board of the Company (as appropriate) (each,
a &#8220;<B>Board Action</B>&#8221;) in accordance with the articles of association of the Company (the &#8220;<B>Articles of Association</B>&#8221;)
and Netherlands law (and any other applicable laws), in each case so as not to result in a default under or breach of any instrument,
document or agreement binding upon the Company, and so as to comply with any requirement or restriction imposed by any court or governmental
or regulatory body having jurisdiction over the Company.&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will not issue any Securities in excess of the number or amount authorized by a Board Action.&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
Debt Securities will be issued under a valid and legally binding indenture (an &#8220;<B>Indenture</B>&#8221;), as required, as it may
be supplemented by a valid and legally binding supplemental indenture (each a &#8220;<B>Supplemental Indenture</B>&#8221;), and in each
case duly authorized, executed and delivered by the Company, and, if required by the Indenture, accompanied by an officer&#8217;s certificate,
that conforms to the description thereof set forth in the Prospectus, the applicable Prospectus Supplement and any related Free Writing
Prospectus.&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">(4)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the extent that the obligations of the Company under any Indenture or Supplemental Indenture may be dependent upon such matters, the financial
institution to be identified in such Indenture or Supplemental Indenture as trustee or in any other specified capacity (the &#8220;<B>Financial
Institution</B>&#8221;) will be duly organized, validly existing, and in good standing under the laws of its jurisdiction of organization;
the Financial Institution will be duly qualified to engage in the activities contemplated by such agreement; such agreement will have
been duly authorized, executed, and delivered by the Financial Institution and will constitute the legally, valid and binding obligation
of the Financial Institution enforceable against the Financial Institution in accordance with its terms; the Financial Institution will
be in compliance, generally, with respect to acting under such agreement, with applicable laws and regulations; and the Financial Institution
will have the requisite organizational and legal power and authority to perform its obligations under such agreement.&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">(5)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Appropriate
debentures, notes and/or other evidences of indebtedness evidencing the Debt Securities will be executed and authenticated in accordance
with the Indenture, as it may be supplemented by a Supplemental Indenture, and, if required by the Indenture, accompanied by an officer&#8217;s
certificate, will be delivered upon the issuance and sale of the Debt Securities and will comply with the Indenture, any Supplemental
Indenture and any accompanying officer&#8217;s certificate, the Articles of Association and applicable law.&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">&nbsp;(6)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
Warrants will be issued under a valid and legally binding warrant agreement (a &#8220;<B>Warrant Agreement</B>&#8221;) that conforms to
the description thereof set forth in the Prospectus, the applicable Prospectus Supplement and any related Free Writing Prospectus, and
will comply with the Articles of Association and applicable law.&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">(7)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior
to the issuance of any Rights, there will exist, under the Articles of Association, the requisite number of authorized but unissued ordinary
shares and preferred shares (and securities of any class into which any of the preferred shares may be convertible), as the case may be,
and that all actions necessary to the creation and issuance of any such Rights will have been taken.&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">(8)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
Rights will be issued under a valid and legally binding rights agreement (a &#8220;<B>Rights Agreement</B>&#8221;) that conforms to the
description thereof set forth in the Prospectus, the applicable Prospectus Supplement and any related Free Writing Prospectus, and will
comply with the Articles of Association and applicable law.&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">(9)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior
to the issuance of any Units, there will exist, under the Articles of Association, the requisite number of authorized but unissued ordinary
shares and preferred shares (and securities of any class into which any of the preferred shares may be convertible), as the case may be,
and that all actions necessary to the creation of any such Units, will have been taken.&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify">Sono Group N.V.</P>

<P STYLE="font-size: 10pt; margin: 0 0 0.25in">May 12, 2026<BR>
Page 3</P>

<P STYLE="margin: 6pt 0; font-size: 10pt; text-indent: 0.5in">(10)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
Units will be issued under a valid and legally binding unit agreement (a &#8220;<B>Unit Agreement</B>&#8221;) that conforms to the description
thereof set forth in the Prospectus, the applicable Prospectus Supplement and any related Free Writing Prospectus and will comply with
the Company&#8217;s Articles of Association and applicable law.</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">(11)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
underwriting or other agreements for offerings of the Securities (each, an &#8220;<B>Underwriting Agreement</B>&#8221;) will be valid
and legally binding contracts that conform to the description thereof set forth in the Prospectus, the applicable Prospectus Supplement
and any related Free Writing Prospectus.&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">(12)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Registration Statement will have been declared effective and will remain effective under the Securities Act.&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">We do not express any opinion with respect to the laws of any jurisdiction
other than the substantive, internal laws of the State of New York, except that we express no opinion and make no statement as to the
municipal laws or the laws, rules or regulations of any local agencies or governmental authorities of or within the State of New York
or, in each case, as to any matters arising thereunder or relating thereto (the &#8220;<B>Opined-on Law</B>&#8221;). We do not express
any opinion as to the laws of any other jurisdiction, domestic or foreign. We understand that various matters concerning the laws of the
Netherlands with respect to the Debt Securities, the Warrants, the Rights, and the Units (and also the ordinary shares and preferred shares
of the Company) are addressed in the opinion of DLA Piper Nederland N.V., which has been separately provided to you. We express no opinion
with respect to those matters herein, and, to the extent such matters are necessary to the conclusions expressed herein, we have, with
your consent, assumed all such matters.</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">As used herein, &#8220;<B>Transaction Documents</B>&#8221; means, as applicable,
the Indenture, any Supplemental Indenture, any certificates for Debt Securities, the Warrants and Warrant Agreement, the Rights Agreement,
the Unit Agreement, and any Underwriting Agreement. We have assumed that all Transaction Documents will be governed by the Opined-on Law.</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">Based upon the foregoing and subject to the qualifications and assumptions
stated herein, we are of the opinion that:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 27pt">(1)</TD><TD>Upon issuance and delivery of certificates for such Debt Securities against payment therefor in accordance with the terms and provisions
of the applicable Board Action, the Debt Securities and the applicable Indenture, Supplemental Indenture together with an officer&#8217;s
certificate, if any, the Registration Statement, the Prospectus, the applicable Prospectus Supplement and any related Free Writing Prospectus,
and, if applicable, an Underwriting Agreement, or upon issuance and delivery of certificates for such Debt Securities pursuant to the
conversion terms of one or more series of Securities convertible into or exercisable for Debt Securities, the Debt Securities represented
by such certificates will be duly authorized and, when duly authenticated in accordance with the terms of the applicable Indenture, will
be valid and binding obligations of the Company, enforceable against the Company in accordance with their terms under the laws of the
State of New York.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 27pt">(2)</TD><TD>Upon execution, issuance, and delivery of the Warrants against payment therefor in accordance with the terms and provisions of the
applicable Board Action, the Company charter documents and applicable law, the Warrant Agreement, the Registration Statement, the Prospectus,
the applicable Prospectus Supplement and any related Free Writing Prospectus, and, if applicable, an Underwriting Agreement, the Warrants
will be duly authorized and will constitute valid and legally binding obligations of the Company, enforceable against the Company in accordance
with their terms under the laws of the State of New York.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 27pt">(3)</TD><TD>Upon execution, issuance, and delivery of the Rights against payment therefor in accordance with the terms and provisions of the applicable
Board Action, the Company charter documents and applicable law, the Rights Agreement, the Registration Statement, the Prospectus, the
applicable Prospectus Supplement, and any related Free Writing Prospectus, and, if applicable, an Underwriting Agreement, the Rights will
be duly authorized and will constitute valid and legally binding obligations of the Company, enforceable against the Company in accordance with their
terms under the laws of the State of New York.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify">Sono Group N.V.</P>

<P STYLE="margin: 0; font-size: 10pt">May 12, 2026<BR>
Page 4</P>

<P STYLE="margin: 0; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 27pt">(4)</TD><TD>Upon execution, issuance, and delivery of the Units against payment therefor in accordance with the terms and provisions of the applicable
Board Action, the Company charter documents and applicable law, the Unit Agreement, the Registration Statement, the Prospectus, the applicable
Prospectus Supplement, and any related Free Writing Prospectus, and, if applicable, an Underwriting Agreement, the Units will be duly
authorized and will constitute valid and legally binding obligations of the Company, enforceable against the Company in accordance with
their terms under the laws of the State of New York.</TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">The opinions stated herein are subject to the following qualifications:</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
we do not express any opinion with respect to the effect on the opinions stated herein of any bankruptcy, insolvency, reorganization,
moratorium, fraudulent transfer, preference and other similar laws affecting creditors&#8217; rights generally, and the opinions stated
herein are limited by such laws and by general principles of equity (regardless of whether enforcement is sought in equity or at law);</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
we do not express any opinion with respect to any law, rule or regulation that is applicable to any party to any of the Transaction Documents
or the transactions contemplated thereby solely because such law, rule or regulation is part of a regulatory regime applicable to any
such party or any of its affiliates as a result of the specific assets or business operations of such party or such affiliates;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
we do not express any opinion with respect to the enforceability of any provision contained in any Transaction Document relating to any
indemnification, contribution, non-reliance, exculpation, release, limitation or exclusion of remedies, waiver or other provisions having
similar effect that may be contrary to public policy or violative of federal or state securities laws, rules or regulations, or to the
extent any such provision purports to, or has the effect of, waiving or altering any statute of limitations;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
we call to your attention that irrespective of the agreement of the parties to any Transaction Document, a court may decline to hear a
case on grounds of forum non conveniens or other doctrine limiting the availability of such court as a forum for resolution of disputes;
in addition, we call to your attention that we do not express any opinion with respect to the subject matter jurisdiction of the federal
courts of the United States of America in any action arising out of or relating to any Transaction Document;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
we have assumed that any Financial Institution, Warrant Agent, Rights Agent, and/or Unit Agent each has the power, corporate or other,
to enter into and perform all obligations under the applicable Transaction Document to which it is a party, and we have also assumed the
due authorization by all requisite action, corporate or other, and the execution and delivery by such party of the applicable Transaction
Document, and that each such Transaction Document constitutes the valid and binding obligation of such party, enforceable against such
party in accordance with its terms; and</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
to the extent that any opinion relates to the enforceability of the choice of New York law and choice of New York forum provisions contained
in any of the Transaction Documents, the opinions stated herein are subject to the qualification that such enforceability may be subject
to, in each case, (i) the exceptions and limitations in New York General Obligations Law sections 5-1401 and 5-1402 and (ii) principles
of comity and constitutionality.</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">In addition, in rendering the foregoing opinions we have assumed that:</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the Company (i) is and at all relevant times will continue to be duly incorporated and is validly existing and in good standing, (ii)
has and at all relevant times will continue to have requisite legal status and legal capacity under the laws of the Netherlands and (iii)
has complied and will continue to comply with all aspects of the laws of the Netherlands in connection with the transactions contemplated
by, and the performance of its obligations under, the Transaction Documents. We have also assumed that the laws of the Netherlands would
not impose any requirements or have any consequences relevant to our understanding of such matters that would impact our conclusions with
respect thereto;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify">Sono Group N.V.</P>

<P STYLE="margin: 0; font-size: 10pt">May 12, 2026<BR>
Page 5</P>

<P STYLE="margin: 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 6pt 0; font-size: 10pt; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the Company has and at all relevant times will continue to have the corporate power and authority to execute, deliver and perform all
its obligations under the Transaction Documents;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
each of the Transaction Documents will have been duly authorized, executed and delivered by all requisite Board Action and other corporate
action on part of the Company;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
neither the execution and delivery by the Company of the Transaction Documents nor the performance by the Company of its obligations thereunder,
including the issuance and sale of the Securities, (i)&nbsp;conflicts or will conflict with the articles of association of the Company,
(ii) constitutes or will constitute a violation of, or a default under, any lease, indenture, instrument or other agreement to which the
Company or its property is subject, (iii) contravenes or will contravene any order or decree of any governmental authority to which the
Company or its property is subject, or (iv) violates or will violate any law, rule or regulation to which the Company or its property
is subject (except that we do not make the assumption set forth in this clause (iv) with respect to the Opined-on Law); and</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
neither the execution and delivery by the Company of the Transaction Documents nor the performance by the Company of its obligations
thereunder, including the issuance and sale of the Securities, requires or will require the consent, approval, licensing or authorization
of, or any filing, recording or registration with, any governmental authority under any law, rule or regulation of any jurisdiction.</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">The opinions expressed herein are limited to the matters set forth in this
letter, and no other opinion should be inferred beyond the matters expressly stated. This opinion is rendered as of the date first written
above, and we disclaim any obligation to advise you of facts, circumstances, events or developments which hereafter may be brought to
our attention and that may alter, affect or modify the opinions expressed herein or of any subsequent changes in applicable laws.</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">We hereby consent to the reference to our firm under the heading &#8220;Legal
Matters&#8221; in the prospectus forming part of the Registration Statement. We also hereby consent to the filing of this opinion with
the Commission as Exhibit 5.1 to the Registration Statement. In giving this consent, we do not thereby admit that we are within the category
of persons whose consent is required under Section 7 of the Securities Act, the General Rules and Regulations under the Securities Act,
or Item 509 of Regulation S-K.</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 6pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0.25in 0 8pt">Very truly yours,</P>

<P STYLE="font-size: 10pt; margin: 0 0 8pt">/s/ DLA Piper LLP (US)</P>

<P STYLE="font-size: 10pt; margin: 0 0 8pt"><B>DLA PIPER LLP (US)</B></P>

<P STYLE="margin: 0 0 8pt; font-size: 10pt"><B>&nbsp;</B></P>

<P STYLE="margin: 0 0 8pt; font-size: 10pt"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0 0 8pt; font-size: 10pt"><B>&nbsp;</B></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.2
<SEQUENCE>3
<FILENAME>exh_52.htm
<DESCRIPTION>EXHIBIT 52
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 5.2</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 81%"><IMG SRC="dlapiper.jpg" ALT="" STYLE="height: 96px; width: 150px"></TD>
    <TD STYLE="width: 19%; font-weight: bold"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-weight: normal">DLA Piper Nederland N.V.</FONT></P>
                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-weight: normal">Prinses Amaliaplein 3</FONT></P>
                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-weight: normal">1077 XS Amsterdam</FONT></P>
                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-weight: normal">P.O. Box 75258</FONT></P>
                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-weight: normal">1070 AG Amsterdam</FONT></P>
                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-weight: normal">The Netherlands</FONT></P></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><B>T</B>+31 20 541 9888</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><B>F</B>+31 20 541 9999</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><B>W</B>&nbsp;dlapiper.nl</TD>
    </TR>
  </TABLE>


<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR>
    <TD ROWSPAN="6" STYLE="vertical-align: top; width: 62%">
    <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">To:</P></TD>
    <TD ROWSPAN="6" STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 36%; text-align: left; font-weight: bold">Your Ref:</TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: left; font-weight: bold">Our Ref:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="vertical-align: middle; text-align: center">12 May 2026 </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: bold; text-align: justify">Sono Group N.V.</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">4965 Trinidad Drive </FONT></P>
    <P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">Land O&#8217; Lakes, FL 34639</FONT></P>
    <P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">United States of America</FONT></P></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 17%; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>Re:</B></FONT></TD>
    <TD STYLE="width: 83%; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>LEGALITY opinion &#8211; Form s-3</B></FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify">INTRODUCTION</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.1</TD><TD STYLE="text-align: justify">We act as legal adviser (<I>advocaat</I>) and (<I>notaris</I>) respectively under Netherlands Law to the
Company in connection with the filing of the Registration Statement, which contains, amongst others, a prospectus, which covers the offering,
issuance and sale by the Company, from time to time of, among others, an indeterminate number of the Company's Ordinary Shares. This legal
opinion is furnished to you in order to be filed with the U.S. Securities and Exchange Commission (the &quot;<B>SEC</B>&quot;) as an exhibit
to the Registration Statement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.2</TD><TD STYLE="text-align: justify">Capitalised terms used in this legal opinion have the meanings ascribed to such terms in the Annex to
this legal opinion or in this legal opinion. In addition, any capitalised terms not specifically defined in this legal opinion have the
meaning ascribed to such terms in the Registration Statement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify">APPLICABLE LAW</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">This legal opinion is limited to Netherlands
Law in effect as at the date of this legal opinion and is, together with all terms used in it, to be construed in accordance with Netherlands
Law. We do not express any opinions (factual or legal) on any matters not expressly set out in this legal opinion.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify">DOCUMENTS AND CONFIRMATIONS FORMING THE BASIS OF THE LEGAL OPINION</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.1</TD><TD STYLE="text-align: justify">We have examined (prints of electronic) copies of the following Documents for purposes of the issue of
this legal opinion:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.75in">3.1.1</TD><TD STYLE="text-align: justify">the Registration Statement;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 3pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;<IMG SRC="dlapiper.jpg" ALT="" STYLE="height: 96px; width: 150px"></TD><TD STYLE="width: 50%; text-align: right">Continuation <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.75in">3.1.2</TD><TD STYLE="text-align: justify">the Company&#8217;s deed of incorporation as well as its articles of association, dated or amended, as
the case may be on the dates specified in the Excerpt; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.75in">3.1.3</TD><TD STYLE="text-align: justify">the Excerpt.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.2</TD><TD STYLE="text-align: justify">In addition, we have received the Confirmations.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.3</TD><TD STYLE="text-align: justify">Our examination has been limited to the literal text of the Documents and we have not had regard to any
matters not expressly set out in the Documents. We have not performed any factual or legal investigation other than the review of the
Documents and consideration of the Confirmations referred to above.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify">ASSUMPTIONS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.5in">For the purpose of the legal opinions expressed herein, we have
assumed:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.1</TD><TD STYLE="text-align: justify">that all copy Documents received by us are (and their content is) correct and complete and conform to
the original Documents in all respects;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.2</TD><TD STYLE="text-align: justify">the genuineness and completeness of all signatures on the Documents received by us, such signatures being
the signatures of the relevant individuals concerned whereby in respect of any electronic signatures (i) such electronic signatures meet
the requirements of a qualified electronic signature within the meaning of Regulation (EU) No 910/2014 (eIDAS Regulation) or, where such
requirements are assumed to be not met, (ii) such electronic signatures are otherwise sufficiently reliable as required under Section
3:15a DCC;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.3</TD><TD STYLE="text-align: justify">that the Registration Statement has been or will have been filed with the SEC in the form reviewed by
us and has been or will be declared effective by the SEC in the form reviewed by us;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.4</TD><TD STYLE="text-align: justify">that at each Relevant Moment, the Ordinary Shares shall have been admitted for trading on a trading system
outside the European Economic Area comparable to a regulated market or a multilateral trading facility as referred to in Section 2:86c(1)
DCC and (ii) no financial instruments issued by the Company (or depository receipts for or otherwise representing such financial instruments)
have been admitted to trading on a regulated market, multilateral trading facility or organised trading facility operating in the European
Economic Area (and no request for admission of any such financial instruments to trading on any such trading venue has been made);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.5</TD><TD STYLE="text-align: justify">that at each Relevant Moment, the Company's authorised share capital (<I>maatschappelijk kapitaal</I>)
was or will be sufficient to allow for the issuance of the Registration Shares;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.6</TD><TD STYLE="text-align: justify">that the articles of association as in force at the date of this legal opinion will be in force at each
Relevant Moment;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.7</TD><TD STYLE="text-align: justify">any Registration Shares shall be issued, and any pre-emption rights in connection therewith shall have
been excluded, pursuant to resolutions validly passed by the corporate body (<I>orgaan</I>) of the Company duly authorised to do so;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 3pt solid"><P STYLE="font-size: 10pt; margin: 0pt 0">Legal opinion &ndash; Sono Group N.V.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;<IMG SRC="dlapiper.jpg" ALT="" STYLE="height: 96px; width: 150px"></TD><TD STYLE="width: 50%; text-align: right">Continuation <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.8</TD><TD STYLE="text-align: justify">that at each Relevant Moment, the Company will not have (i) been dissolved (<I>ontbonden</I>), (ii) ceased
to exist pursuant to a legal merger (<I>fusie</I>) or a legal demerger (<I>splitsing</I>), (iii) been converted (<I>omgezet</I>) into
another legal form, either national or foreign, (iv) had its assets placed under administration (<I>onder bewind gesteld</I>), (v) been
declared bankrupt (<I>failliet verklaard</I>), (vi) been granted a suspension of payments (<I>surseance van betaling verleend</I>), (vii)
started or become subject to statutory proceedings for the restructuring of its debts (<I>akkoordprocedure</I>) or (viii) been made subject
to similar proceedings in any jurisdiction or otherwise been limited in its power to dispose of its assets;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.9</TD><TD STYLE="text-align: justify">that at each Relevant Moment, the issue price for any Registration Shares shall at least equal the aggregate
nominal value thereof, any conversion, exchange or exercise price of other Registered Securities shall at least equal the aggregate nominal
value of the underlying Registration Shares, any such issue, conversion, exchange or exercise price shall have been satisfied in cash
and shall have been received and accepted by the Company ultimately upon the issuance of the relevant Registration Shares and, where relevant,
the Company shall have consented to payment in a currency other than Euro;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.10</TD><TD STYLE="text-align: justify">that at each Relevant Moment, each party other than the Company has validly entered into or will validly
enter into any relevant deed of issue;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.11</TD><TD STYLE="text-align: justify">any Registration Shares issued in connection with the conversion, exchange or exercise of other Registered
Securities shall be issued pursuant to a valid conversion, exchange or exercise of such Registered Securities in accordance with their
respective terms;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.12</TD><TD STYLE="text-align: justify">no Registered Securities shall be offered to the public (<I>aanbieden aan het publiek</I>) in the Netherlands
or any other member state of the European Economic Area other than in conformity with the Prospectus Regulation, the PRIIPs Regulation
and the rules promulgated thereunder;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.13</TD><TD STYLE="text-align: justify">that no acquiror of any Registration Shares is subject to, controlled by or otherwise connected with a
person, organisation or country which is subject to United Nations, European Union or Dutch sanctions implemented or effective in The
Netherlands under or pursuant to the Sanction Act 1977 (<I>Sanctiewet 1977</I>), the Economic Offences Act (<I>Wet economische delicten</I>),
the General Customs Act (<I>Algemene Douanewet</I>) or Regulations of the European Union;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.14</TD><TD STYLE="text-align: justify">any issuance of Registered Securities by the Company will be effected for bona fide commercial reasons
in the ordinary course of the Company&#8217;s business;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.15</TD><TD STYLE="text-align: justify">that any foreign law which may apply with respect to the issue of the Registration Shares does not affect
this legal opinion; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.16</TD><TD STYLE="text-align: justify">that all Confirmations are true, complete, and correct.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD STYLE="text-align: justify">LEGAL OPINIONS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 3pt solid"><P STYLE="font-size: 10pt; margin: 0pt 0">Legal opinion &ndash; Sono Group N.V.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;<IMG SRC="dlapiper.jpg" ALT="" STYLE="height: 96px; width: 150px"></TD><TD STYLE="width: 50%; text-align: right">Continuation <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.5in">Based upon a review of the Documents and a consideration of the
Confirmations, and subject to the assumptions and qualifications referred to in paragraphs 4 and 6 respectively and any matters not disclosed
to us, we are of the following legal opinion:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.1</TD><TD STYLE="text-align: justify">The Company has been incorporated as a <I>besloten vennootschap met beperkte aansprakelijkheid</I> and
exists as a legal entity in the form of a public limited liability company (<I>naamloze vennootschap</I>).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.2</TD><TD STYLE="text-align: justify">Subject to receipt by the Company of payment in full for, or other satisfaction of the issue, conversion,
exchange or exercise price for, the Registration Shares, when issued by the Company and accepted by the acquiror(s), shall be validly
issued, fully paid and non-assessable.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">Without detracting from the generality of paragraph
2 and save as expressly otherwise provided herein, we do not give any legal opinion on tax, (including, for the avoidance of doubt and
without detracting from the generality of the aforementioned any real estate transfer tax (<I>overdrachtsbelasting</I>) on which we do
not give any opinions) competition or anti-trust, works council, ranking and subordination or <I>in rem</I> matters.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.</TD><TD STYLE="text-align: justify">QUALIFICATIONS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.5in">The legal opinions that are given in this legal opinion are subject
to the following qualifications:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.1</TD><TD STYLE="text-align: justify">The legal opinions may be affected or limited by the provisions of any applicable bankruptcy, suspension
of payments or emergency measures, insolvency or pre-insolvency proceedings (including Insolvency Proceedings), rules relating to conflicts
of rights between a debtor and its creditors and/or shareholders, or its creditors and/or shareholders amongst each other, intervention
measures in relation to financial enterprises or their affiliated entities and other or similar laws of general application now or hereafter
in effect.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.2</TD><TD STYLE="text-align: justify">Although, pursuant to the provisions of the 2007 Trade Register Act (<I>Handelsregisterwet 2007</I>) a
legal entity or partnership cannot invoke the incorrectness or incompleteness of its Trade Register registration against third parties
who were unaware of its incorrectness or incompleteness (subject to limited exceptions) an extract from the Trade Register does not provide
conclusive evidence that the facts set out in it are correct. In addition, any relevant confirmations obtained as part of the Confirmations
do not provide conclusive evidence that an entity is not subject to Insolvency Proceedings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.3</TD><TD STYLE="text-align: justify">Although the European Union undertakes every effort to ensure that the EU Sanction List is kept up-to-date,
it is not an official publication of the European Union and therefore does not provide conclusive evidence that an entity is not the subject
of any sanctions imposed by the European Union.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.4</TD><TD STYLE="text-align: justify">Our opinions expressed herein may be affected by (i)&nbsp;the rules&nbsp;of good faith (<I>redelijkheid
en billijkheid</I>), force majeure (<I>niet-toerekenbare tekortkoming</I>) and unforeseen circumstances (<I>onvoorziene omstandigheden</I>),
(ii)&nbsp;the general defences available to debtors under Dutch law which include rights to suspend performance (<I>opschortingsrechten</I>),
rights of set-off (<I>verrekening</I>), error (<I>dwaling</I>), duress (<I>bedreiging</I>), fraud (<I>bedrog</I>), undue influence (<I>misbruik
van omstandigheden</I>), (iii) the Anti-Boycott Regulation, Anti Money Laundering Laws and related legislation and fraudulent preference
(pauliana), (iiii) a successful claim in tort (<I>onrechtmatige daad</I>) and (v)&nbsp;the rules&nbsp;of decency (<I>goede zeden</I>)
and public order (<I>openbare orde</I>).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 3pt solid"><P STYLE="font-size: 10pt; margin: 0pt 0">Legal opinion &ndash; Sono Group N.V.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;<IMG SRC="dlapiper.jpg" ALT="" STYLE="height: 96px; width: 150px"></TD><TD STYLE="width: 50%; text-align: right">Continuation <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.5</TD><TD STYLE="text-align: justify">If any legal act (<I>rechtshandeling</I>) performed by a Dutch legal entity exceeds such entity's objects
or is not in such entity's interest, such legal act may, apart from exceeding such entity's corporate power, be in violation of its articles
of association and be nullified by it if the other party or parties to the act knew or should have known that the legal act is not in
the entity&#8217;s interest.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.6</TD><TD STYLE="text-align: justify">Any issuance of Registered Securities by the Company in violation of Section 2:98c DCC (<I>financial assistance</I>)
may be null and void.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.7</TD><TD STYLE="text-align: justify">The opinion expressed in paragraph 5.1 should not be construed as implying that the Company cannot be
dissolved (<I>ontbonden</I>), including by way of a court order pursuant to Sections 2:19 et seq. or Section 2:21 DCC.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.8</TD><TD STYLE="text-align: justify">The term &#8220;non-assessable&#8221; which term has no equivalent in Dutch, means, in relation to a share,
that the issuer of the share has no right to require the holder of the share to pay to the issuer any amount (in addition to the amount
required for the share to be fully paid) solely as a result of its shareholdership.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.9</TD><TD STYLE="text-align: justify">This legal opinion does not purport to express any opinion or view on the operational rules and procedures
of any clearing or settlement system or agency.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.</TD><TD STYLE="text-align: justify">RELIANCE</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">This legal opinion is given for the benefit
of and may only be relied upon on the conditions that:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.1</TD><TD STYLE="text-align: justify">No person other than DLA Piper Nederland N.V. may be held liable in connection with this legal opinion.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.2</TD><TD STYLE="text-align: justify">By accepting this legal opinion, the persons who may rely on it agree that they will be bound by the preceding
sentences which, for the avoidance of doubt and together with the remaining provisions of this legal opinion, are governed by Netherlands
Law.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.3</TD><TD STYLE="text-align: justify">Any liability arising out of or in connection with this legal opinion is limited to the amount which is
paid out under any relevant insurance policy of DLA Piper Nederland N.V. in the matter concerned, plus the amount of the deductible which
must be borne by DLA Piper Nederland N.V. pursuant to such insurance policy</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 3pt solid"><P STYLE="font-size: 10pt; margin: 0pt 0">Legal opinion &ndash; Sono Group N.V.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;<IMG SRC="dlapiper.jpg" ALT="" STYLE="height: 96px; width: 150px"></TD><TD STYLE="width: 50%; text-align: right">Continuation <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.4</TD><TD STYLE="text-align: justify">We hereby consent to the filing of this legal opinion in connection with the registration of the Registration
Shares with the SEC under the U.S. Securities Act of 1933, as amended and the reference to DLA Piper Nederland N.V. in the Registration
Statement. In giving such consent, we do not admit that we come within the category of persons whose consent is required under Section&nbsp;7
of the U.S. Securities Act of 1933, as amended or the rules&nbsp;and regulations promulgated thereunder.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 3pt solid"><P STYLE="font-size: 10pt; margin: 0pt 0">Legal opinion &ndash; Sono Group N.V.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;<IMG SRC="dlapiper.jpg" ALT="" STYLE="height: 96px; width: 150px"></TD><TD STYLE="width: 50%; text-align: right">Continuation <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.75in; text-align: center; text-indent: 0in"><B>Annex</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.75in; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><B>&quot;Anti Money Laundering Laws&quot; </B>means
the European Anti-Money Laundering Directives, as implemented in the Netherlands in the Money Laundering and Terrorist Financing Prevention
Act (<I>Wet ter voorkoming van witwassen en financieren van terrorisme</I>) and the Dutch Criminal Code (<I>Wetboek van Strafrecht</I>);</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><B>&quot;Anti-Boycott Regulation&quot; </B>means
the Council Regulation (EC) No 2271/96 of 22 November 1996 on protecting against the effects of the extra-territorial application of legislation
adopted by a third country, and actions based thereon or resulting therefrom;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><B>&quot;Company&quot;</B> means Sono Group
N.V., a public limited liability company (<I>naamloze vennootschap</I>) with corporate seat in Amsterdam, the Netherlands, having its
address at Waldmeisterstrasse 93, 80935 Munich, Federal Republic of Germany and which is registered with the Chamber of Commerce under
number 80683568;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><B>&quot;Confirmations&quot;</B> means a:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(a)</TD><TD STYLE="text-align: justify">confirmation through www.kvk.nl/actualiteitencheck of the Chamber of Commerce that the relevant parts
of the Excerpt that are monitored via this website are complete and up to date;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(b)</TD><TD STYLE="text-align: justify">confirmation through www.rechtspraak.nl derived from the segment for the European Union registrations
of the Central Insolvency Register that the Company is not registered as being subject to Insolvency Proceedings; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(c)</TD><TD STYLE="text-align: justify">confirmation through https://webgate.ec.europa.eu/fsd/fsf#!/files that the Company is not included on
any EU Sanction List;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><B>&quot;DCC&quot; </B>means the Dutch Civil
Code (<I>Burgerlijk Wetboek</I>);</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><B>&quot;Documents&quot;</B> means each of
the documents referred to in paragraph 3.1which have been reviewed by us;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><B>&quot;EU Sanction List&quot;</B> means each
list of persons and entities subjected to economic sanctions imposed by the European Union as published by the European Union Consolidated
Financial Sanctions List (derived through https://webgate.ec.europa.eu/fsd/fsf#!/files as at the date of this legal opinion);</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><B>&quot;Excerpt&quot;</B> means the electronically
certified extract from the Trade Register in respect of the Company provided by the Chamber of Commerce and dated on the date of this
legal opinion;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><B>&quot;Insolvency Proceedings&quot;</B> means
any (i)&nbsp;proceedings as defined in Article 2 paragraph 4 of EU Council Regulation (EC) No. 848/2015 of 20 May 2015 on insolvency proceedings
as amended by Regulation (EU) 2021/2260 of the European Parliament and of the Council of 15 December 2021 or (ii)&nbsp;preventive restructuring
framework as implemented by a relevant member state of the European Union in a local law (pre-)insolvency proceeding as meant in Article
4 paragraph 1 of Directive (EU) 2019/1023 of the European Parliament and of the Council of 20 June 2019 on preventive restructuring frameworks,
on discharge of debt and disqualifications, and on measures to increase the efficiency of procedures concerning restructuring, insolvency
and discharge of debt, and amending Directive (EU) 2017/1132;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 3pt solid"><P STYLE="font-size: 10pt; margin: 0pt 0">Legal opinion &ndash; Sono Group N.V.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;<IMG SRC="dlapiper.jpg" ALT="" STYLE="height: 96px; width: 150px"></TD><TD STYLE="width: 50%; text-align: right">Continuation <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"></P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><B>&quot;Netherlands&quot;</B> means the European
part of the Kingdom of the Netherlands;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><B>&quot;Netherlands Law&quot;</B> means the
laws of the Netherlands which are directly applicable and as they exist and are interpreted at the date of this legal opinion; and</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><B>&quot;Ordinary Shares&quot; </B>means ordinary
shares in the Company's capital, with a nominal value of EUR 0.01 per share;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><B>&quot;Preferred Shares&quot; </B>means the
preferred shares in the Company's capital, with a nominal value of EUR 300.00 per share;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><B>&quot;PRIIPs Regulation&quot; </B>means
Regulation (EU) No 1286/2014 of the European Parliament and of the Council of 26 November 2014 on key information documents for packaged
retail and insurance-based investment products (PRIIPs);</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><B>&quot;Prospectus Regulation&quot; </B>means
Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities
are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><B>&quot;Registered Securities&quot; </B>means
the Registration Shares;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><B>&quot;Registration Shares&quot;</B> means
the Ordinary Shares and Preferred Shares, collectively;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><B>&quot;Registration Statement&quot;</B> means
the registration statement in the Form S-3 filed by you with the SEC; and</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><B>&quot;Relevant Moment&quot; </B>means each
time when one or more Registered Securities are issued by the Company.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: -0.55pt; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 3pt solid"><P STYLE="font-size: 10pt; margin: 0pt 0">Legal opinion &ndash; Sono Group N.V.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;<IMG SRC="dlapiper.jpg" ALT="" STYLE="height: 96px; width: 150px"></TD><TD STYLE="width: 50%; text-align: right">Continuation <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; font-weight: bold; text-align: justify">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; font-size: 10pt; text-align: left">Yours faithfully</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; font-weight: bold; text-align: justify"></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: -0.55pt; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><P STYLE="margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left; font-size: 10pt"><FONT STYLE="text-transform: uppercase"><B>/s/
                         MANON DEN BOER</B></FONT></P>
                         <P STYLE="margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left; font-size: 10pt"><FONT STYLE="text-transform: none"><B>Notary <B>- Partner</B></B></FONT></P>
                         <P STYLE="margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left; font-size: 10pt"><FONT STYLE="text-transform: uppercase"><B><B></B></B></FONT></P>

<P STYLE="margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left; font-size: 10pt"><FONT STYLE="text-transform: uppercase"><B>DLA Piper Nederland N.V.</B></FONT></P>
<P STYLE="margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left; font-size: 10pt"><FONT STYLE="text-transform: uppercase"><B><B></B></B></FONT></P>
</TD>
  <TD STYLE="width: 50%"><P STYLE="font-size: 10pt; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>/s/ Gerard Kneppers</B></FONT></P>
                         <P STYLE="margin: 0pt 0; font-size: 10pt"><FONT STYLE="text-transform: uppercase"><B></B></FONT></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>Advocaat - Partner</B></P>
<P STYLE="margin: 0pt 0; font-size: 10pt"><FONT STYLE="text-transform: uppercase"><B></B></FONT></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>DLA Piper Nederland N.V.</B></FONT></P>
<P STYLE="margin: 0pt 0; font-size: 10pt"><FONT STYLE="text-transform: uppercase"></FONT></P>
</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><P STYLE="margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left; font-size: 10pt">Direct +31 20 541 9871</P>
</TD>
  <TD><P STYLE="font-size: 10pt; margin: 0pt 0">Direct +31 20 541 9811</P>
</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Manon.denboer@dlapiper.com</TD>
  <TD><P STYLE="font-size: 10pt; margin: 0pt 0">Gerard.Kneppers@dlapiper.com</P>
</TD></TR>
</TABLE>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; font-weight: bold; text-align: justify; text-indent: -0.55pt"></P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; font-weight: bold; text-align: justify; text-indent: -0.55pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">Legal opinion &ndash; Sono Group N.V.</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 3pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>exh_231.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 23.1</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><IMG SRC="grassi.jpg" ALT=""></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>Consent of Independent Registered Public Accounting Firm</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">We hereby consent to the incorporation by reference in this Registration
Statement on Form S-3 of our report dated April 1, 2026, as of and for the years ended December 31, 2025 and 2024. We also consent to
the reference to our firm under the heading &ldquo;Experts&rdquo; appearing therein.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; color: Red"></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"><IMG SRC="grassi_sig.jpg" ALT="" STYLE="height: 40px; width: 200px"></P>

<P STYLE="margin: 0pt 0; font-size: 10pt">Grassi &amp; Co., CPAs, P.C.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">Glastonbury, Connecticut</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">May 11, 2026</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>5
<FILENAME>exh_107.htm
<DESCRIPTION>EXHIBIT 107
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:ffd="http://xbrl.sec.gov/ffd/2026">
  <head>
    <title>EX-FILING FEES</title>
  </head>
  <body>
    <div style="font-size: 10pt; display: none">
      <ix:header>
        <ix:hidden>
          <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-426">S-3</ix:nonNumeric>
          <ix:nonNumeric name="ffd:SubmissnTp" contextRef="rc" id="ixv-427">S-3</ix:nonNumeric>
          <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="rc" id="ixv-428">EX-FILING FEES</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="rc" id="ixv-429">0001840416</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-430">Sono Group N.V.</ix:nonNumeric>
          <ix:nonNumeric name="ffd:OfferingTableNa" contextRef="rc" id="hiddenrcOfferingTableNa" xsi:nil="true"></ix:nonNumeric>
          <ix:nonNumeric name="ffd:OffsetTableNa" contextRef="rc" id="hiddenrcOffsetTableNa">N/A</ix:nonNumeric>
          <ix:nonNumeric name="ffd:CombinedProspectusTableNa" contextRef="rc" id="hiddenrcCombinedProspectusTableNa">N/A</ix:nonNumeric>
          <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="7" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-434">0.0001381</ix:nonFraction>
          <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="7" format="ixt:numdotdecimal" contextRef="offrl_2" id="ixv-435">0.0001381</ix:nonFraction>
          <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="7" format="ixt:numdotdecimal" contextRef="offrl_3" id="ixv-436">0.0001381</ix:nonFraction>
          <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="7" format="ixt:numdotdecimal" contextRef="offrl_4" id="ixv-437">0.0001381</ix:nonFraction>
          <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="7" format="ixt:numdotdecimal" contextRef="offrl_5" id="ixv-438">0.0001381</ix:nonFraction>
          <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="7" format="ixt:numdotdecimal" contextRef="offrl_6" id="ixv-439">0.0001381</ix:nonFraction>
        </ix:hidden>
        <ix:references>
          <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2026/ffd-2026.xsd" xlink:type="simple"/>
        </ix:references>
        <ix:resources>
          <xbrli:context id="rc">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001840416</xbrli:identifier>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2026-05-11</xbrli:startDate>
              <xbrli:endDate>2026-05-11</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_1">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001840416</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2026-05-11</xbrli:startDate>
              <xbrli:endDate>2026-05-11</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_2">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001840416</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2026-05-11</xbrli:startDate>
              <xbrli:endDate>2026-05-11</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_3">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001840416</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>3</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2026-05-11</xbrli:startDate>
              <xbrli:endDate>2026-05-11</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_4">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001840416</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>4</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2026-05-11</xbrli:startDate>
              <xbrli:endDate>2026-05-11</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_5">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001840416</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>5</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2026-05-11</xbrli:startDate>
              <xbrli:endDate>2026-05-11</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_6">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001840416</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>6</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2026-05-11</xbrli:startDate>
              <xbrli:endDate>2026-05-11</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_7">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001840416</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>7</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2026-05-11</xbrli:startDate>
              <xbrli:endDate>2026-05-11</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:unit id="USD">
            <xbrli:measure>iso4217:USD</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="pure">
            <xbrli:measure>xbrli:pure</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="Shares">
            <xbrli:measure>xbrli:shares</xbrli:measure>
          </xbrli:unit>
        </ix:resources>
      </ix:header>
    </div>

<p style="font-size: 10pt; margin: 0; text-align: right"><b>Exhibit 107</b></p>

<p style="font-size: 10pt; margin: 0; text-align: right">&#160;</p>
    <div style="font-size: 10pt">
      <table style="font: 10pt Arial, Helvetica, sans-serif; width: 99%; text-align: center">
        <tr style="font-size: 10pt">
          <td colspan="4" style="font-size: 10pt; padding-bottom: 0.5em">
            <p style="font-size: 10pt">
              <b>Calculation of Filing Fee Tables</b>
            </p>
          </td>
        </tr>
        <tr style="font-size: 10pt">
          <td style="font-size: 10pt; padding-bottom: 0.25em">
            <p style="font-size: 10pt">
              <b>
                <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-518">S-3</ix:nonNumeric>
              </b>
            </p>
          </td>
        </tr>
        <tr style="font-size: 10pt">
          <td style="font-size: 10pt; padding-bottom: 0.25em">
            <p style="font-size: 10pt">
              <b>
                <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-519">Sono Group N.V.</ix:nonNumeric>
              </b>
            </p>
          </td>
        </tr>
      </table>
    </div>
    <div style="font-size: 10pt; padding-bottom: 20px">
      <table style="font-size: 10pt; width: 100%; text-align: left">
        <tr style="font: 10pt Arial, Helvetica, sans-serif">
          <th style="font-size: 10pt; vertical-align: bottom; text-align: left; word-wrap: break-word">
            <b>Table 1: Newly Registered and Carry Forward Securities</b>
          </th>
          <th style="font-size: 10pt; vertical-align: bottom; word-wrap: break-word; text-align: right">
            <span style="-sec-ix-hidden: hiddenrcOfferingTableNa">&#9744;Not Applicable</span>
          </th>
        </tr>
      </table>
      <table style="border: black 1px solid; font: 10pt Arial, Helvetica, sans-serif; width: 100%; text-align: center">
        <tr style="font-size: 10pt; background-color: #9ADAF6">
          <th style="font-size: 10pt; width: 12%">
            <!-- BLANK -->
          </th>
          <th style="font-size: 10pt; width: 2%">
            <!-- BLANK -->
          </th>
          <th style="font-size: 10pt; width: 12%">
            <p style="font-size: 10pt; margin: 0pt; text-align: center">
              <b>Security Type</b>
            </p>
          </th>
          <th style="font-size: 10pt; width: 14%">
            <p style="font-size: 10pt; margin: 0pt; text-align: center">
              <b>Security Class Title </b>
            </p>
          </th>
          <th style="font-size: 10pt; width: 2%">
            <p style="font-size: 10pt; margin: 0pt; text-align: center">
              <b>Fee Calculation or Carry Forward Rule</b>
            </p>
          </th>
          <th style="font-size: 10pt; width: 5%">
            <p style="font-size: 10pt; margin: 0pt; text-align: center">
              <b>Amount Registered</b>
            </p>
          </th>
          <th style="font-size: 10pt; width: 15%">
            <p style="font-size: 10pt; margin: 0pt; text-align: center">
              <b>Proposed Maximum Offering Price Per Unit</b>
            </p>
          </th>
          <th style="font-size: 10pt; width: 10%">
            <p style="font-size: 10pt; margin: 0pt; text-align: center">
              <b>Maximum Aggregate Offering Price</b>
            </p>
          </th>
          <th style="font-size: 10pt; width: 5%">
            <p style="font-size: 10pt; margin: 0pt; text-align: center">
              <b>Fee Rate</b>
            </p>
          </th>
          <th style="font-size: 10pt; width: 6%">
            <p style="font-size: 10pt; margin: 0pt; text-align: center">
              <b>Amount of Registration Fee</b>
            </p>
          </th>
          <th style="font-size: 10pt; width: 1%">
            <p style="font-size: 10pt; margin: 0pt; text-align: center">
              <b>Carry Forward Form Type</b>
            </p>
          </th>
          <th style="font-size: 10pt; width: 7%">
            <p style="font-size: 10pt; margin: 0pt; text-align: center">
              <b>Carry Forward File Number</b>
            </p>
          </th>
          <th style="font-size: 10pt; width: 6%">
            <p style="font-size: 10pt; margin: 0pt; text-align: center">
              <b>Carry Forward Initial Effective Date</b>
            </p>
          </th>
          <th style="font-size: 10pt; width: 7%">
            <p style="font-size: 10pt; margin: 0pt; text-align: center">
              <b>Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</b>
            </p>
          </th>
        </tr>
        <tr style="font-size: 10pt">
          <td colspan="14" style="font-size: 10pt; text-align: center">
            <b>Newly Registered Securities</b>
          </td>
        </tr>
        <tr style="font-size: 10pt; background-color: #E7E7E2">
          <td style="font-size: 10pt; text-align: left">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: left">
            <span style="text-indent: 0px; display:inline-block; padding-left: 20px;">
              <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_1" id="ixv-520">Equity</ix:nonNumeric>
            </span>
          </td>
          <td style="font-size: 10pt; text-align: left">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_1" id="ixv-521">Ordinary Shares, nominal value EUR0.01 per share</ix:nonNumeric>
          </td>
          <td style="font-size: 10pt; text-align: center">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_1" format="ixt:booleantrue" id="ixv-522">457(o)</ix:nonNumeric>
          </td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
        </tr>
        <tr style="font-size: 10pt; background-color: #E7E7E2">
          <td style="font-size: 10pt; text-align: left">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: left">
            <span style="text-indent: 0px; display:inline-block; padding-left: 20px;">
              <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_2" id="ixv-523">Equity</ix:nonNumeric>
            </span>
          </td>
          <td style="font-size: 10pt; text-align: left">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_2" id="ixv-524">Preferred Shares, nominal value EUR300.00 per share</ix:nonNumeric>
          </td>
          <td style="font-size: 10pt; text-align: center">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_2" format="ixt:booleantrue" id="ixv-525">457(o)</ix:nonNumeric>
          </td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
        </tr>
        <tr style="font-size: 10pt; background-color: #E7E7E2">
          <td style="font-size: 10pt; text-align: left">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: left">
            <span style="text-indent: 0px; display:inline-block; padding-left: 20px;">
              <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_3" id="ixv-526">Debt</ix:nonNumeric>
            </span>
          </td>
          <td style="font-size: 10pt; text-align: left">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_3" id="ixv-527">Debt Securities</ix:nonNumeric>
          </td>
          <td style="font-size: 10pt; text-align: center">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_3" format="ixt:booleantrue" id="ixv-528">457(o)</ix:nonNumeric>
          </td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
        </tr>
        <tr style="font-size: 10pt; background-color: #E7E7E2">
          <td style="font-size: 10pt; text-align: left">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: left">
            <span style="text-indent: 0px; display:inline-block; padding-left: 20px;">
              <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_4" id="ixv-529">Other</ix:nonNumeric>
            </span>
          </td>
          <td style="font-size: 10pt; text-align: left">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_4" id="ixv-530">Warrants</ix:nonNumeric>
          </td>
          <td style="font-size: 10pt; text-align: center">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_4" format="ixt:booleantrue" id="ixv-531">457(o)</ix:nonNumeric>
          </td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
        </tr>
        <tr style="font-size: 10pt; background-color: #E7E7E2">
          <td style="font-size: 10pt; text-align: left">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: left">
            <span style="text-indent: 0px; display:inline-block; padding-left: 20px;">
              <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_5" id="ixv-532">Other</ix:nonNumeric>
            </span>
          </td>
          <td style="font-size: 10pt; text-align: left">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_5" id="ixv-533">Rights</ix:nonNumeric>
          </td>
          <td style="font-size: 10pt; text-align: center">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_5" format="ixt:booleantrue" id="ixv-534">457(o)</ix:nonNumeric>
          </td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
        </tr>
        <tr style="font-size: 10pt; background-color: #E7E7E2">
          <td style="font-size: 10pt; text-align: left">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: left">
            <span style="text-indent: 0px; display:inline-block; padding-left: 20px;">
              <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_6" id="ixv-535">Other</ix:nonNumeric>
            </span>
          </td>
          <td style="font-size: 10pt; text-align: left">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_6" id="ixv-536">Units</ix:nonNumeric>
          </td>
          <td style="font-size: 10pt; text-align: center">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_6" format="ixt:booleantrue" id="ixv-537">457(o)</ix:nonNumeric>
          </td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
        </tr>
        <tr style="font-size: 10pt; background-color: #E7E7E2">
          <td style="font-size: 10pt; text-align: left">
            <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="offrl_7" format="ixt:booleanfalse" id="ixv-538">Fees to be Paid</ix:nonNumeric>
          </td>
          <td style="font-size: 10pt; text-align: center">
		1
	</td>
          <td style="font-size: 10pt; text-align: left">
            <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_7" id="ixv-539">Unallocated (Universal) Shelf</ix:nonNumeric>
          </td>
          <td style="font-size: 10pt; text-align: left">

	</td>
          <td style="font-size: 10pt; text-align: center">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_7" format="ixt:booleantrue" id="ixv-540">457(o)</ix:nonNumeric>
          </td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">
            <span>$</span>
            <ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="2" format="ixt:numdotdecimal" contextRef="offrl_7" id="ixv-541">100,000,000.00</ix:nonFraction>
          </td>
          <td style="font-size: 10pt; text-align: right">
            <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="7" format="ixt:numdotdecimal" contextRef="offrl_7" id="ixv-542">0.0001381</ix:nonFraction>
          </td>
          <td style="font-size: 10pt; text-align: right">
            <span>$</span>
            <ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="2" format="ixt:numdotdecimal" contextRef="offrl_7" id="ixv-543">13,810.00</ix:nonFraction>
          </td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
        </tr>
        <tr style="font-size: 10pt; background-color: #E7E7E2">
          <td style="font-size: 10pt; text-align: left">
		Fees Previously Paid
	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: left">

	</td>
          <td style="font-size: 10pt; text-align: left">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
        </tr>
        <tr style="font-size: 10pt">
          <td colspan="14" style="font-size: 10pt; text-align: center">
            <b>Carry Forward Securities</b>
          </td>
        </tr>
        <tr style="font-size: 10pt; background-color: #E7E7E2">
          <td style="font-size: 10pt; text-align: left">
		Carry Forward Securities
	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: left">

	</td>
          <td style="font-size: 10pt; text-align: left">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
        </tr>
        <tr style="font-size: 10pt">
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td colspan="3" style="font-size: 10pt; vertical-align: top">
            <p style="font-size: 10pt; margin: 0pt; text-align: right">Total Offering Amounts:</p>
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt; vertical-align: top; width: 16%">
            <p id="MaxAggtOfferingPrice" style="font-size: 10pt; margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="rc" decimals="2" format="ixt:numdotdecimal" unitRef="USD" id="ixv-544">100,000,000.00</ix:nonFraction>
            </p>
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt; vertical-align: top; border-bottom-color: black; border-bottom-width: 1px; width: 16%">
            <p id="TotalFeeAmt" style="font-size: 10pt; margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlFeeAmt" contextRef="rc" decimals="2" format="ixt:numdotdecimal" unitRef="USD" id="ixv-545">13,810.00</ix:nonFraction>
            </p>
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
        </tr>
        <tr style="font-size: 10pt">
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td colspan="3" style="font-size: 10pt; vertical-align: top">
            <p style="font-size: 10pt; margin: 0pt; text-align: right">
					Total Fees Previously Paid:
				</p>
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt; vertical-align: top">
            <p id="TotalPreviouslyPaidAmt" style="font-size: 10pt; margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="rc" decimals="2" format="ixt:numdotdecimal" unitRef="USD" id="ixv-546">0.00</ix:nonFraction>
            </p>
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
        </tr>
        <tr style="font-size: 10pt">
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td colspan="3" style="font-size: 10pt; vertical-align: top">
            <p style="font-size: 10pt; margin: 0pt; text-align: right">
					Total Fee Offsets:
				</p>
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt; vertical-align: top">
            <p id="TotalOffsetAmt" style="font-size: 10pt; margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="rc" decimals="2" format="ixt:numdotdecimal" unitRef="USD" id="ixv-547">0.00</ix:nonFraction>
            </p>
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
        </tr>
        <tr style="font-size: 10pt">
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td colspan="3" style="font-size: 10pt; vertical-align: top">
            <p style="font-size: 10pt; margin: 0pt; text-align: right">
					Net Fee Due:
				</p>
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt; vertical-align: top">
            <p id="NetFeeAmt" style="font-size: 10pt; margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:NetFeeAmt" contextRef="rc" decimals="2" format="ixt:numdotdecimal" unitRef="USD" id="ixv-548">13,810.00</ix:nonFraction>
            </p>
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
          <td style="font-size: 10pt">
            <!-- BLANK -->
          </td>
        </tr>
      </table>
    </div>
    <div style="font-size: 10pt">
      <table style="font-size: 10pt; width: 100%; text-indent: 0px">
        <tbody style="font-size: 10pt">
          <tr style="font: 10pt Arial, Helvetica, sans-serif; vertical-align: top">
            <td style="font-size: 10pt">
              <p style="font-size: 10pt; margin: 0pt; text-align: left; margin-bottom: 5px">
                <b>Offering Note</b>
              </p>
            </td>
            <td style="font-size: 10pt"/>
          </tr>
        </tbody>
      </table>
    </div>
    <div style="font-size: 10pt; padding-bottom: 20px">
      <table style="font-size: 10pt; width: 100%; text-indent: 0px">
        <tr style="font: 10pt Arial, Helvetica, sans-serif; vertical-align: top">
          <td style="font-size: 10pt; width: 10pt">
            <p style="font-size: 10pt; margin: 0pt; text-align: left">
              <sup style="vertical-align:top;line-height:120%;font-size:10px">1</sup>
            </p>
          </td>
          <td colspan="7" style="font-size: 10pt; white-space: pre-line">
            <ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="offrl_7" id="ixv-549">(1)	Except where a value is indicated, the Amount Registered and Proposed Maximum Offering Price Per Unit are omitted as to each class of security pursuant to Instructions 2.A.ii.b. and 2.A.iii.b. to Item 16(b) of Form S-3.
(2)	The securities registered hereunder include such indeterminate number of (a) shares of Ordinary Shares, (b) shares of Preferred Shares, (c) debt securities, (d) warrants, (e) rights and (f) units as may be sold from time to time by the registrant. There are also being registered hereunder an indeterminate number of shares of Ordinary Shares and Preferred Shares as shall be issuable upon conversion, exchange or exercise of any securities that provide for such issuance.
(3)	Pursuant to Rule 416 under the Securities Act, this registration statement also covers any additional shares of the registrant's securities that become issuable by reason of any share splits, share dividends or similar transactions.
(4)	The Registrant does not have any fee offsets.

</ix:nonNumeric>
          </td>
        </tr>
        <tr style="font-size: 10pt">
          <td colspan="7" style="font-size: 10pt">
            <hr style="width:100%;text-align:left;margin-left:0"/>
          </td>
        </tr>
      </table>
    </div>
    <div style="font-size: 10pt; padding-bottom: 20px">
      <table style="font-size: 10pt; width: 100%; text-align: left">
        <tr style="font: 10pt Arial, Helvetica, sans-serif">
          <th style="font-size: 10pt; vertical-align: bottom; text-align: left; word-wrap: break-word">
            <b>Table 2: Fee Offset Claims and Sources</b>
          </th>
          <th style="font-size: 10pt; vertical-align: bottom; word-wrap: break-word; text-align: right">
            <span style="-sec-ix-hidden: hiddenrcOffsetTableNa">&#9745;Not Applicable</span>
          </th>
        </tr>
      </table>
      <table style="border: black 1px solid; font: 10pt Arial, Helvetica, sans-serif; width: 100%; text-align: center">
        <tr style="font-size: 10pt; background-color: #9ADAF6">
          <th style="font-size: 10pt; width: 10%; text-align: left">
            <!-- BLANK -->
          </th>
          <th style="font-size: 10pt; width: 8%; text-align: left">
            <!-- BLANK -->
          </th>
          <th style="font-size: 10pt; width: 16%">
				Registrant or Filer Name
			</th>
          <th style="font-size: 10pt; width: 6%">
				Form or Filing Type
			</th>
          <th style="font-size: 10pt; width: 7%">
				File Number
			</th>
          <th style="font-size: 10pt; width: 6%">
				Initial Filing Date
			</th>
          <th style="font-size: 10pt; width: 6%">
				Filing Date
			</th>
          <th style="font-size: 10pt; width: 6%">
				Fee Offset Claimed
			</th>
          <th style="font-size: 10pt; width: 6%">
				Security Type Associated with Fee Offset Claimed
			</th>
          <th style="font-size: 10pt; width: 8%">
				Security Title Associated with Fee Offset Claimed
			</th>
          <th style="font-size: 10pt; width: 6%">
				Unsold Securities Associated with Fee Offset Claimed
			</th>
          <th style="font-size: 10pt; width: 9%">
				Unsold Aggregate Offering Amount Associated with Fee Offset Claimed
			</th>
          <th style="font-size: 10pt; width: 6%">
				Fee Paid with Fee Offset Source
			</th>
        </tr>
        <tr style="font-size: 10pt">
          <td colspan="14" style="font-size: 10pt; text-align: center">
            <b>Rules 457(b) and 0-11(a)(2)</b>
          </td>
        </tr>
        <tr style="font-size: 10pt; background-color: #E7E7E2">
          <td style="font-size: 10pt; text-align: left">
		Fee Offset Claims
	</td>
          <td style="font-size: 10pt">

	</td>
          <td style="font-size: 10pt; text-align: left">

	</td>
          <td style="font-size: 10pt">

	</td>
          <td style="font-size: 10pt">

	</td>
          <td style="font-size: 10pt">

	</td>
          <td style="font-size: 10pt">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: left">

	</td>
          <td style="font-size: 10pt; text-align: left">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
        </tr>
        <tr style="font-size: 10pt; background-color: #E7E7E2">
          <td style="font-size: 10pt; text-align: left">
		Fee Offset Sources
	</td>
          <td style="font-size: 10pt">

	</td>
          <td style="font-size: 10pt; text-align: left">

	</td>
          <td style="font-size: 10pt">

	</td>
          <td style="font-size: 10pt">

	</td>
          <td style="font-size: 10pt">

	</td>
          <td style="font-size: 10pt">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: left">

	</td>
          <td style="font-size: 10pt; text-align: left">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
        </tr>
        <tr style="font-size: 10pt">
          <td colspan="14" style="font-size: 10pt; text-align: center">
            <b>Rule 457(p)</b>
          </td>
        </tr>
        <tr style="font-size: 10pt; background-color: #E7E7E2">
          <td style="font-size: 10pt; text-align: left">
		Fee Offset Claims
	</td>
          <td style="font-size: 10pt">

	</td>
          <td style="font-size: 10pt; text-align: left">

	</td>
          <td style="font-size: 10pt">

	</td>
          <td style="font-size: 10pt">

	</td>
          <td style="font-size: 10pt">

	</td>
          <td style="font-size: 10pt">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: left">

	</td>
          <td style="font-size: 10pt; text-align: left">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
        </tr>
        <tr style="font-size: 10pt; background-color: #E7E7E2">
          <td style="font-size: 10pt; text-align: left">
		Fee Offset Sources
	</td>
          <td style="font-size: 10pt">

	</td>
          <td style="font-size: 10pt; text-align: left">

	</td>
          <td style="font-size: 10pt">

	</td>
          <td style="font-size: 10pt">

	</td>
          <td style="font-size: 10pt">

	</td>
          <td style="font-size: 10pt">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: left">

	</td>
          <td style="font-size: 10pt; text-align: left">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
        </tr>
      </table>
    </div>
    <div style="font-size: 10pt; padding-bottom: 20px">
      <table style="font-size: 10pt; width: 100%; text-align: left">
        <tr style="font: 10pt Arial, Helvetica, sans-serif">
          <th style="font-size: 10pt; vertical-align: bottom; text-align: left; word-wrap: break-word">
            <b>Table 3: Combined Prospectuses</b>
          </th>
          <th style="font-size: 10pt; vertical-align: bottom; word-wrap: break-word; text-align: right">
            <span style="-sec-ix-hidden: hiddenrcCombinedProspectusTableNa">&#9745;Not Applicable</span>
          </th>
        </tr>
      </table>
      <table style="border: black 1px solid; font: 10pt Arial, Helvetica, sans-serif; width: 100%">
        <tr style="font-size: 10pt; background-color: #9ADAF6">
          <th style="font-size: 10pt; width: 4%">
            <!-- Note column -->
          </th>
          <th style="font-size: 10pt; width: 14%">
            <p style="font-size: 10pt; margin: 0pt; text-align: center">
              <b>Security Type</b>
            </p>
          </th>
          <th style="font-size: 10pt; width: 25%">
            <p style="font-size: 10pt; margin: 0pt; text-align: center">
              <b>Security Class Title</b>
            </p>
          </th>
          <th style="font-size: 10pt; width: 14%">
            <p style="font-size: 10pt; margin: 0pt; text-align: center">
              <b>Amount of Securities Previously Registered</b>
            </p>
          </th>
          <th style="font-size: 10pt; width: 18%">
            <p style="font-size: 10pt; margin: 0pt; text-align: center">
              <b>Maximum Aggregate Offering Price of Securities Previously Registered</b>
            </p>
          </th>
          <th style="font-size: 10pt; width: 6%">
            <p style="font-size: 10pt; margin: 0pt; text-align: center">
              <b>Form Type</b>
            </p>
          </th>
          <th style="font-size: 10pt; width: 10%">
            <p style="font-size: 10pt; margin: 0pt; text-align: center">
              <b>File Number</b>
            </p>
          </th>
          <th style="font-size: 10pt; width: 8%">
            <p style="font-size: 10pt; margin: 0pt; text-align: center">
              <b>Initial Effective Date</b>
            </p>
          </th>
        </tr>
        <tr style="font-size: 10pt; background-color: #E7E7E2">
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt">

	</td>
          <td style="font-size: 10pt">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: right">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
          <td style="font-size: 10pt; text-align: center">

	</td>
        </tr>
      </table>
    </div>
  </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>dlapiper.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dlapiper.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #* 3L# 2(  A$! Q$!_\0
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M1D/S9Q1]5PG_ #[7W#^N8M_;9N?\)]XO_P"AFU'_ +_&C_A/_%__ $,VH_\
M?XUA!XR<;R#[U)B,#ERWTIO"83I37W"^NXO^=FS_ ,)]XO\ ^AEU'_OZ:/\
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M=\A8FORG$470FX36J/V? XFGC*"K0V9;HHHK$[0HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH B<XSMY->3_M!?%4_##1=/G!V_:G:,_E7JN2V1^M?(O\
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MZGUF3\/U<T]^]HH\/_9^_8TO+ZZBUSQB/+B.'6T/<5]F:%X5TCPW#'#8:=%
MD8VJ50 XK<2T52%)Y'W0.@J80'ZU^18[,\1BYWD]#]GRS)<+@()<MV0+'))R
M&PGI4JQMCKQ3S&V,9XJ14VKBO-^)>\>\W?1:(A",">:4H1WJ79[T@0]SFH=.
M'8I:=2(HQ[U&\#MT;!]:M!<<TQT9CD'%7%);$ZQU13EC61#'.@ESP01FO*OB
MW^SQX?\ B?I,JFTCLM153Y5PB@8^N*]@\MB.U)Y39P3P:VI8FK0GS0=CBQ>"
MP^,ARU((_*?XF_ CQ+\)+J8:A:/<:46.VX12=PKS^:2.2U00_+'_ '#U%?L%
MKGA;3_$UG/8ZA;1W,#J1B10<9K\[_P!I_P#9WNOA5J<FLZ9 TVDW+G*(/]77
MZCDF?JK-4J[LS\BS?A2=!2KT'HNAX)3HCB1?K0B+(BNKY0]3Z4XQM!(NX<'D
M>]?>TDYS<H['Y[;1I[GKG[,7_):--^@K]05Z1?[HK\OOV83GXS::>V :_4"(
M[U0CCY17Y!Q6^;$QY3]KX*UP+)QU-+2#K2U\6?H84444 %%%% !1110 4444
M %%%% !1110 4444 0?P-7R#_P %%/\ D4/#I_Z>C_2OK[^!J^0?^"BG_(H>
M'?\ KZ/]*]K)/^1E3]3YGB#_ )%E3T/B!3M<'VI)"7;=0QY'TJ2W4,#7[U+6
M5C^=-8KVB(48J<CM3Y%),8;EKA@B >IZ4P_*YST%>T_LK?"4_%/Q_'=7L>[1
M].8,RD=6'2N',<3'!8=S.W!X66,Q$(+J?1G[*G[-</@[3[;Q%K4(EU24!T5Q
M]T'D5]6HV% 48^E5+2W2V@CA VB,!5 ]!TJ\H^45^"XO%RQ=5SF]3^C<MP,<
M!15.(FU5.X]:=U%-*[LYZ4X# KC/7#I0!2T@&* %I ,4M% !1112 *:QP,XI
M336W;AC[O>F A7C<I^:L'QEX9L?%>D2Z?J5NEQ!*"I##.*WFB&<Y(]A4<R\C
MO5PG[.7.GL<]>G[6FX/J?EE^T/\ !VX^$?C&2RAC(T:<^='-CC)_AKS&X5F=
M'+94# 'I7Z<?M.?"R'XE?#V["1J;NQ4S0G')8=J_,B>![66:"8$7$3E9 >QK
M]FX:S/ZS3Y)O4_!N(LK_ +/Q*Y=F>L?LNG=\8M,_W17ZA6^ %'^R*_+O]EO_
M )+#IOTK]0X1_JS_ +(KXOBI<F*1]OP0_P#9ZD2QD"EIHZTZOBC]*"BBB@ I
M,\TM% !1110 4444 %%%% !1112 ****8$'\!KY!_P""B?\ R*'AW_KZ_P *
M^OOX#7R#_P %$_\ D4/#O_7T?Z5[.2?\C*GZGS'$'_(LJ>A\/G[WX4L+E"1V
M-(W)_"F[2)53^(\BOWZUYG\[6YHM!= A3M&6(X^M?HO^QOX 'AOX96NHLFRZ
MU ;VR.:^ ?#&F/K/B[1;"-/,:6Y0.O\ LYYK];O">C0Z!H-C90QB.&&%0F/7
M%?FO%6,=U03/TK@W!*JW6FMC89/F!ZX%3C[HJNA9 -PX-3,P%?EZBD[G[+S7
M0X8%+47FKGI3PPQ572"]Q:6F-(%H60'I1=!?H/HIBR!L^U*&% QU%,$@+8%!
ME4'%#=MQ#Z3H*3>,9IOGKFFAC^W-1RC./2G>8"N>U1-,KG;2MS:$RERE6X@$
MHECD :-U((/>OS(_:?\ AI+\/?B1=R*N+2_8SKMZ#-?IVZ%F&ZOE+]O7PJLO
M@6VUB.$O<1S!,@<[:^ER#%?5L4HI[Z'Q/%F#>(POM4M8GS;^RWQ\8]-^@K]1
M%<+Y0_O**_+O]EOGXO:<_08 YK]/PK,UN1T5!FN[BAMUXN1Q\'12P<I+=EWB
M@#%0M.J-@]:>\RJ 3QFOCK,_0DU)V0_-&:B:=% /7-*LBNN1THLPYE>Q)2TQ
M9 W2E+@'%(:UV'44W<!2YS0,!2TW>,TN10 M%)D4A<"@!U(3BDW#&::90,5-
MT"U)**:)%-+D4[W A_@:OD'_ (*)_P#(H>'?^OH_TKZ^_@-?(/\ P43_ .10
M\._]?7^%>WDG_(RI^I\QQ!_R+*A\/L,GWQ37DS&I_C!Q4B_ZQ:1(E,\A/W0,
M_C7[XW::/YVB]T>S?LE^'X/$'QNTZ&X7=''$91GU%?IL  @0?PC&*_/#]A>W
M%Q\4_M+_ 'UB8+]*_0Y.96^M?C'$\KX]KR/W'@VDE@&_,>5RHIH<]"*>O?O3
M%GRVW%?'0=UJ??<RBDF/!&.!2%R.U D# D=J:91Z9J[+J+G2'\,.>M"K@GTH
M#=S35D&\CI7/*<4TD4ES:CP!S2(,9I%<<\\4H/!JI.TD*UP7 )Q0%&[FFH0"
M3VH!#-UP:N5F[,-]6/8X^E,#*3TP:<64#GK30%SDFFI+8AJ:=T2  J?2HMBE
MABGNRK@9Y/2F*"IS0Y***Y%)78K(,\UY/^TUH']O?"G5U&,V\1E&1Z5ZQ(#Q
M69XBTB#7](N=.N4\R"Y0QNOL:VP<O858U?,X,=2EB</.DNJ/S$_91D.I?%W3
M_+ER4)W*/8U^I4<H(CP.=HKP_P"&G[*_A?X7>*)M>L4^<DD(>V:]NCD68*ZC
M KULUQT<?-2['C9%EM3+L-9]24@.>G--F&Y..U+NVR<U%#*6D(/W37BJ+[GT
MLI*E):;C@=\'3I1O\M%'K3I%Q&0*85)1<]C0T[7N&CJ[%D #H*;M.:7JHQS3
M"S$\<5E%.6MRY2Y-+$H&1S2'--7-+DYJY1;V8*5]6A Y],TX$D].*3>JJ#FA
MS@9]>E0DV4W97'&FL3VIJ;N]29&.:;BX[,49\W0:&R*7@]:0R!>*%*N.*$XR
M!J2V% !Z4[;3<8Q2U=NQ*EW(_P" U\@_\%%/^10\._\ 7U_A7U]_ :^0?^"B
M?_(H>'?^OK_"O9R3_D94_4^;X@_Y%E0^( =K@^E-)*3X_A?K2D?-CMBF1-O?
M#<8Z&OWZUYH_G:*6K/HC]B"[\GXR+; _*8&.*_1@##L:_+#]G3Q4O@KXP:3=
MO($CG(B+'ID]J_4V*02V\;J<[E!K\9XG@UCF^Z/V[@RLI8&45T9*.!]:@9U@
M)8#+&I2?EXJ+A\96OBTK,_0DXV38R.X9F/&U:D>>-3DLOUS7&?%W7[CPQ\.=
M=U*U^6XM[=G0U^:*?&GQ]KEV6AU:\\R=B5B1SZ]!7T&!RN>/BY1=DCY;.<]H
MY=)0M=L_6%F66/*2+GZU&DI&%!#8ZXK\M9?'OQ3TE2]U=:G"F,DL3Q7IGP(_
M:ZU?2/$EII.O2M<VDS!3/(<E3[UU5.'W"#J0FI6Z(\_#<3PKRC"4''U/T :8
MQLFU?D/4^E);W2RR,-P;V%<+\5O&3:+\*]2U[29!,RP[XV0YZBODW]E[XW^)
M_$?Q+DLM4O3/;R/D*6X^E<&'R^>)I3JQ^R>OC<TCA\33I])'W6K^;+MZ 5*3
M^\!7MQ4'/GEONY%+:LQW[@0<\5XJUNV?057=Q2V)IHRQP.IJ$8M_O2*/8FC4
M+Q+2"29G"B-2QSV%?G;\>?VF?%6J>/+W3M O#:V=J^!(K</CTKT\ORVKC9/V
M9X>:9S3RV*4S]%%N\E4(WD_Q#M4L"E,HS9.:^7_V//CU>_$JWO-*UDA;RR "
MR,?]9]*^FXYA+.V!R.M<V.PDL+6]G/='3EV-6.H>VCJBW@ 53+D2D]JLL>.M
M<G\3-8E\/^!=9OK9L7$5NSJ?0UA1?M:GLUU.^O66&HRJOHC?)BNE9-X!SZTU
M'CA 3>B%>Y85^6)^,_Q#\0:G(;;4KIY&D.V"!CDC-65\5?%:WN9KHMK#"/DA
MR=H]Z^O?#DJ<5*<TKGP=+BKVU.T*;E8_4T?,Y*D'CUI57*AFP&'X5^<GPP_:
M[\8>'==MH=<E%UICR"-Y,\KSCFOH#]K+XQZEX?\ A=H^H>';KRQJ1&94/(!'
M:O,Q.2UZ-2$)/26QZM#B&AB*,ZC6L3Z<>95PVX<\=:1I$BB.XCYN0":^/_V*
M?BYKWC/4;_1]6N&O/(A\P/*<FO'_ (W?'KQ;J_Q&U?3[34IK"WL)C$%B;&<5
M='):M2M*A?5*[(J\1T:>#CBK;NQ^CT#JJDA@OU8&I6*3C <9]C7Y71>+/BO=
M(DT<^L/"_*2*QPU:&D_M!_$KX?ZC E[-<$[@3'<DY85Z/^K5;E]R:;['G4^+
M:4I)S@TNY^G1,BL$]>]3+*(D^=ES]:\>\"?&^W^('PRGUF"11J$%N3/"I^:-
ML=Z^#?$7QL\;>(_$US#9:Q>HZW#JL*.<D9KS,#D5?$U90;LUW/5QW$E##TE4
MC&Z9^IZR1 E000><EA4C,J+NW@^@S7Y8KXG^*EL))!<:PQ(^7).,UU/PJ\=_
M%Z3X@:/:7*7]S9M*IF#Y^5>Y-=V(R"6'3DZB.#"\3K$:>R9^DJOYJG>0@[<T
MUGCC3(<-_P "KXI_;%^+OBGPOXATS3-'NWM$EBW.R-@]*\%M/''Q/UJQD-O=
MZK<Q9_UT#$BIP^05J]-5')),*_%=&G-TX0N^Q^IGVB(G8DJEAUYJ<%'[XQW'
M>OROF^*OQ3\'B)[BXN[>*,@[[HG+U]@_LP?M(1_%&R_L[5&6'5H5 *L>6KGQ
MN1SPD.=2NO(Z,!Q$L74Y)1L?2JGCVI>*@5P5 )YI^XU\PW*+L?9Q:DKH3^!J
M^0?^"BG_ "*'AW_KZ/\ 2OK[^!J^0?\ @HI_R*/AW_KZKW\D_P"1E3]3YGB#
M_D65/0^'V//X4Q1DCO3R,G\*?;*#DFOW[:1_.K]V#D2VEX+#5-/N^@MIEE_(
MU^LOPB\5+XS^'^D:JI!,L('Y#%?D?<*)-ZYZC%?='["WQ/75O#<_AV>4*]@=
ML2L>6'M7Y_Q5@G*"K1Z'Z!PCCEA:OLI?:/KK@*?4TG"*!ZTS!W9I6.%&>.:_
M(5)MN)^X.T8W/.?VAA_Q:+Q%_P!>S5^<W[/217OQ-T>*X&]?.&%(XZU^C/[0
MO/PC\1<X'V5J_.C]G%3/\4M&P NV8?CS7Z3D%2,,OK*6_P#P#\HXAA&>:T6U
M='Z?WW@O0+^%8[K2X)U91D,@QTK\^OVM/A99?#WX@)=:?&MG:W_[R*%. "/2
MOTA 9P@SQM%?#7_!0.ZM;OQ7X9B5_GMXV\P]A7C\.XB4L<H:M:W/=XFPU".6
M2J17*U:QT?@7QG+XB_93U:*63S;FUC*L"<G%>'?LFLD_Q<M5C7:?,YKT'X'Z
M9-:_L^^,M2)+6MRFV//0\=JX#]D5-OQIM5(P?,SBOHW*GAEC(4EHSY14WB*F
M#55ZGZ9)& J[^2*:1DXSUZ&B=R)0HY]:5PIVKTYZU^72<5[Q^Q0M;E?0\;_:
M;^(A^'OPMU.XB_X_)<P)GJ0>]?#WP4^%4WQ575M1\PR_84>24>_6O2/VYOB#
M-XB\96FB6,X-G:*5N4S_ !5%^S=\:O OPD\-:I;:B[QW-Z")65<@\8K].P.&
MQ&799[6G'WIGX_FF*HYAFO)5?N1/._V?O&4_@?XT6"B0)8M<-%*"<=\5^H=C
M/'<1+-" 5E4-GZU^17C+4M+OO&EUJ.@R-%;K/YRGIWR:_3?]G_QI'X[^&&E:
ME&=Q"")CWRHQ7!Q-1O1HXMK6UF>MPKBDZ]7"TW[M[H]&^7IT-<+\:D'_  J_
MQ$W (M'Z_2NTE5]P(KB/C?S\*_$6X9 M'./PKXK!6>)IM=U^9]SCY*6&J*:T
MLS\\OV5I)+_XOV*2VX>,$C)''4U^EU[HFDQV+J]E 5D3#Y4<C'-?DIX0O-;B
MU2VF\,SR07ZEL>4,GK7ILWBOXYW"212W^ILC#;CRSR*_3.(\'*=>G)5+*Q^5
M9-F-/"T)TZ5)R;ZG-_M!V>D6'Q@U6TT?$.G1N&$4?W"V:],^,MY<W?[.'@HW
MJ>7+Y^U%/]WM7,_#S]F?QQ\1?$4-SJ=LT-O'())YILAGYS7LO[:OA^#PW\.O
M"6FQJ%2W<( /4"M:F)HXBKA<-"5W%_H<RPU>AA:]><;)G._\$_4!^(.NC_IU
MKP?XF.(_C5XD4C*_;VR/QKWK_@GZ<?$37O\ KUKP/XJQ&3XO^+'7J+UL8^M=
M&%@ZF<5Z:_E1>,Y89'0EUYF?I-\)](LF^&FAN;%+AF@4@;02*^>/VX])TC2H
M=*>"W@@U.5<CH"!7AVB>+?C+;Z1;C2]1U&'3E&V$(A(QVJO)\./BQ\8M:B35
MDN;^>([1-<J5 4UXM#!U,!C?;3K*R?<]"IF-/,,!]4I89\]M['?_ +)4D[>'
M/'<2MD30'+$^U>4_!J2UL?CEI;WK1I:"^<7$ET<*!FOM7P1\$[/X,_"+4@W[
MS49;=C-)W!QTKX)T+0+KQQXT.@V0$U_?W;I$6.W!S7KX&M1QM3$R4N5.^OZG
MFXVEB,)AL/0E&\M-#]/X_$WP\ !;4M)V]LR+BMG0-4\(ZA>EM&N=/GNBN&%N
MREL?A7P7-^PY\06B$6$.._GG_&O8?V9_V7O%7PK\8/JNK7!$!CVB,2%AFOC<
M;@\-1I\T,5SOL?9X+'XIS4'A.5=['E'[>4K6/Q)L,/N+PD*@[5[]^QAI%O/\
M-/\ 2[=78G.' YKP']O*-1\3=*+)\XBZUP'@/4/BNEOGPSJ%W%IX&1Y*DK7U
M<J#Q63THPGRL^2CB:6$S:I4E2YO(^T_VJO#^AM\*=5N);.!;F-/W)( 93[5\
M4_LQR7%C\;_#GV21Y?/EVS@=%7WK"\:_$'QUKET=+\1:Q<N$;;+#+P?Q%?7O
M[&WP&LO#MD?%=UY=S-<J#"W7;]*Y9T5E>6S6(ES.6QI1JO-<TC+#1Y4MSZP4
M(K 'K4V*@9TB.6Y)J=9 0#FORU1G-79^QQE"'NH;C"&OD'_@HI_R*'AW_KZ/
M]*^OOX#FOD'_ (**?\BAX=_Z^O\ "OH,D_Y&-/U/G.(-,LJ>A\/L"#^%+&^Q
M:=&-TJCM3)QME(K]\EH[G\Z)<[Y!G#-\WW<\UV_PB^(K?"GQS8:V%:2,2"-(
M >"I/)-<5$,L.,U(FWS9'<98# S_  URXNC'%T7"1U4*\L-64X_9/V \*>)K
M7Q3H5K?VLRS1SQA]RG."1TK35A*N">0:_/3]DS]H)_A[K"Z)K]TSZ1>/M@9S
MGRC7Z#6\\,MO'/"XDBE4.K*<@@]*_"<QP$\#B.5K1G]"93F*S#"J3W.$_:%P
MOP?\2$J7 M6X%?F1\(_%B>!_%UGK]S&LJ0'A">1@U^M&MV%KK6FW&F7R>9;7
M*%&!'8UX%>?L/^!I+F640NJR-NVAN!7MY'F>%PL9TL1LSP>(,JQF(JTZV%W1
MR%Q_P4!TZVLO,ATH3.HX7=7R_P"+O&FN?M ^/Y;A;65DNY J0*I(C!/K7V4W
M[$_@1=N4*QKU&>M>H> /@EX/^'J0RZ3IL9EQ_K64&NB&98#+W*I@H^\SA659
MMF4/8XYV@FCSJ[^'G_"N?V7+G1G3;)%!O..H)KXN^$'Q#MOA9XYBUJ;%T _+
M'M7ZD:UIMMK-A/87R">UG7:R8[5X%??L/^"+V]DD1659'+[,],UCE.:X:BZJ
MQNJF=F:Y+B:M6B\&U^[.8;]O[P^PDQ9?.!QSUKM?AM^UMHGQ"%_#'$(;FUMS
M<% >H K.?]AKP.5*^7M/K73> /V6/"'@"[N9;:U:2YN8C"TF>-A[5SU)91*F
M_97YKET(9S&?[]KE9\&>))Y/BO\ &"^^RJ[2ZC=\!>=J9YKZ8MOV ]-GLXI)
M-:<^8@;R]O0XKU[P!^R_X8^'WC*?Q!8JLEP<[8V&=N:]HC^[P,>WI6^99_.M
M"G3P[M&*0\MX9474GBM7(_/+X_?LG+\*_!"ZU8W[W @.)OEZBO3_ /@GWX^.
MHZ1J/AD',=FHF!^M?4?C/P;8^._#=[HVHH)8+E<,,?E7#_!#]G[0_@T]]+IR
M_P"EW)Q(Q_N]A7/5S=8G+I4*VLKZ&N'R.>!S*-;#Z0MJ>L1DOS7$?&W/_"KO
M$8'WOL;X_*NV+[&"CI67K]K:ZUI]SIMVN8;A#&W'8U\Q1J.G4A*7<^OQ5-XB
MC4IPW:9^8_[*@C/Q=T^W3$Y9B74C(')K]08[" NH^S0A-HQ\@KQ?X8?LO>&?
MA=XINM>M?FN)"=@/\.:]I5MS(ZDY'&*]O.LRABJT7%O8^:R'+JN HRC7@M23
MRXXL>5&J?[HQ7R=_P4(*KX-\/,0=QN#R.U?6N]7.T<-ZUPOQ;^&&E_%7PZ=*
MU)0S1\H^/NFN' XGZMBJ=5]#V,TP\,5@9TH+<^1/^"?T@E^(6O-#ED^QX+=L
MUX5\2+KR/C#XEC<%9FU!L CJ,U^C'P2^!6A_!NTE_L]-US.-KR8Y(KF_&W[)
MWACQ;XP7Q$4$,XD\R10/O&OIX9TJ.+JXB.\E9'QE?(JM; T**^RVSO/@_I=K
M+\-- :2VCW&W7(*"NT%O%;YVQ1QCMM4 U4TRPBTFPL[&V7;#%&%4"KQ4+A7S
MDU\/7JSJN524GO<^^P^&CAZ45"*O8Y/XGEG\"ZPR1[LPMQZ\5^7W@/Q3#X$^
M*]AK]ZH'V"\=RF?>OUFO["'4+.6TE7,#J5(]<U\^:K^Q5X*UC5;F[DC;]\Q8
MC/0FOJ\FQV&H4)PQ%_>1\GGN4UL5.%:C+WT<N_\ P4"T02R(-/RRC(.[K6KX
M/_;HT#Q5KEGI9A\NZN7$:C/0FK$?["_@Z"1Y,;RPP/:M'PU^Q?X(\/ZU:ZK'
M 3=VKB13[BG.>40HMQBW(6'6<.HH5F?.O[=,YF^(.GSRGRE-L0&/?(KZ%_8L
MMD7X51*8DG)Y#LM=7\:/V=M!^,@M)+_]RUN-H(ZXKLOAWX!TWX:^'[?1=/XC
MC&,TL5FE*OEU.A#1HQR_*,3ALRJ5ZJ4DSY8_;4^ XB@D\;Z7!AU'^EQQCKZ5
M'^P[\;PR#P3J,C-(IW6^?X<]J^P];\/V_B/2+O2[^,36TZE2&&:\H^%_[+GA
MWX;^);G6K==]V[%E;'W:5+,Z6)P#P^*U:V-IY34PN8K$8564MSVQHDE& ?F'
M6GA" !3HXP2&/6G&3!QBODU4<%:1]K*E&3NB*>/><$D+7RE^WWHTVK^$M"2)
M"_EW&>*^L'PR8/>N8\;^!;+QM:Q17J!XX02H/KBO0P%94*\:CZ'F9MAWB\+*
MBC\CYH3;3-$QX0=?>H3,6[5UOQ?\$WOP_P#B!JFEWBE%EG:6'/\ =[5R;6[@
M^U?OV$Q%/&45),_G/$X=82JX5-&,W'_]5)G/X]?>G-&R]J;73*,HKW3CM&3T
M8;2=I!PRG*GT-?47[-G[4][X-EAT'Q5<&XL'PL5PYSY0]Z^7<XJ281RQJT@;
M;VC_ (L^M>1C,#2S"#C66I[& S#%9?-.E+0_8/0O$MCXCLHKRQECN[>0?+*A
MR*U=ZRG:K L.HK\L/A+^T!XM^$EUML;DWNGOPT$IR$'M7U_\,_VT?"OBT1VV
MI@Z3=?=9Y^%8U^39AD&(P\FX1NC]CR[B;!UH*%6=I'T9+$C'YX\_2IH_+2,*
M%P/2L[1]:L_$%DMSIUY'=0-R'1LBM2-/E&[K7SKBJ>C6I]=&HZL5*,KH-B-V
MIP11R ,T=.U+D'VK%\KT9JDT&Q3U%*J#K@9I&R*6,Y%6H1CL'-=V8>6H.0 *
M<%'I2T4RQ-H':C: <XYI:*5@&[!G.*:T2.>5'Y5)13!:;$9A4_P@_44HC4=
M*?12:3=V S8H.<4-&I_A!I]%,5D-"*!]T4;%QT%.HH"PW8O' XI2H/49I:*3
M5]QC=@/:D$:_W<4^BBVEA66XW:!V%(% /W13Z*?D WRU/51BD\I"<[1GZ4^B
ME88FT>@HVCT%+10E8!OX4NT'M2T4-7 @D0D#%*?E49Z=Z"^%SFFE\1\\YJ)>
M[*Y-E9R/GS]I_P#9VM_BMIQU.S 35[9,QL!RV.U? 'BGPIXB\$WK6VJZ>]N
M<&61<+7[ ,JB,<9)Z"N;\4?#WP]XX@:VUC2X;P$8^=>GXU];EN>5, N1ZH^$
MS7AFGF,_:K1GY%+>1#_5J\K=VQ\M&8G.>17WOXA_8*\+ZMJ,DUIJMSI\+'/V
M>(?**R/^'=GAS_H8;W\O_KU]M1XLP\5[Q\+7X/Q2E^Z/B PQG^*FO$%<N6);
MUK[A_P"'=_AP?\S'>#_/UIX_X)V>&S_S,=[^7_UZVEQ7@9ZS_(PCPAF3W7XG
MPPKJA^4D9]*<+7[3@M@MV)[5]RG_ ()U>&Q_S,5[GZ?_ %Z:W_!._P /,,+X
MBO1COC_Z]3/BO!5%RN.GH7/A+,HV<8Z^I\G>$_B;XR\$@+8:S<+:KTA#\5ZO
MHG[<?CCP];K$UG%J*^K\M7K:?\$\= C^]XGO<>F/_KU#)_P3UT/>3#XFO8R?
MX@/_ *]>4\?D-=MU5J_(]2AEG$&$2Y7IZECX0_MNGQ[XGMM!U+3S9WEP<+@8
M%?6MK<"5%/J*^</AI^Q9X?\ AUXHMM>;5Y]2N[<Y7SAQ7T99Q;$ . >P%?$9
MC4P,JG^R;'Z'ED,?&/\ M189\4Z-MPSC%-<#O2Q8QP<UXMF?277S)**3'-+5
M@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
MPQ@@#'%!B!&,4^BAZAY#=@QC%+M [4M%*P"8'I36C![4^BF! ;5#R5J01*O2
MGT4FD]P&>6OI2[%':G446 C:%6ZBD-LA&,<5+14\B @>SCD7!&13UA1  !]*
MDHH4(K8=QK(&'-"H$Z4ZBK)MU$QSFEHHH&%%%% !1110 4444 %%%% !1110
; 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>grassi.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 grassi.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !  ),# 2(  A$! Q$!_\0
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MY[N95_A,ABPJD@9QS]3BO9/V4_VRQ\>==O\ PKXAT1/#WBJTB:=$A=C%<(I
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BDO>JM-=E9W.M8&4:M"47I337KI8[6BBBO"/7"BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>grassi_sig.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 grassi_sig.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  \ 2P# 2(  A$! Q$!_\0
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M +"J?$CQ'^VMXA\3^/M;N+O6+SPC'J>HZ<'*PV(NI%:VM@F<#;&%. .,GW-
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M7PJ_;#^%/QK\4:=X=\'>)/[6UF]T^74A:"VD1X(HY!&XF#*/+<,?NM@D<]*
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M5KP/H5QX7\%Z!HUW=&]NM.T^WM);D_\ +9XXU1G_ !()_&O'_P!D?]FGX?\
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MQ_"OF_\ :,^ .D?LW_L=?#M]/$:>.O"NLZ4=,U.-<7!O)+A3,JX)W;R7R.A
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MUWPKHOBA(DUG1[#5DB),:WUJDP0G&<;@<=!^57;&PMM+LX;2SMXK2UA4)%!
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M!FOI_P "_M>_"7QWX&LO$]IXWT>WLY8%EECNKM(I+=B/F216(*D'(/TKD/\
M@GW\#=7^"/[->E:9XGM?L_B35YIM6U*UD3#Q/,V1&_\ M!< _B.U6O$/_!/+
M]G_Q3XJE\07_ ,.=.^V2R>;)%:O+! ['DEHD<*<GT SDT 8V@_M]^$OB'\?-
M ^&WP^T^Y\:070F_M/Q!89^QV&U"4PV,."1@G( R,9KSK]A?SOBO^U+^T5\5
M]1B+20ZHGAFP,B@B**#(=5/TCCS]?>OL7P%\,?"7PNTD:9X1\.:9X<L,Y,&F
MVRPJ3G/.!S^-:>@>%M'\*PW46C:79Z5'=7#W=PMG"L0EF<Y>1L 98GJ3S0!\
MD?MQVOBCXX?$SX:_L^Z-'?6'AGQ*[ZOXJU:&-E0Z?;N#Y"R8QDD9(]?*[$BO
MIAO@YX*;PY_8G_",:4+'[)]B ^QQ[Q'LV?>VYSCOUKLZ* /SA_97_:$U3]G'
MX,?%[X82>&-0\8^*?A-J-P\&DVIV/=:;)<X$JG!.$#LY !.TBM+Q[>_LM>+_
M (*ZA\6O".J:=X!\;):M>VDOAN]^R:E#J>W<D#6RD"1_-PI!3!Y[&OM+3/@G
MX.T?XN:O\3+/25@\8ZK8QZ=>7ZNV)8D(VY7.-V%4%L9PH%9[?LV?"H^-#XO/
MP]\._P#"2%Q,=2.GQ^:'!R'SC ;/\77WH \;_: _::\;_ K]GGX3^*Y=+L)/
M%.O:CI.GZOI]\K;LS1;IUC"XP^5(YX&>AQBOJUF5%+,0J@9))X K\Q?B;\;9
MOV__ -KGP#\-/ -L\OP]\$ZPFO:IKWEM^_>'JV"!L3.Z-<\L7SV K]-;RTAU
M"TGM;B-9K>=&BDC;HRD8(/U!H ^&_P!A'1_^%W?'SXS?M%WXD>'4=3D\.>'A
M)R%LH=@9QP.H2(<?[8KZZ^+VM>*_#OPS\1ZEX'T2'Q'XMMK1GTW2YY1&EQ+Q
M@$DCH,G&1G&,C-/^%GPI\*_!;P9:>%/!FDQZ+H-JSO%:1N[X9V+.Q9R6)))/
M)KK: /@_]J?4M<MO%_['&M_$B"VL)8_$*MKT<&/LL&HO#$47))& X?!R> >:
M^[SG''6N ^.?P0\,?M"_#J_\&^++>273KDK+'/;OLGMIE.4EC;LP/Y@D'K7S
M$OP+_;#\ P6WAWPC\9_#FO\ ANW'E6^H>(M-_P!/BBS@;SL;>P'JQH ^I/B?
M\8-!^%W@3Q9XGNG?5D\-6WVB^T[2R)[I<@;4,8.5+9&-V!CGH":G^#WQ,M/C
M)\-/#_C2PT^]TJTUBW^T1V>HQ>7/$-Q&&'X9![C![UY7^RC^RI=?L_2>+M?\
M2>+KKQQXX\77"7&L:I,GEQ,4W!51,G^\>3[ 8 KZ&H **** ,WQ#-K$&ER/H
M5I8WVHAEV0ZC=/;0D9YRZ1R$''3Y3GVKDO[5^*7_ $+'A#_PH[K_ .0*[^B@
M#@/[5^*7_0L>$/\ PH[K_P"0*/[5^*7_ $+'A#_PH[K_ .0*[^B@#@/[5^*7
M_0L>$/\ PH[K_P"0*/[5^*7_ $+'A#_PH[K_ .0*[^B@#@/[5^*7_0L>$/\
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MHE_L_=C''7I7LU% ' ?VK\4O^A8\(?\ A1W7_P @4?VK\4O^A8\(?^%'=?\
MR!7?T4 <!_:OQ2_Z%CPA_P"%'=?_ "!1_:OQ2_Z%CPA_X4=U_P#(%=_10!P'
M]J_%+_H6/"'_ (4=U_\ (%']J_%+_H6/"'_A1W7_ ,@5W]% ' ?VK\4O^A8\
M(?\ A1W7_P @5%=W?Q-OK6:VG\+>$'AF1HW7_A)+L94C!&189'!KT2B@#YU^
M!/P(U;]F_P -7.B>!? /A'3[>ZN&N;FXN/$]W-<3N?[\AL,D#H!T'YUZ7_:O
MQ2_Z%CPA_P"%'=?_ "!7?T4 <!_:OQ2_Z%CPA_X4=U_\@4?VK\4O^A8\(?\
MA1W7_P @5W]% ' ?VK\4O^A8\(?^%'=?_(%']J_%+_H6/"'_ (4=U_\ (%=_
M10!P']J_%+_H6/"'_A1W7_R!73^&+C7[FQD;Q%8:;I]X)"$CTR]DNHRF!@EG
2AB(.<\;3VYK8HH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>May 11, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001840416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Sono Group N.V.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>May 11, 2026 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Ordinary Shares, nominal value EUR0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Preferred Shares, nominal value EUR300.00 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=3', window );">Offering: 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Debt Securities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=4', window );">Offering: 4</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Warrants<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=5', window );">Offering: 5</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Rights<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=6', window );">Offering: 6</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Units<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=7', window );">Offering: 7</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Unallocated (Universal) Shelf<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 100,000,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 13,810.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">(1)	Except where a value is indicated, the Amount Registered and Proposed Maximum Offering Price Per Unit are omitted as to each class of security pursuant to Instructions 2.A.ii.b. and 2.A.iii.b. to Item 16(b) of Form S-3.
(2)	The securities registered hereunder include such indeterminate number of (a) shares of Ordinary Shares, (b) shares of Preferred Shares, (c) debt securities, (d) warrants, (e) rights and (f) units as may be sold from time to time by the registrant. There are also being registered hereunder an indeterminate number of shares of Ordinary Shares and Preferred Shares as shall be issuable upon conversion, exchange or exercise of any securities that provide for such issuance.
(3)	Pursuant to Rule 416 under the Securities Act, this registration statement also covers any additional shares of the registrant's securities that become issuable by reason of any share splits, share dividends or similar transactions.
(4)	The Registrant does not have any fee offsets.

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457oFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection o<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457oFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=6">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=6</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=7">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=7</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>May 11, 2026 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 100,000,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">13,810.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 13,810.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>8</ContextCount>
  <ElementCount>21</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>2</UnitCount>
  <MyReports>
    <Report instance="exh_107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="exh_107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="exh_107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="exh_107.htm">exh_107.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://xbrl.sec.gov/dei/2026</BaseTaxonomy>
    <BaseTaxonomy items="43">http://xbrl.sec.gov/ffd/2026</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "exh_107.htm": {
   "dts": {
    "inline": {
     "local": [
      "exh_107.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2026/dei-2026.xsd",
      "https://xbrl.sec.gov/ffd/2026/ffd-2026.xsd"
     ]
    }
   },
   "keyStandard": 21,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 14,
    "http://xbrl.sec.gov/dei/2026": 2,
    "http://xbrl.sec.gov/ffd/2026": 12
   },
   "contextCount": 8,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 2,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2026": 43,
    "http://xbrl.sec.gov/dei/2026": 3
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:Rule457oFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exh_107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:Rule457oFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exh_107.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exh_107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exh_107.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal8ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001171843-26-003312-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001171843-26-003312-xbrl.zip
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M.(X!\L"#LSKR2M<KU??BCC, R:D+>ABJ]H,HSH1PVV"@S+JQ*>EI:P2GCV0
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M][S!-^5.TK/Z6)A&__]02P$"% ,4    "  #A*Q<!P60@*D.  #5J@  "P
M            @ $     97AH7S$P-RYH=&U02P4&      $  0 Y    T@X
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>exh_107_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2026/ffd-2026.xsd"
      xlink:type="simple"/>
    <context id="rc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840416</identifier>
        </entity>
        <period>
            <startDate>2026-05-11</startDate>
            <endDate>2026-05-11</endDate>
        </period>
    </context>
    <context id="offrl_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840416</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-11</startDate>
            <endDate>2026-05-11</endDate>
        </period>
    </context>
    <context id="offrl_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840416</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-11</startDate>
            <endDate>2026-05-11</endDate>
        </period>
    </context>
    <context id="offrl_3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840416</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>3</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-11</startDate>
            <endDate>2026-05-11</endDate>
        </period>
    </context>
    <context id="offrl_4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840416</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>4</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-11</startDate>
            <endDate>2026-05-11</endDate>
        </period>
    </context>
    <context id="offrl_5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840416</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>5</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-11</startDate>
            <endDate>2026-05-11</endDate>
        </period>
    </context>
    <context id="offrl_6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840416</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>6</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-11</startDate>
            <endDate>2026-05-11</endDate>
        </period>
    </context>
    <context id="offrl_7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840416</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>7</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-11</startDate>
            <endDate>2026-05-11</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <ffd:FormTp contextRef="rc" id="ixv-426">S-3</ffd:FormTp>
    <ffd:SubmissnTp contextRef="rc" id="ixv-427">S-3</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="rc" id="ixv-428">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="rc" id="ixv-429">0001840416</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-430">Sono Group N.V.</dei:EntityRegistrantName>
    <ffd:OfferingTableNa contextRef="rc" id="hiddenrcOfferingTableNa" xsi:nil="true"/>
    <ffd:OffsetTableNa contextRef="rc" id="hiddenrcOffsetTableNa">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="rc" id="hiddenrcCombinedProspectusTableNa">N/A</ffd:CombinedProspectusTableNa>
    <ffd:FeeRate
      contextRef="offrl_1"
      decimals="7"
      id="ixv-434"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeRate
      contextRef="offrl_2"
      decimals="7"
      id="ixv-435"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeRate
      contextRef="offrl_3"
      decimals="7"
      id="ixv-436"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeRate
      contextRef="offrl_4"
      decimals="7"
      id="ixv-437"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeRate
      contextRef="offrl_5"
      decimals="7"
      id="ixv-438"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeRate
      contextRef="offrl_6"
      decimals="7"
      id="ixv-439"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FormTp contextRef="rc" id="ixv-518">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-519">Sono Group N.V.</dei:EntityRegistrantName>
    <ffd:OfferingSctyTp contextRef="offrl_1" id="ixv-520">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_1" id="ixv-521">Ordinary Shares, nominal value EUR0.01 per share</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_1" id="ixv-522">true</ffd:Rule457oFlg>
    <ffd:OfferingSctyTp contextRef="offrl_2" id="ixv-523">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_2" id="ixv-524">Preferred Shares, nominal value EUR300.00 per share</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_2" id="ixv-525">true</ffd:Rule457oFlg>
    <ffd:OfferingSctyTp contextRef="offrl_3" id="ixv-526">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_3" id="ixv-527">Debt Securities</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_3" id="ixv-528">true</ffd:Rule457oFlg>
    <ffd:OfferingSctyTp contextRef="offrl_4" id="ixv-529">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_4" id="ixv-530">Warrants</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_4" id="ixv-531">true</ffd:Rule457oFlg>
    <ffd:OfferingSctyTp contextRef="offrl_5" id="ixv-532">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_5" id="ixv-533">Rights</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_5" id="ixv-534">true</ffd:Rule457oFlg>
    <ffd:OfferingSctyTp contextRef="offrl_6" id="ixv-535">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_6" id="ixv-536">Units</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_6" id="ixv-537">true</ffd:Rule457oFlg>
    <ffd:PrevslyPdFlg contextRef="offrl_7" id="ixv-538">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="offrl_7" id="ixv-539">Unallocated (Universal) Shelf</ffd:OfferingSctyTp>
    <ffd:Rule457oFlg contextRef="offrl_7" id="ixv-540">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_7"
      decimals="2"
      id="ixv-541"
      unitRef="USD">100000000.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="offrl_7"
      decimals="7"
      id="ixv-542"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="offrl_7"
      decimals="2"
      id="ixv-543"
      unitRef="USD">13810.00</ffd:FeeAmt>
    <ffd:TtlOfferingAmt contextRef="rc" decimals="2" id="ixv-544" unitRef="USD">100000000.00</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt contextRef="rc" decimals="2" id="ixv-545" unitRef="USD">13810.00</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt contextRef="rc" decimals="2" id="ixv-546" unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt contextRef="rc" decimals="2" id="ixv-547" unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt contextRef="rc" decimals="2" id="ixv-548" unitRef="USD">13810.00</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="offrl_7" id="ixv-549">(1)	Except where a value is indicated, the Amount Registered and Proposed Maximum Offering Price Per Unit are omitted as to each class of security pursuant to Instructions 2.A.ii.b. and 2.A.iii.b. to Item 16(b) of Form S-3.
(2)	The securities registered hereunder include such indeterminate number of (a) shares of Ordinary Shares, (b) shares of Preferred Shares, (c) debt securities, (d) warrants, (e) rights and (f) units as may be sold from time to time by the registrant. There are also being registered hereunder an indeterminate number of shares of Ordinary Shares and Preferred Shares as shall be issuable upon conversion, exchange or exercise of any securities that provide for such issuance.
(3)	Pursuant to Rule 416 under the Securities Act, this registration statement also covers any additional shares of the registrant's securities that become issuable by reason of any share splits, share dividends or similar transactions.
(4)	The Registrant does not have any fee offsets.

</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
